captopril has been researched along with Cardiac Failure in 1015 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 491 (48.37) | 18.7374 |
| 1990's | 342 (33.69) | 18.2507 |
| 2000's | 147 (14.48) | 29.6817 |
| 2010's | 30 (2.96) | 24.3611 |
| 2020's | 5 (0.49) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, Y; Ishikawa, M; Ito, A; Kiyomoto, K; Matsuo, I; Mitsubayashi, T; Morii, A; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Suita, K; Tomonari, H; Tsunoda, M | 1 |
| Amitani, Y; Gomi, K; Hayakawa, Y; Ishikawa, M; Ito, A; Kiyomoto, K; Matsuo, I; Morii, A; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Suita, K; Tsunoda, M | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM | 1 |
| Ade, CJ; Baumfalk, DR; Butenas, ALE; Colburn, TD; Copp, SW; Hageman, KS; Musch, TI; Poole, DC | 1 |
| Alali, AS; AlAsmari, AF; Alasmari, F; Ali, M; Ali, N; Ali, S; Alqahtani, F; Asiri, AM; Imran, I; Khalid, R; Khalid, S; Majeed, A; Rasool, MF; Saeed, H; Usman, M | 1 |
| Amar, M; Faulkenberg, K; Lam, SW; Perez, A; Tang, WHW; Williams, JB | 1 |
| Azevedo, ER; Floras, JS; Mak, S; Parker, JD | 1 |
| Li, J; Passantino, A; Pugliese, M; Wang, L; Wang, X; Zhang, J; Zhang, K | 1 |
| Bastacky, SI; Jackson, EK; Salah, EM; Tofovic, SP | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Omboni, S; Vinereanu, D | 1 |
| Akalın, F; Erolu, E; Saylan Çevik, B; Yücelten, D | 1 |
| Fan, X; Kou, J; Li, F; Yang, W; Yu, B; Zhang, L; Zhang, Y | 1 |
| Borghi, C; Cicero, AF; Cosentino, ER; Rinaldi, ER | 1 |
| Helal, F; Lane, ME | 1 |
| Califf, RM; Kober, L; Lewis, EF; Li, Y; Pfeffer, MA; Reed, SD; Rouleau, JL; Schulman, KA; Solomon, SD; Velazquez, EJ; Weinfurt, KP; White, HD | 1 |
| Chai, X; Han, J; Li, C; Qiu, Q; Shi, T; Wang, W; Wang, Y; Wu, Y | 1 |
| Califf, R; Claggett, B; Køber, L; Lam, CS; Lewis, E; Liu, J; McEntegart, M; McMurray, JJ; Pfeffer, M; Rouleau, J; Skali, H; Solomon, S; Velazquez, E | 1 |
| Agha, HM; Hamza, H; Mostafa, FA; Zakaria, R | 1 |
| Hagendorff, A; Hawlitschek, C; Rabald, S; Rassler, B; Zimmer, HG; Zimmer, J | 1 |
| Chen, C; Chen, H; Chen, YZ; Lin, XM; Qiu, SD; Zou, XG | 1 |
| Hongyuan, B; Jingwen, Z; Li, G; Xin, D; Yajuan, N | 1 |
| Balasingam, M; George, K; Kantor, PF; Manlhiot, C; McCrindle, BW; Roche, SL; Timberlake, K; Wilson, J | 1 |
| Ang, CY; Korzh, V; Li, M; Li, P; Tan, SY; Teh, C; Zhao, Y | 1 |
| Baenziger, O; Bauersfeld, U; Bernet, V; Frey, B; Gantenbein, MH; Neuhaus, T; Sennhauser, F | 1 |
| Bosomworth, J | 1 |
| Ambrosioni, E; Borghi, C; Cicero, AF | 1 |
| Bing, OH; Brooks, WW; Colucci, WS; Conrad, CH; Robinson, KG | 1 |
| Bocchi, EA; Carvalho, VO; Guimarães, GV | 1 |
| Anker, SD; Belonje, AM; Dickstein, K; Ponikowski, P; van Veldhuisen, DJ; von Haehling, S; Voors, AA; Westenbrink, BD | 1 |
| Esmaeilzadeh, A; Jaberi, Y; Khani, M; Moosaeefard, M; Shafaqatian, M; Sheikhi, A | 1 |
| Brozovich, FV; Ogut, O | 1 |
| Ararat, E; Brozovich, FV | 1 |
| Dai, YL; Su, D; Wu, DZ; Yan, HR; Zhang, BB | 1 |
| Krum, H | 1 |
| Apps, A; Orchard, EA; Wilson, N | 1 |
| Bing, OH; Brooks, WW; Conrad, CH; Deng, LL; Goldstein, RH; Shen, S | 1 |
| Alosh, M; Huque, MF | 1 |
| Califf, R; Kober, L; Maggioni, A; McMurray, JJ; Pfeffer, MA; Rouleau, J; Signorovitch, JE; Solomon, SD; Swedberg, K; Thune, JJ; Velazquez, E | 1 |
| Carr, MR; Chang, AC; Du, LZ; Kuzin, JK; Moffett, BS; Tan, LH | 1 |
| Abuladze, GV; Erkomaishvili, IG; Narsiia, EV; Nebieridze, MI; Pipiia, NG | 1 |
| Blaich, A; Domes, K; Hofmann, F; Lenhardt, P; Lipp, P; Moosmang, S; Oberhofer, M; Pahlavan, S; Poomvanicha, M; Ruppenthal, S; Scholz, A; Tian, Q; Wegener, JW | 1 |
| Ambrosio, G; Ambrosioni, E; Borghi, C; Novo, S; Vinereanu, D | 1 |
| Creteur, J; De Backer, D; Donadello, K; Favory, R; Ortiz, JA; Rocco, JR; Salgado, DR; Silva, E; Vincent, JL | 1 |
| Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Cao, XB; He, JC; Hu, YH; Ren, Y; Wang, HY; Wang, YF; Zhang, G | 1 |
| Dickinson, BA; Hullinger, TG; Latimer, PA; Lewton, SM; Lynch, JM; Montgomery, RL; Semus, HM; Seto, AG; Stack, C; van Rooij, E | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Spooner, PH | 1 |
| Bicket, DP | 1 |
| Colier, WN; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ; Verheugt, FW | 1 |
| Huang, CM; Young, MS | 1 |
| Hisatome, I; Igawa, O; Kato, M; Kinugawa, T; Ogino, K; Osaki, S; Shigemasa, C; Shimoyama, M; Tomikura, Y | 1 |
| Mareev, VIu | 2 |
| Frick, M; Gouya, G; Hügel, H; Pachinger, O; Pölzl, G; Ulmer, H | 1 |
| Kong, QF; Song, SZ; Xie, XY | 1 |
| Karkishchenko, NN; Makliakov, IuS; Sarbilina, IV | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Esposti, DD | 1 |
| Dickstein, K | 1 |
| Bauer, JA; Ghosh, S; Holycross, BJ; Kambara, A; Kwiatkowski, P; McCune, SA; Schanbacher, B; Wung, P | 1 |
| Da Luz, PL; Pamplona, D; Park, M; Ramires, JA; Silva, SR; Viecili, PR | 1 |
| Li, VV; Suvorova, SS; Timofeeva, NIu; Zadionchenko, VS | 1 |
| Clarke, K; Cole, MA; Hulbert, K; Lygate, CA; Monfared, M; Neubauer, S | 1 |
| Orda, A; Przewłocka-Kosmala, M; Salomon, P | 1 |
| Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH | 1 |
| Califf, RM; Edwards, S; Gallo, P; Henis, M; Kober, L; Leimberger, JD; Maggioni, AP; McMurray, JV; Pfeffer, MA; Rouleau, JL; Sellers, MA; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
| Baran, DA; Galin, I | 1 |
| Deswal, A; Mann, DL | 1 |
| Califf, RM; Edwards, S; Henis, M; Køber, L; Leimberger, JD; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Sellers, MA; Solomon, SD; Swedberg, K; Van de Werf, F; Velazquez, EJ; White, H; Zelenkofske, S | 1 |
| Gensini, GF; Modesti, PA; Vanni, S | 1 |
| Adam, A; Blais, C; Clément, R; Deschepper, CE; Lapointe, N; Parker, TG; Rouleau, D; Rouleau, JL; Slaughter, G; Tsoporis, JN | 1 |
| Pfeffer, M | 1 |
| McAnulty, JH | 1 |
| Liebson, PR | 1 |
| Evdokimova, AG; Kovalenko, EV; Pichugina, TA; Radzevich, AE; Tereshchenko, OI | 1 |
| Piña, IL | 1 |
| Aguilar, D; Belenkov, YN; Califf, RM; Diaz, R; Francis, GS; Henis, M; Køber, L; Leimberger, JD; McMurray, JJ; O'Connor, CM; Pfeffer, MA; Rouleau, JL; Skali, H; Solomon, SD; Varshavsky, S; Velazquez, EJ | 1 |
| Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
| Nguyen, A; Sharma, S | 1 |
| Finn, JI; Koelling, TM; Rangaswamy, C | 1 |
| Aukrust, P; Damås, JK; Dickstein, K; Frøland, SS; Gullestad, L; Kjekshus, J; Otterdal, K; Ueland, T; Yndestad, A | 1 |
| Ba, SA; Dia, AA; Diop, IB; Diouf, SM; Kane, A; Sarr, M | 1 |
| Hartung, DM; Hunt, J; Miller, H; Siemienczuk, J; Touchette, DR | 1 |
| Erhardt, LR | 1 |
| Bos, R; Lechat, P; Médiani, O; Mougenot, N | 1 |
| Borghi, C; de Kam, PJ; Hochman, JS; van den Berg, MP; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Bradstreet, DC; Camm, AJ; Carides, GW; Dasbach, EJ; Dickstein, K; Ikeda, LS; Konstam, MA; Martinez, FA; Neaton, JD; Pitt, B; Poole-Wilson, PA; Riegger, G; Santoro, EP; Segal, R; Sharma, D | 1 |
| Allsbrook, JS; Califf, RM; Masselink, LE; McMurray, JJ; Pfeffer, MA; Radeva, JI; Reed, SD; Schulman, KA; Sellers, MA; Velazquez, EJ; Weinfurt, KP | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Gao, XY; Wang, HJ; Wang, W; Zhang, F; Zhang, Y; Zhu, GQ | 1 |
| Liu, GF; Liu, K; Snavely, DB; Wang, J | 1 |
| Jhund, PS; MacIntrye, IM; McMurray, JJ | 1 |
| August, M; Baldus, S; Daiber, A; Fleming, I; Hink, U; Kleschyov, AL; Materne, A; Mollnau, H; Münzel, T; Nickenig, G; Oelze, M; Schulz, E; Wendt, M; Wenzel, P | 1 |
| Aylward, PE; Barvik, S; Califf, RM; Dalby, AJ; Huang, Z; Marin-Neto, JA; McMurray, JJ; Murin, J; Nordlander, RO; Pfeffer, MA; van Gilst, WH; Weaver, WD; White, HD; Zannad, F | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Aukrust, P; Dickstein, K; Frøland, SS; Gullestad, L; Kjekshus, J; Omland, T; Squire, IB; Ueland, T | 1 |
| Borghi, C; Cosentino, E; De Sanctis, D | 1 |
| Abel, ED; Bisping, E; Buerger, A; Dorfman, AL; Izumo, S; Jay, PY; Pu, WT; Rozhitskaya, O; Sherwood, MC | 1 |
| Brozovich, FV; Chen, FC; Hoit, BD; Ogut, O; Rhee, AY | 1 |
| Anker, SD; Banasiak, W; Cicoira, M; Clark, AL; Coats, AJ; Davos, CH; Haass, M; Pitt, B; Ponikowski, P; Poole-Wilson, PA; Senges, J; Winkler, R; Zardini, P; Zugck, C | 1 |
| Batyraliev, TA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA | 1 |
| Ambrosioni, E; Bacchelli, S; Borghi, C; Degli Esposti, D | 1 |
| Di Sessa, TG; Howard, SC; Salim, MA | 1 |
| Dai, M; He, JR; Wen, QX | 1 |
| Białkowski, J; Dziubek, B; Kalarus, Z; Kukulski, T; Lenarczyk, A; Rycaj, J; Szulik, M | 1 |
| Dilsizian, V; Eckelman, WC; Narula, J; Narula, N; Shirani, J | 1 |
| Brower, GL; Janicki, JS; Levick, SP | 1 |
| Aylward, PG; Califf, RM; Kober, L; McMurray, JJ; Pfeffer, MA; Pieper, KS; Skali, H; Solomon, SD; Stephenson, K; Van de Werf, F; Velazquez, EJ; White, HD | 1 |
| Ott, P | 1 |
| Bu'Lock, F; Mulla, H; Pandya, HC; Samani, N; Tofeig, M | 1 |
| Howlett, JG; Lamond, NW | 1 |
| Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE | 1 |
| Costa-e-Sousa, RH; Marassi, MP; Marinho, A; Martins, OP; Mattos, EC; Olivares, EL; Reis, LC; Trindade, DC; Trindade, RC | 1 |
| Billalabeitia, EG; Carmona-Bayonas, A; Díaz, MP; Gómez, FI; Saura, HP; Soler, IO; Tafalla, MS | 1 |
| Califf, RM; Howlett, J; Kober, L; Maggioni, AP; McMurray, JJ; Pfeffer, MA; Rouleau, JL; Signorovitch, J; Solomon, SD; Thune, JJ; Velazquez, EJ; Zelenkofske, S | 1 |
| Adamson, C; Bahl, JJ; Goldman, S; Greer, K; Hoying, J; Klewer, S; Maitra, N; Morkin, E | 1 |
| Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Al-Khatib, SM; Califf, RM; Kober, L; Lokhnygina, Y; McMurray, JJ; Solomon, SD; Thomas, KL; Velazquez, EJ | 1 |
| Asif, H; Chaudhari, MP; Crossland, DS; Kirk, RC; O'Sullivan, JJ; Roche, SL | 1 |
| Brozovich, FV; Chen, FC | 1 |
| Kageyama, S | 1 |
| Havranek, EP | 1 |
| Califf, RM; Francis, GS; Huang, Z; Lewis, EF; McMurray, JJ; Pfeffer, MA; Prisant, LM; Thomas, KL; Velazquez, EJ; Weaver, WD | 1 |
| Atlas, SA; Case, DB; Cody, RJ; Laragh, JH | 1 |
| Ikram, H | 1 |
| Kolloch, R; Overlack, A; Stumpe, KO | 1 |
| Enghoff, E; Hägg, A; Hedlund, A; Lantz, P | 1 |
| Medina, N; Packer, M; Yushak, M | 6 |
| Ferguson, RK; Rotmensch, HH; Vlasses, PH | 3 |
| Ferguson, RK; Riley, LJ; Vlasses, PH | 2 |
| de Treglode, D; Mimran, A; Ribstein, J | 1 |
| Ball, SG; Cleland, JG; Dargie, HJ; Hodsman, GP; Robertson, JI | 1 |
| Levine, TB | 2 |
| Cleland, JG; Dargie, HJ; Robertson, JI | 1 |
| Davies, RO; Gabriel, MA; Kramsch, DM; McFate Smith, W; Moncloa, F; Rush, JE; Walker, JF | 1 |
| Dollery, CT | 1 |
| Forslund, T; Fyhrquist, F; Grönhagen-Riska, C; Hortling, L; Tikkanen, I | 1 |
| Blaine, EH; Gaul, SL; Reitz, PM; Ribeiro, LT; Sweet, CS | 1 |
| Kulaga, SF; McFate Smith, W; Moncloa, F; Pingeon, R; Walker, JF | 1 |
| Bounhoure, JP; Fauvel, JM; Giraud, P; Kayanakis, JG | 2 |
| Coxon, RJ; Douglas, JE; Long, B; Sharpe, DN | 1 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG | 4 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG; Turner, JG | 1 |
| Fischer, E; Siegenthaler, W | 1 |
| Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, KL | 1 |
| Ader, JL; Bories, P; Durand, D; Emal, V; Girolami, JP; Suc, JM | 1 |
| Frishman, W; Kugler, J; LeJemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
| Koller, H; Prager, H | 1 |
| Reid, JL; Rubin, PC | 1 |
| Riecker, G | 1 |
| Shevchenko, VA | 1 |
| Boichis, H; Grossman, E; Knecht, A; Morag, B; Nussinovitch, N; Rosenthal, T | 1 |
| Banks, DC; Goodfield, MJ; Millard, LG; Morris, GK | 1 |
| Bleifeld, W; Mathey, DG | 1 |
| Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, K | 1 |
| Dipalma, JR | 1 |
| Bodem, G; Ochs, HR | 1 |
| Brunner, H; Charocopos, F; Gavras, H; Gavras, I | 1 |
| Sharpe, DN; Taylor, KM | 1 |
| Hollenberg, NK | 2 |
| Cohn, JN; Levine, TB | 3 |
| Brunner, HR; Turini, GA | 1 |
| Bass, TA; Creager, MA; Faxon, DP; Gavras, H; Halperin, JL; Melidossian, CD; Ryan, TJ | 1 |
| Froer, KL; Hall, D; Rudolf, W | 1 |
| Sullivan, JM | 1 |
| Abraham, AS; Hershko, C; Zimran, A | 1 |
| Assey, ME; Gazes, PC | 1 |
| Bernard, DB; Creager, MA; Faxon, DP; Halperin, JL; Ryan, TJ | 1 |
| Cody, RJ | 2 |
| Kawamura, K; Kubo, S; Nishimura, H; Nishioka, A; Takatsu, T | 2 |
| Materson, BJ | 1 |
| Liebau, G | 2 |
| Solinger, AM | 1 |
| Braunwald, E; Mirsky, I; Pfeffer, JM; Pfeffer, MA | 2 |
| Rosendorff, C | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Romankiewicz, JA; Speight, TM | 1 |
| Albagnac, N; Bounhoure, JP; Doat, P; Durand, D; Fauvel, JM; Grenet, B; Kayanakis, JG; Suc, JM | 1 |
| Kramer, BL; Massie, BM; Topic, N | 5 |
| Ader, R; Brundage, B; Chatterjee, K; Hiramatsu, B; Parmley, W; Ports, T | 1 |
| Colucci, WS; Curfman, G; Dzau, VJ; Hollenberg, NK; Meggs, L; Williams, GH | 1 |
| Cohn, JN | 3 |
| Cohn, JN; Franciosa, JA; Levine, TB | 1 |
| Brunner, HR; Gavras, H; Turini, GA; Waeber, B; Wauters, JP | 1 |
| Awan, NA; Evenson, MK; Mason, DT; Needham, KE; Win, A | 1 |
| Bernard, DB; Creager, MA; Faxon, DP; Gavras, H; Halperin, JL; Melidossian, CD; Ryan, TJ | 1 |
| Bounhoure, JP; Cassagneau, B; Fauvel, JM; Giraud, P; Kayanakis, JG; Puel, J; Sabot, G | 1 |
| Karlberg, BE; Ohman, KP | 1 |
| Denham, IM; Johnston, CI; McGrath, BP | 1 |
| Zanchetti, A | 1 |
| Henderson, SG; Kramer, BL; Massie, B; Topic, N | 1 |
| Bechtold, H; Philipp, T | 1 |
| Antonaccio, MJ | 1 |
| Awan, NA; Mason, DT | 1 |
| Chatterjee, K; Parmley, WW; Rouleau, JL | 3 |
| Creager, MA; Faxon, DP; Halperin, JL; McCabe, CH; Melidossian, CD; Ryan, TJ; Schick, EC | 1 |
| Coxon, R; Sharpe, DN | 2 |
| Kramer, B; Massie, B; Topic, N | 2 |
| Cody, RJ; Covit, A; Schaer, G; Williams, G | 1 |
| Cody, RJ; Laragh, JH | 1 |
| Baraldi, P; Mattioli, G; Ricci, S; Teglio, V; Zaniol, P | 1 |
| Frishman, WH; Kugler, J; LeJemtel, TH; Maskin, C; Sonnenblick, EH | 1 |
| Lee, CL; MacDonald, GJ; Walsh, WF | 1 |
| Atkinson, AB; Ball, SG; Dargie, HJ; Robertson, JI | 1 |
| Brunner, HR; Turini, GA; Waeber, B | 1 |
| Drobinski, G; Eugène, M; Evans, J; Ganty, J; Grosgogeat, Y; Guedj, D; Hubermann, JP; Komajda, M; Laurenceau, JL; Leprince, JL; Thomas, D; Wajman, A | 1 |
| Guerrera, G; Melina, D | 1 |
| Biollaz, J; Brunner, HR; Gavras, H; Gavras, I; Waeber, B | 1 |
| Holzschuh, M; Kochsiek, K; Liebau, G; Riegger, GA; Steilner, H; Witkowski, D | 1 |
| Abrams, WB; Davies, RO; Ferguson, RK | 1 |
| Rahn, KH; Stumpe, KO | 1 |
| Dunkman, WB; Franciosa, JA; Leddy, CL | 1 |
| Kawai, C; Yui, Y | 1 |
| Cody, RJ; Covit, AB; Laragh, JH; Schaer, GL | 1 |
| Godtfredsen, J; Jarden, JO; Paulson, OB; Vorstrup, S | 1 |
| Cooper, R; Ledingham, JG; Raine, AE; Rajagopalan, B | 1 |
| Medina, N; Meller, J; Packer, M; Yushak, M | 3 |
| Boomsma, F; Hugenholtz, PG; Laird-Meeter, K; Man in't veld, AJ; Schalekamp, MA; Simoons, ML; Wenting, GJ; Woittiez, AJ | 1 |
| Chatterjee, K; Parmley, WW | 2 |
| Gavras, H | 1 |
| Romankiewicz, N | 1 |
| Artman, M; Graham, TP; Parrish, MD | 1 |
| Jerie, P | 1 |
| Cody, RJ; Franklin, KW; Laragh, JH | 2 |
| Brown, JJ; Fraser, R; Lever, AF; Robertson, JI | 1 |
| David, AS; Farr, MJ; Flowers, CI; Ireland, AC | 1 |
| Froer, KL; Hall, D; Rudolph, W | 1 |
| Cohn, JN; Cowley, AW; Francis, GS; Goldsmith, SR; Levine, TB | 1 |
| Cohn, JN; Levine, TB; Pierpont, GL | 1 |
| Combs, DT; Hanlon, JT; Massie, BM; Packer, M | 1 |
| Zhukova, IM | 1 |
| Aranda, JM; Cintrón, G; Hernández-López, E; Linares, E; Ramírez, EA; Rivera del Río, JR | 1 |
| Camerini, F; Humar, F; Maras, P; Mestroni, L; Morgera, T | 1 |
| Chatterjee, K; Schwartz, AB | 1 |
| Allman, B; Barlow, JB; Goldman, AP; Jardine, R; King, J; Pocock, WA; Steingo, L | 1 |
| Larbig, D; Nasse, H | 1 |
| Dzau, VJ; Hollenberg, NK; Williams, GH | 1 |
| Fitz, A; Hanna, M | 1 |
| Feldman, R | 1 |
| Beekman, RH; Crowley, DC; Dick, M; Rocchini, AP; Rosenthal, A | 1 |
| Chocair, PR; de Paula, FJ; Ianhez, LE; Sabbaga, E | 1 |
| Bazzi, A; Cassin, M; Charmet, P; Dall'Aglio, V; Manfroni, A; Meneguzzo, N; Menin, A; Rellini, G; Variola, A | 1 |
| Braunwald, E; Colucci, WS | 1 |
| Rømer, FK | 1 |
| Forslund, T; Fyhrquist, F; Grönhagen-Riska, C; Hortling, L; Immonen, I; Tikkanen, I | 1 |
| Bravo, EL; El-Tobgi, S; Fouad, FM; Hart, NJ; Lim, J; Shirey, EK; Tarazi, RC | 1 |
| Punzengruber, C; Silberbauer, K; Sinzinger, H | 1 |
| Abinader, EG; Malouf, S; Rosenfeld, T; Sharif, D | 1 |
| Wang, ZS | 1 |
| Inagaki, Y; Ogawa, M | 1 |
| Dzau, VJ; Hollenberg, NK | 1 |
| Buckalew, VM; Hamilton, RW | 1 |
| Cohn, JN; Levine, TB; Olivari, MT | 2 |
| Grajek, S; Jasiński, K | 1 |
| Packer, M | 4 |
| Bravo, EL; Fouad, FM; Gifford, RW; Hart, N; Mujais, SK; Tarazi, RC; Textor, SC | 1 |
| Escobar, E; Ojeda, G; Saavedra, M; Thumala, A | 1 |
| Garty, M; Rabinovitz, M; Rosenfeld, J | 1 |
| Ball, S; Cleland, J; Dargie, H; Ford, I; Hodsman, P; Semple, P | 1 |
| Firth, BG | 1 |
| Ball, SG; Cleland, JG; Dargie, HJ; East, BW; Gillen, G; Hodsman, GP; Morton, JJ; Murray, GD; Robertson, I; Robertson, JI | 1 |
| Burnakis, TG; Mioduch, HJ | 1 |
| Gross, E; Koprowski, A; Manitius, J; Wyrzykowski, B | 1 |
| Allard-Latour, G; Arnaud, A; Philip-Joet, F; Saadjian, A; Torresani, J | 1 |
| Mokhova, OV; Ol'binskaia, LI | 1 |
| Zheng, DY | 1 |
| Michajlik, A; Wiernikowski, A; Wysznacka-Aleksandrow, W | 1 |
| Blakeley, C; Tinker, J | 1 |
| You, K | 1 |
| Ciafone, RA | 1 |
| Bounhoure, JP; Breton, J; Fauvel, JM; Kayanakis, JG; Maillet, J | 1 |
| Gopalaswamy, C; Gould, L | 1 |
| Lederle, RM; Philipp, T | 1 |
| Bertel, O | 1 |
| Allal, J; Barraine, R; Bordage, JP; Pornin, M; Poupet, JY; Rossi, F | 1 |
| Baubion, N; Di Matteo, J; Heulin, A; Le Pailleur, C; Metzger, JP; Vacheron, A | 1 |
| Allal, J; Bouziri, S; Maurice, P; Melanidis, J; Ourbak, P; Pornin, M; Sellier, P | 1 |
| Heidland, A; Schaefer, RM | 1 |
| Bolte, HD | 1 |
| Fouad, FM; Nakashima, Y; Tarazi, RC | 1 |
| Hirota, Y; Kawamura, K; Kubo, S; Nishioka, A; Takatsu, T | 1 |
| Awan, NA; Massie, BM | 1 |
| Bannerman, KS; Cannon, PJ; Escala, EL; Kalischer, A; Powers, ER; Reison, DS; Sciacca, RR; Stone, J; Weiss, MB | 1 |
| Awan, NA; Hermanovich, J; Lui, H; Mason, DT | 1 |
| Amsterdam, EA; Awan, NA; Lui, H; Mason, DT; Needham, KE; Rutledge, J | 1 |
| Kincaid-Smith, P; Walter, NM; Whitworth, JA | 1 |
| Lee, CL; Walsh, WF | 1 |
| Coxon, RJ; Sharpe, DN | 1 |
| Creager, MA; Faxon, DP; Halperin, JL | 1 |
| Bounhoure, JP; Fauvel, JM; Kayanakis, JG; Puel, J | 1 |
| Liebau, G; Oehrlein, S; Riegger, AJ; Schanzenbächer, P; Steilner, H | 1 |
| Barlow, JB; Flax, H; Pocock, WA; Stein, M; Steingo, L | 1 |
| Fitzgerald, DJ; Horgan, J; O'Brien, E; O'Callaghan, WG; O'Malley, K | 1 |
| Dahlström, U; Karlberg, BE | 1 |
| Drobinski, G; Eugene, M; Evans, J; Grosgogeat, Y; Komajda, M; Laurenceau, JL | 1 |
| Cody, RJ; Covit, AB; Pondolfino, K; Schaer, GL; Williams, G | 1 |
| Hull, FT; Ikram, H; Nicholls, MG | 1 |
| Delius, W | 1 |
| Arnman, K; Cavalli-Björkman, U; Rydén, L; Smedgård, P | 1 |
| Kendall, MJ; Smith, SR; Thomson, MH | 1 |
| Ansalone, G; Bellocci, F; Loperfido, F; Scabbia, E; Schiavoni, G; Zecchi, P | 2 |
| Gross, F | 1 |
| Boccalon, H; Bounhoure, JP; Cassagneau, B; Fauvel, JM; Giraud, P; Kayanakis, JG; Puel, J | 1 |
| Brivet, F; Delfraissy, JF; Dormont, J; Giudicelli, JF; Legrand, A; Richer, C | 1 |
| Amsterdam, EA; Awan, NA; Bommer, WJ; Hermanovich, J; Mason, DT; Needham, KE | 1 |
| Emslie-Smith, D; Montgomery, AJ; Shepherd, AN | 1 |
| de Bruyn, JH; Derkx, FH; Man in't Veld, AJ; Schalekamp, MA; Wenting, GJ; Woittiez, AJ | 1 |
| Bravo, EL; Castle, LW; Fouad, FM; Hart, NJ; Salcedo, EE; Tarazi, RC | 1 |
| Espiner, EA; Ikram, H; Maslowski, AH; Nicholls, MG; Penman, T; Scandrett, MS | 1 |
| Cody, RJ; Franklin, KW; Kluger, J; Laragh, JH | 2 |
| Lavigne, G; Morand, P | 2 |
| Baba, M; Fujii, M; Hamada, M; Kawanami, C; Konishi, T; Morimoto, Y; Nakano, T; Takahashi, T; Takezawa, H | 1 |
| Hirota, Y; Kawamura, K; Kino, M; Kitaura, Y; Kubo, S; Morita, H; Nishioka, A; Suwa, M; Takatsu, T; Tsutsumi, J | 1 |
| Kubo, S; Nishimura, H; Nishioka, A; Sonotani, N; Takatsu, T | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
| Creager, MA; Faxon, DP; Gavras, H; Halperin, JL; Ryan, TJ; Schick, EC | 1 |
| Espiner, EA; Ikram, H; Lun, S; Maslowski, AH; Nicholls, MG; Scandrett, MS | 1 |
| Evans, DB; Hamilton, DV; Maidment, G; Pryor, JS | 1 |
| Bravo, EL; Fouad, FM; Salcedo, EE; Saragoca, M; Tarazi, RC | 1 |
| Belkahia, C; Ben Ayed, H; El Matri, A; Kechrid, C; Larabi, M | 1 |
| Eugène, M; Evans, J; Grosgogeat, Y; Komajda, M; Lecossier, D | 1 |
| Cohn, JN; Francis, GS; Pierpont, GL | 1 |
| Ikram, H; Maslowski, AH; Nicholls, MG | 1 |
| Bravo, EL; Fouad, FM; Vidt, DG | 1 |
| Hirosawa, K; Kimata, S; Nakao, H; Noda, H; Sugino, N; Takahahashi, S; Tokuyasu, Y | 1 |
| Gunnar, RM; LaBarre, TR; O'Connell, JB | 1 |
| Espiner, EA; Julius, S; Miles, KD; Nicholls, MG; Zweifler, AJ | 1 |
| Cohn, JN; Franciosa, JA; Levine, TB; Vrobel, T | 1 |
| Benge, W; Chatterjee, K; Hiramatsu, B; Parmley, WW; Rouleau, JL | 1 |
| Harris, C; Smith, GH | 1 |
| Tarazi, RC | 1 |
| Frishman, WH; Keung, E; LeJemtel, TH; Ribner, HS; Sonnenblick, EH | 1 |
| Cody, RJ; Kluger, J; Laragh, JH | 1 |
| Ikäheimo, M; Pirttiaho, H; Takkunen, J | 1 |
| Andrews, R; Cowley, AJ; Evans, A; Walsh, JT | 1 |
| Scheen, AJ | 1 |
| Azevedo, JE; Campos Filho, O; Cantarelli, MJ; Carvalho, AC; de Almeida, DR; Martinez Filho, EE; Smith, AC | 1 |
| de Graeff, PA; Lie, KI; Smit, AJ; van der Broek, SA; van Gilst, WH; van Veldhuisen, DJ; van Wijngaarden, J; Wesseling, H | 1 |
| Majewski, H; Minatoguchi, S | 1 |
| Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
| Ogilvie, RI; Zborowska-Sluis, D | 3 |
| Kowolik, H; Opie, LH | 1 |
| Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T | 1 |
| Elisaf, M; Pappas, C; Siamopoulos, K; Theodorou, J | 1 |
| Bridges, A; Haffner, CA; Kendall, MJ; Stott, DJ; Struthers, AD | 1 |
| Arcensio, SR; Arteaga, E; Barretto, AC; Bellotti, G; da Luz, PL; Mady, C; Pileggi, F; Szambock, F | 1 |
| Cheung, B | 1 |
| Belch, JJ; Bridges, AB; McLaren, M | 1 |
| Arsencio, SR; Barretto, AC; Bodanese, LC; Marafon, LP; Oliveira Júnior, MT | 1 |
| Barcina Sánchez, C; Fernández Fernández, A; Martín Cortés, M | 1 |
| Bonte, J; Le Pen, C; Lévy, E | 1 |
| Boman, K; Dahlström, U; Edvardsson, N; Pehrsson, K; Persson, S | 1 |
| Lehmann, Z; Michalski, M; Ozegowski, S; Stasiński, T; Wierzchowiecki, M | 1 |
| Eschenhagen, T; Hanrath, P; Jakob, H; Mende, U; Patten, M; Schmitz, W; Scholz, H; Schulte am Esch, J; Sigmund, M; Steinfath, M | 1 |
| de Graeff, PA; Girbes, AR; Hillege, H; Lie, KI; Smit, AJ; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Andrews, R; Cowley, AJ; Johnston, ID; Kinnear, WJ; Starling, R; Walsh, JT | 1 |
| Barnett, DB; Bexton, RS; Boyle, R; Cowley, AJ; Hampton, JR; Hanley, SP; McEntegart, DJ; Millar-Craig, M; Morris, GK; Nicholls, AJ | 1 |
| Cerimele, B; Greene, P; Reed, S; Ryan, T; Schwertschlag, U; Voelker, J; Weinberger, M | 1 |
| Chaudhry, GM; Haneef, N | 1 |
| Herold, M | 1 |
| Fuchs, W | 1 |
| Acanfora, D; Furgi, G; Lanzillo, T; Longobardi, G; Melillo, E; Papa, A; Rengo, C; Rengo, F | 1 |
| Davies, MK; Doran, J; Lote, CJ; Townend, JN | 1 |
| Han, YL; Hu, XL; Jing, QM; Liu, JQ; Tong, M | 1 |
| Giles, TD | 3 |
| Fyhrquist, F; Helin, K; Hohenthal, U; Tikkanen, I | 1 |
| Kalashnikov, VF; Sinopal'nikov, VI | 1 |
| Dietz, R; Nagel, F; Osterziel, KJ | 3 |
| Jougasaki, M; Kato, H; Kikuta, K; Nakao, K; Sumida, H; Tanaka, H; Yasue, H; Yoshimura, M | 1 |
| Han, YL; Jing, QM; Tong, M | 1 |
| Connors, KF; Lamas, GA | 1 |
| Basta, L; Braunvald, Iu; Dévis, BR; Fleĭker, GS; Geltman, EM; Goldman, S; Kaddi, TE; Moĭe, LA; Pfeffer, MA | 1 |
| Wu, H; Zhao, HY | 2 |
| Campana, C; Gavazzi, A; Marioni, R; Montemartini, C | 1 |
| Ambrosioni, E; Borghi, C; Magnani, B | 3 |
| Bonhomme, MC; Diebold, S; Garcia, R | 1 |
| Fenwick, MK; Motwani, JG; Struthers, AD | 2 |
| Filipek, B; Finik, M; Jonderko, G; Marcisz, C | 1 |
| Brady, AJ; Cleland, JG; Good, JM; Noormohamed, FH; Oakley, CM | 1 |
| Bralet, J; Gros, C; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC | 1 |
| Delamere, F; Dutka, DP; Elborn, JS; Morris, GK; Shale, DJ | 1 |
| Adachi, T; Kinoshita, M; Maeda, Y; Ohbayashi, Y; Tsutamoto, T; Wada, A | 1 |
| Broderick, GT; DiBianco, R; Gottlieb, SS; Kostis, J; Lang, RM; Lyle, PA; Makris, L; Rajfer, SI; Rucinska, EJ | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Rosenfeld, T | 2 |
| Inoue, M; Kanda, T; Murata, K; Suzuki, T | 1 |
| Lou, ZJ; Sun, XL; Zhu, GL | 1 |
| Borchard, F; Horstkotte, D; Kober, R; Königshausen, T; Krahwinkel, W; Strauer, BE; Winter, J | 1 |
| Beil, S; Doering, W; Hinzmann, S; Kleber, FX; Kosloswki, B; Reindl, I; Rodewyk, P; Sabin, GV; Wenzel, M; Winter, UJ | 1 |
| Drexler, H; Just, H; Schulgen, G; Schumacher, M; Siegrist, J; Taylor, SH | 1 |
| Beaufort, CJ; Handlin, LR; Koenig, CA; Vacek, JL | 1 |
| Iwai, T; Kato, M; Nagano, M; Noma, K; Takeda, N; Tanamura, A | 1 |
| Arnold, MO; Bichet, D; de Champlain, J; Hall, C; Klein, M; Moyè, L; Packer, M; Rouleau, J; Rouleau, JL; Sussex, B | 1 |
| Davies, M; Doran, J; Jones, S; Townend, J | 1 |
| Reid, J | 1 |
| Auty, R; Colucci, RD; Glassner-Cohen, L; Scavone, JM | 1 |
| Fenwick, MK; Morton, JJ; Motwani, JG; Struthers, AD | 2 |
| Bridges, AB; Fraser, CG; McLay, JS; McMurray, JJ; Struthers, AD | 1 |
| O'Mara, NB; Zimmerman, WB | 1 |
| Harris, RL; McCabe, J; Sacchetti, A; Torres, M | 1 |
| Baylen, BG; Cyran, SE; Gleason, MM; Myers, JL; Roloff, JS; Weber, HS | 1 |
| Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
| Mohr, K | 1 |
| Bhandari, B; Chakraborty, S; Ghose, JC; Mondal, M | 1 |
| Birnbaum, AJ; Brottman, MD; Skosey, JL; Sobotka, PA; Weitz, Z; Zarling, EJ | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Raya, TE | 2 |
| Kopal, V; Svejda, J; Václavík, P | 1 |
| Anguita, M; Arizón, JM; Bueno, G; Concha, M; Giménez, D; Latre, JM; Sancho, M; Torres, F; Vallés, F | 1 |
| Byttebier, G; Van Hedent, T; Van Mieghem, W | 1 |
| Young, BA | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL; Squire, IB | 2 |
| Asaad, MM; Fennell, SA; Langenbacher, KM; Lanoce, VM; Rogers, WL; Seymour, AA | 1 |
| Jing, HB; Liu, WH; Wang, HJ | 1 |
| Cines, M; Fisher, ML; Gottlieb, SS; Kukin, ML; Medina, N; Packer, M; Penn, J; Taylor, M; Yushak, M | 1 |
| Dahlström, U; Karlsson, E | 1 |
| Zannad, F | 1 |
| Bindels, AJ; Vandenbroucke, JP | 1 |
| Binkley, PF; Cody, RJ; Haas, GJ; Hatton, PA; Leier, CV; Nunziata, E; Starling, RC | 1 |
| Munger, MA | 1 |
| Baumgartner, W; Bergler-Klein, J; Globits, S; Glogar, D; Ogris, E; Pacher, R; Teufelsbauer, H; Wutte, M | 1 |
| Kleber, FX; Niemöller, L | 1 |
| Adams, KF; Cody, RJ; Costantini, PJ; Gheorghiade, M; Gourley, LA; Jolly, MK; Packer, M; Smith, LK; Van Voorhees, L; Young, JB | 1 |
| Agner, E; Kelbaek, H; Marving, J; Vasehus Madsen, P; Wroblewski, H | 1 |
| Reisin, L | 1 |
| Krishna, EV; Mehta, AV; Subrahmanyam, AB; Wattad, AA | 1 |
| Kobayasi, R; Sanbe, A; Takeo, S; Tanonaka, K | 1 |
| Clark, RG; Gillett, N; Jin, H; Ko, A; Paoni, NF; Yang, R | 1 |
| Kersten, U; Morisse, B | 1 |
| Ernst, E; Weihmayr, T | 1 |
| Bendel-Stenzel, M; Najarian, JS; Sinaiko, AR | 1 |
| Antila, S; Eha, J; Heinpalu, M; Lehtonen, L; Loogna, I; Mesikepp, A; Planken, U; Sandell, EP | 1 |
| al-Furaih, TA; Hughes, CM; McElnay, JC; Nicholls, DP; Scott, MG | 1 |
| Averbuch, M; Dotan, I; Golan, Y; Iaina, A; Kornowski, R; Levo, Y; Schwartz, D; Schwartz, IF; Weinreb, B | 1 |
| Gong, L; Hu, H; Shen, W; Zhang, X | 1 |
| Dambrink, JH; Kingma, JH; Peels, KH; St John Sutton, M; van Gilst, WH | 1 |
| Brown, AR; Riley, JA; Walker, BE | 1 |
| Berger, K; Kleber, FX; Schulte-Hillen, J; Szucs, T | 1 |
| Sonntag, F | 1 |
| Duraković, Z | 1 |
| Kageyama, Y; Matsumoto, A; Murakami, M; Naitoh, M; Saruta, T; Suzuki, H; Tsujimoto, G | 1 |
| Charles, CJ; Espiner, EA; Fitzpatrick, MA; Nicholls, MG; Rademaker, MT; Richards, AM; Sybertz, E | 1 |
| Carayon, A; Grenier, O; Guerot, C; Isnard, R; Kalotka, H; Komajda, M; Lechat, P; Maistre, G; Pousset, F; Thomas, D | 1 |
| Giles, TD; Quiroz, A; Roffidal, L; Sander, G; Tresznewsky, O | 1 |
| Hofmann, S; Kersten, U | 1 |
| Amadi, A; Coats, A; Gibson, DG; Henein, MY; O'Sullivan, C | 1 |
| Adewole, AD; Adigun, AQ; Ajayi, AA; Akintomide, AO; Balogun, MO; Ikem, RT | 1 |
| Bresnahan, M; Cokkinos, D; Gavras, H; Gavras, I; Handanis, S; Manolis, AJ; Olympios, C; Sifaki, M | 1 |
| Cioffi, G; Pozzoli, M; Sanarico, M; Stenner, R; Tavazzi, L; Traversi, E | 1 |
| Chang, PI; Cowley, AJ; Deedwania, PC; Martinez, FA; Meurers, G; Ney, DE; Pitt, B; Segal, R; Snavely, DB; Thomas, I | 1 |
| Avdeev, VG; Balakhonova, NP; Kuznetsov, NE; Liapon, DO; Senchikhin, PV | 1 |
| Khaper, N; Singal, PK | 1 |
| Arsencio, SR; Barretto, AC; Bodanese, LC; Canesin, MF; Marafon, P; Oliveira Júnior, MT | 1 |
| Argenziano, L; Condorelli, M; Crepaldi, G; Morisco, C; Rizzon, P; Trimarco, B; Villa, G; Zardini, P | 1 |
| Jenkinson, C; Jenkinson, D; Layte, R; Petersen, S; Shepperd, S | 1 |
| Jensen, BV; Nielsen, SL | 1 |
| Bartoli, E; Catena, C; Sechi, LA | 1 |
| Achard, JM; Fernandez, LA; Fournier, A | 1 |
| Ball, SG | 1 |
| Dorszewski, A; Dorsźewski, B; Figulla, HR; Göhmann, E; Kreuzer, H; Werner, GS | 1 |
| Zoneraich, S | 1 |
| Friedrich, S; Knight, DR; Mathier, M; Shannon, RP | 1 |
| Kamen, PW; Krum, H; Tonkin, AM | 1 |
| Chelimsky-Fallick, C; Fonarow, GC; Hamilton, MA; Kartashov, A; Moriguchi, JD; Steimle, AE; Stevenson, LW; Tillisch, JH | 1 |
| Alföldi, S | 1 |
| Kékes, E | 1 |
| Beil, S; Doering, W; Fischer, M; Kleber, FX; Reindl, I; Sabin, GV; Wenzel, M; Winter, UJ | 1 |
| Beynon, JH; Pathy, MS | 1 |
| de Graeff, PA; Hillege, H; Lie, KI; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| Szucs, TD | 1 |
| Dohmen, HJ; Dunselman, PH; Poole-Wilson, PA | 1 |
| Baker, KM; Bing, OH; Boluyt, MO; Brooks, WW; Conrad, CH; Crow, MT; Dostal, DE; Lakatta, EG; O'Neill, L | 1 |
| Bodemann, T; Eichstädt, H; Gareis, R; Möckel, M; Müller, R; Störk, T | 1 |
| Cserhalmi, L | 1 |
| Pitt, B | 3 |
| Halawa, B; Mazurek, W | 1 |
| Kandaswamy, V; Sen, S; Yang, CM; Young, D | 1 |
| Brij, SO; Clesham, GJ; Nash, KL | 1 |
| Davis, BR; Hager, WD; Lamas, GA; Moye, LA; Pfeffer, MA; Riba, A; Rouleau, JL; Wun, CC | 1 |
| Bestetti, RB; Bombonato, R; Brasil, JC; Caixe, SH; Finzi, LA; Kato, M; Muccillo, G | 1 |
| Krakoff, LR; Rajasekharaiah, V | 1 |
| Alvarez, J; de Mora, M; Malpartida, F; Mancha, I; Olveira, G; Soriguer, F; Vázquez, F; Vivancos, R | 1 |
| Gheorghiade, M; Lee, P; McDermott, MM; Mehta, S | 1 |
| Endo, A; Hamada, T; Hisatome, I; Kato, M; Kato, T; Kinugawa, T; Miyakoda, H; Mori, M; Noguchi, N; Ogino, K; Omodani, H; Osaki, S; Shigemasa, C | 1 |
| Inada, M; Masaki, H; Matsubara, H; Mori, Y | 1 |
| Kawada, T; Miyano, H; Sato, T; Shishido, T; Sugimachi, M; Sunagawa, K; Yoshimura, R | 1 |
| Struthers, AD | 1 |
| Bastert, G; Bode, C; Unkels, R; Wacker, J; Werner, P | 1 |
| Brown, K; Kalra, PA; MacDowall, P; Mamtora, H; O'Donoghue, DJ; Waldek, S | 1 |
| Sayed, MA; Smoger, SH | 1 |
| Channer, K; O'Toole, L; Padfield, P; Stewart, M | 1 |
| Bestetti, RB; Bombonato, R; Brasil, JC; Haddad, J; Moreira-Neto, F; Sgarbieri, RN | 1 |
| Carraway, JW; Holycross, BJ; McCune, SA; Park, S; Radin, MJ | 1 |
| Bulpitt, CJ; Dössegger, L; Fletcher, AE; Neiss, A; Nielsen, T; Viergutz, S | 1 |
| Benatar, D; Gheorghiade, M; Hall, V; Reddy, S | 1 |
| Kokkonen, JO; Kovanen, PT; Kuoppala, A; Lindstedt, KA; Saarinen, J | 1 |
| Dukić, M; Gradinac, S; Hercog, D; Jovanović, I; Jovović, L; Kokai, G; Simeunović, S; Stajević, M | 1 |
| Baan, J | 1 |
| Ben-Ami, H; Edoute, Y; Krivoy, N; Nagachandran, P; Roguin, A | 1 |
| Battler, A; Behar, S; Boyko, V; Goldbourt, U; Gottlieb, S; Leor, J; Reicher-Reiss, H | 1 |
| Dahlström, U; Jansson, K; Karlberg, BE; Karlberg, KE; Karlsson, E; Nylander, E; Nyquist, O | 1 |
| Rutgers, SR; Schweitzer, M | 1 |
| Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
| Lee, AF; MacFadyen, RJ; Morton, JJ; Pringle, SD; Struthers, AD | 1 |
| Caspi, A; Ermer, W; Lewis, BS; Markiewicz, W; Rabinowitz, B; Rosenfeld, T; Schlesinger, Z; Sclarovsky, S | 1 |
| Camm, AJ; Dickstein, K; Klinger, GH; Konstam, MA; Martinez, FA; Neaton, J; Pitt, B; Poole-Wilson, P; Riegger, G; Segal, R; Sharma, D; Thiyagarajan, B | 1 |
| Ambrosioni, E; Bacchelli, S; Bignamini, A; Borghi, C; Esposti, DD; Magnani, B | 1 |
| Brooksby, P; Cowley, AJ; Klinger, G; Pitt, B; Robinson, PJ; Segal, R | 1 |
| Dhalla, NS; Ganguly, PK; Ren, B; Shao, Q; Zarain-Herzberg, A | 1 |
| Litwin, SE; Morgan, JP | 2 |
| McDermott, P; Moakes, ME; Moyer, V; Ramoska, E; Sacchetti, A | 1 |
| Riegger, GA | 1 |
| Chaou, WT; Lee, ML; Lue, HC; Wang, JK; Wu, MH | 1 |
| Topol, E | 1 |
| Ceiler, DL; De Mey, JG; Nelissen-Vrancken, M; Smits, JF | 1 |
| Berger, R; Frey, B; Kozanly, I; Kuchling, G; Pacher, R; Stanek, B | 1 |
| Clement, DL; De Buyzere, M; Tomas, M; Vanavermaete, G | 1 |
| Berger, D | 1 |
| Luft, FC | 1 |
| Banerjee, T; Clark, AL; Cleland, JG; Thackray, S; Witte, K | 1 |
| Meyer, GJ | 1 |
| Califf, RM; Velazquez, EJ | 1 |
| Camm, AJ; Dickstein, K; Klinger, GH; Konstam, MA; Martinez, FA; Neaton, J; Pitt, B; Poole-Wilson, PA; Riegger, G; Segal, R; Sharma, D; Thiyagarajan, B | 1 |
| Bittner, V; Ford, T; Goldman, S; Gradman, A; Kinan, D; Konstam, MA; La Bresh, K; Lewis, W; Patten, RD; Ramahi, T; Rand, W; Segal, R; Self, KS; Smith, JJ; Thomas, I; Udelson, JE | 1 |
| Hauser, M; Wilson, N | 1 |
| Einecke, D | 1 |
| Dahlström, U; Jansson, K; Karlberg, KE; Karlsson, E; Nylander, E; Nyquist, O | 1 |
| Cowley, AJ; Harrison, M; Houghton, AR | 1 |
| Lee, AF; MacFadyen, RJ; Struthers, AD | 1 |
| Boon, NA; Currie, PF; Dargie, HJ; Ford, M; McMurray, JJ; Newby, DE; Northridge, DB | 1 |
| Hayashi, Y; Hoshiai, K; Hoshiai, M; Ishida, H; Kanno, T; Kirimoto, T; Matsuura, N; Miyake, H; Nakano, M; Nakazawa, H; Tajima, K | 1 |
| Jackson, EA; Trojian, TH | 1 |
| Armstrong, PW | 1 |
| Kromer, EP | 1 |
| Hall, A | 1 |
| Meyer, FP | 1 |
| Gansevoort, RT; van Veldhuisen, DJ | 1 |
| Lye, M | 1 |
| Mahé, I | 1 |
| Bagirova, GG; Batalina, MV | 1 |
| Balding, LC; Burrell, LM; Farina, NK; Johnston, CI | 1 |
| Cowley, AJ; Dasbach, EJ; Pitt, B; Rich, MW; Santanello, NC; Segal, R; Wiens, BL | 1 |
| Orrù, P; Porcu, M | 1 |
| Xie, XM; Zhao, SP | 1 |
| Ferrari, P; Frey, FJ; Fuster, D | 1 |
| Brunner, HR; Gavras, H | 1 |
| Berry, C; McMurray, JJ; Norrie, J | 1 |
| Chen, YT; Krumholz, HM; Radford, MJ; Wang, Y | 1 |
| Dickstein, K; Kjekshus, J | 1 |
| Francis, GS; Gassler, JP | 1 |
| Haas, GJ | 1 |
| Chauhan, SS; Hasija, PK; Karloopia, SD; Shahi, BN | 1 |
| Ayan, F; Eryonucu, B; Keser, N; Koldas, L; Sirmaci, A | 1 |
| Miller, AB; Srivastava, P | 1 |
| Henze, E; Hetzel, J; Hetzel, M; Hombach, V; Wieshammer, S | 1 |
| Akdeniz, B; Guneri, S; Guven, H; Kalkan, S; Kirimli, O; Ozdamar, M; Tuncok, Y | 1 |
| Khattar, RS; Lahiri, A; Senior, R; Soman, P; van der Does, R | 1 |
| Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 2 |
| Auer, JW; Berent, R; Eber, B | 1 |
| Ogihara, T; Rakugi, H | 1 |
| Johnston, GD; Maguire, SM; McAuley, D; McGurk, C; Nicholls, DP; Nugent, AG | 1 |
| Komajda, M | 1 |
| Chaupin, DF; Christie, RM; Daniel, SL; Entman, ML; Gould, KE; Hartley, CJ; Konkol, DL; Michael, LH; Pocius, JS; Sandusky, GE; Taffet, GE; Zachariah, JP | 1 |
| He, H; Xu, Y; Zhao, W | 1 |
| Barretto, AC | 1 |
| Furuse, Y; Igawa, O; Kato, M; Kinugawa, T; Ogino, K; Osaki, S; Shigemasa, C; Tomikura, Y | 1 |
| De Rooy, SE; De Vries, OO; Jansen, PA; Raymakers, JA | 1 |
| Remme, WJ | 1 |
| Anthopoulos, L; Apostolou, T; Bonoris, P; Foussas, S; Lefkos, N; Zombolos, S | 1 |
| Doing, AH; Renlund, DG; Smith, RA | 1 |
| Kovacs, L; Simko, F; Simková, M | 1 |
| Charles, CJ; Cooper, GJ; Coy, DH; Espiner, EA; Lewis, LK; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J | 1 |
| Felder, RB; Francis, J; Weiss, RM; Zhang, ZH | 1 |
| Atkinson, AB; Robertson, JI | 1 |
| Bravo, EL; Ceimo, JK; Fouad, FM; Tarazi, RC | 1 |
| Cohn, JN; Levine, TB; Mashiro, I; Mehta, J | 1 |
| Han, Y | 1 |
| Kyzek, L; Kyzeková, J | 1 |
| Eschar, Y; Hansch, E; Keren, G; Laniado, S; Pardes, A; Scherez, J | 1 |
| Doering, W; Kleber, FX; Niemöller, L; Nussberger, J | 1 |
| Averbuch, M; Finkelstein, A; Greenland, M; Kornowski, R; Lehrman, H; Levo, Y; Pines, A; Schwartz, D | 1 |
| Anversa, P; Armstrong, PW; Brilla, CG; Burnett, JC; Cruickshank, JM; Devereux, RB; Giles, TD; Korsgaard, N; Leier, CV; Weber, KT | 1 |
| Coutie, WJ; Lang, CC; Motwani, JG; Rahman, AR; Struthers, AD | 1 |
| Sloman, G | 1 |
| Busch, C; Dietz, R; Karr, M; Osterziel, KJ | 1 |
| Dietz, R; Karr, M; Lemmer, B; Osterziel, KJ | 1 |
| Bach, R; Zardini, P | 1 |
| Dzau, VJ; Hirsch, AT; Ingelfinger, JR; Schunkert, H; Smith, AD; Talsness, CE | 1 |
| Ma, C; Qin, S | 2 |
| André, M; Bozio, A; Jocteur-Monrozier, D; Normand, J; Sassolas, F | 1 |
| Armaganijan, D; Barretto, AC; Batlouni, M; Hatab, SA; Nascimento, LO; Simões, R; Spritzer, N; Vichi, FL | 1 |
| Benchimol, C; Ferreira Filho, SR; Hatab, SA; Nascimento, LO; Saragoça, MA | 1 |
| Aizaki, T; Hanawa, H; Izumi, T; Kodama, M; Ohshima, M; Shibata, A; Suzuki, M; Takahashi, M; Tsuda, T; Uchiyama, H | 1 |
| De Bock, V; Mets, T; Praet, JP | 1 |
| Holt, PJ; Long, CC; Wong, SS | 1 |
| Nelissen-Vrancken, HJ; Smits, JF; Struijker-Boudier, HA | 1 |
| Charles, CJ; Espiner, EA; Fitzpatrick, MA; Ikram, H; Nussberger, J; Rademaker, MT; Yandle, TG | 1 |
| Basta, L; Braunwald, E; Brown, EJ; Cuddy, TE; Davis, BR; Flaker, GC; Geltman, EM; Goldman, S; Moyé, LA; Pfeffer, MA | 1 |
| Boissel, JP; Chifflet, R; Girard, P; Leizorovicz, A; Lievre, M; Nony, P | 1 |
| Dakak, N; Flugelman, MY; Halon, DA; Kahana, L; Lewis, BS; Makhoul, N; Yechiely, H | 1 |
| Doering, W; Kleber, FX; Niemöller, L | 1 |
| Opie, LH | 1 |
| Dietz, R; Harder, K; Kübler, W; Osterziel, KJ | 1 |
| Ageev, FT; Grigor'iants, RA; Kazeĭ, DV; Mareev, VIu; Shevliagin, SA | 1 |
| Hand, T; Jones, MC; Minford, EJ | 1 |
| Bagger, JP; Eiskjaer, H; Mogensen, CE; Pedersen, EB; Schmitz, A | 1 |
| Hartter, E; Kargl, R; Zirm, A; Zirm, B | 1 |
| Ajayi, AA; Akintomide, AO; Osodi, OO | 1 |
| Cholewa, M; Dryjański, T; Gawor, Z; Górski, L; Kaczkowska-Marusik, E; Kuś, W; Markiewicz, K | 1 |
| Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Williams, BC | 2 |
| Elkayam, U; Johnson, JV; Mehra, A; Ostrzega, E; Shotan, A | 1 |
| Birkhead, J; Cowley, AJ; Hampton, JR; Skene, A; Swami, A; Wynne, RD | 1 |
| Bridges, A; McLay, JS; McMurray, J; Struthers, AD | 1 |
| Ritz, R; Salathe, M; Weiss, P | 1 |
| Deck, CC; Gaballa, MA; Goldman, S; Raya, TE | 1 |
| Han, YL; Miao, ZL; Tong, M | 1 |
| Beauchet, A; Bejuit, R; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Jondeau, G; Weber, S | 1 |
| Hirooka, Y; Imaizumi, T; Takeshita, A | 1 |
| Brown, G; Douglas, I; Herkes, R; O'Leary, M | 1 |
| Albanese, E; Chelimsky-Fallick, C; Fonarow, GC; Hamilton, MA; Luu, M; Moriguchi, JD; Stevenson, LW; Tillisch, JH; Walden, JA | 1 |
| Barkow, UH; Becher, H; Geller, JC; Glänzer, K; Vetter, H; Zhou, H | 1 |
| Kukin, ML | 1 |
| Zawada, ET | 1 |
| Howard, PA | 1 |
| Jayasuriya, PH | 1 |
| Aizaki, T; Hanawa, H; Izumi, T; Kodama, M; Kuwano, H; Shibata, A; Suzuki, M; Takahashi, M; Tsuda, T; Uchiyama, H | 1 |
| Daly, K; Finn, J; Grimes, H; McMurrough, P; O'Keeffe, S | 1 |
| Ellekilde, G; Hemmingsen, L; Holm, J; Koczulab, B; von Eyben, FE | 1 |
| Astorri, E; Carini, M; Distante, R; Spotti, A; Ziletti, G | 1 |
| Andrade, JL; Araujo, VL; Brito, FS; Horowitz, SF; Martinez, EE; Portugal, OP; Roberti, RR | 1 |
| Brozovich, FV; Gottlieb, NB; Gottlieb, RS; Morganroth, J | 1 |
| Lees, KR; MacFadyen, RJ; Reid, JL | 1 |
| Bagger, JP; Danielsen, H; Eiskjaer, H; Jensen, JD; Jespersen, B; Pedersen, EB; Thomsen, K | 1 |
| Gamble, G; Greaves, S; Hart, H; Murphy, J; Sharpe, N; Smith, H | 1 |
| Frank, GJ; Knapp, LE; McLain, R; Posvar, E; Rieger, MM; Singer, R | 1 |
| Giles, T | 1 |
| Ishii, M; Kobayashi, K; Miyakawa, T; Shionoiri, H; Takasaki, I | 1 |
| Chopra, M; McMurray, J | 1 |
| Cheng, TO | 2 |
| Kleber, FX | 3 |
| Ewing, DJ; Flapan, AD; Neilson, JM; Nolan, J | 1 |
| Alio, J; Angel, J; Domingo, E; Gilabert, MR; Soler-Soler, J | 1 |
| Doering, W; Fischer, M; Kleber, FX; Niemöller, L | 1 |
| Davies, E; Edwards, CR; Flapan, AD; Shaw, TR; Waugh, C; Williams, BC | 2 |
| Davies, E; Edwards, CR; Flapan, AD; Gow, IF; Morris, M; Padfield, PL; Shaw, TR; Williams, BC | 1 |
| Franzen, D; Freiheit, T; Kaufmann, W; Kugel, C; Müller, R; Steffen, HM; Wambach, G | 1 |
| Yodfat, Y | 1 |
| Dietz, R; Lemmer, B; Osterziel, KJ | 1 |
| Sharpe, N | 1 |
| Doering, W; Kleber, FX | 1 |
| Beermann, B; Cederholm, T; Hildebrand, IL; Jansson, E; Sylvén, C | 1 |
| Bosman, FT; Cleutjens, JP; Daemen, MJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA; van Krimpen, C | 1 |
| Bussmann, WD; Dieterich, HA; Kaltenbach, M; Kneissl, GD; Scholz, M | 1 |
| Kokubu, T | 1 |
| Bol'shakova, TD; Golokolenova, GM; Kuznetsov, VA; Ol'binskaia, LI | 1 |
| Brunner, H; Doering, W; Kleber, FX; Niemöller, L; Nussberger, J | 1 |
| Braun, U; Brilla, GG; Heitkamp, HC; Klärner, HG; Krämer, BK; Müller-Schauenburg, W; Risler, T; Seipel, L | 1 |
| Amadi, AA; Davies, JR; Keywood, C; Patterson, DL; Stevenson, RN | 1 |
| Barabino, A; Galbariggi, G; Lotti, G; Pizzorni, C | 1 |
| Belokrinitskaia, OA; Engel'gardt, TI; Rumiantseva, IuN | 1 |
| Harada, N; Inoue, G; Kaku, T; Tsujino, M; Yamasaki, H | 1 |
| DiBianco, R | 4 |
| Collins-Nakai, RL; Pereira, CM; Tam, YK | 1 |
| Noerr, B | 1 |
| Aschenberg, W; Hobuss, M; Schofer, J; Tews, A | 1 |
| Cleland, JG; Dargie, HJ; Findlay, IN; Henderson, E; McLenachan, J | 1 |
| Cowley, AJ | 1 |
| Blackburn, ME; Dickinson, DF; Gibbs, JL | 1 |
| Brooks, NH; Lawrence, GP; Schofield, PM; Testa, HJ; Ward, C | 1 |
| Dietz, R; Osterziel, KJ | 1 |
| Antaloczy, Z; Balogh, I; Bányai, F; Dékány, M; Kékes, E; Vándor, L | 1 |
| Muir, AL; Nolan, J | 1 |
| Sandler, M; Watson, N | 1 |
| Arnolda, L; Johnston, CI; McGrath, BP | 1 |
| Carson, P; Odum, J; Russell, G | 1 |
| Corda, G; Ghiringhelli, S; Lepori, G; Mortarino, G; Onofri, M; Trudu, A | 1 |
| Matsuo, H; Nishida, M; Obata, H; Sano, H; Yasuda, H | 1 |
| Hirooka, Y; Imaizumi, T; Nakamura, M; Nakamura, N; Sakai, K; Suzuki, S; Takeshita, A; Yoshida, M | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Erbel, R; Haude, M; Meyer, J; Steffen, W | 1 |
| Dakak, N; Flugelman, MY; Halon, DA; Lewis, BS; Makhoul, N; Merdler, A; Schneeweiss, A; Shehadeh, H | 1 |
| Bichet, D; Dupuis, J; Lalonde, G; Rouleau, JL | 1 |
| Alunni, GF; Bardelli, G; Boschetti, E; Capponi, EA; Cocchieri, M; Del Favero, A; Fortunati, F; Regi, L | 1 |
| Cowley, AJ; Fullwood, L; Hampton, JR; Muller, AF; Stainer, K | 1 |
| D'Aprile, N; Faglia, S; Galli, M; Kristodhullu, S; Martorelli, T; Mondillo, S; Palazzuoli, V | 1 |
| Ikram, H; White, HD | 1 |
| Franchi, F; Puddu, GM | 1 |
| Bongarzoni, A; Caporotondi, A; Manzinali, C; Marchesi, E; Muggia, C; Radaelli, A | 1 |
| Lambert, M; Luccioni, R | 1 |
| Casanegra, P; Chamorro, G; Corbalán, R; Jalil, J; Valenzuela, P | 1 |
| Iriarte, MM; Martínez, JD; Montes Orbe, PM; Ormaetxe, JM; Rodríguez, E; Ruiz de Azúa, E | 1 |
| Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K | 1 |
| Child, JS; Hamilton, MA; Moriguchi, JD; Stevenson, LW; Woo, M | 1 |
| Ambrosioni, E; Borgi, C; Costa, FV; Magelli, C; Magnani, B | 1 |
| Bartonová, J; Hrdina, R; Krátký, V | 1 |
| Kennedy, GT | 1 |
| Maier, H; Tasman, A; Zech, J | 1 |
| Eilles, C; Ertl, G; Gaudron, P | 1 |
| Greminger, P; Hess, OM; Jenni, R; Krayenbuehl, HP; Maire, R; Tjon-A-Meeuw, L | 1 |
| Ahmad, S; Giles, TD; Given, MB; Haney, Y; Roffidal, LE; Sander, GE | 1 |
| Berg, M; Boosalis, P; Cohn, JN; Francis, GS; Johnson, TH; Ziesche, S | 1 |
| Gheorghiade, M | 1 |
| Wang, H | 1 |
| Galvao, M | 1 |
| Bech, OM; Diamant, B; Jensen, MK; Steiness, E; Sørensen, JD | 1 |
| Follath, F; Grimm, E; Sieber, C | 1 |
| Belch, JJ; Bridges, A; Chopra, M; McLay, J; McMurray, J; Scott, N; Smith, WE | 1 |
| Gulati, S; Marwaha, RK | 1 |
| Shachar, A; Shoenfeld, Y | 1 |
| Barrio Andrés, C; Gutiérrez Larraya, F; Torres Mohedas, J | 1 |
| Abushi, A; Dietz, R; Kübler, W; Osterziel, KJ | 1 |
| Laragh, JH | 1 |
| Fouad, FM; Tarazi, RC | 1 |
| Bayliss, J; Poole-Wilson, P; Thomas, L | 1 |
| Dargie, HJ; Leckie, B; McAlpine, HM; Morton, JJ | 1 |
| Bussmann, WD; Fassbinder, W; Hadler, D; Jungmann, E; Kaltenbach, M; Reifart, N; Störger, H | 1 |
| Agabiti Rosei, E; Alicandri, C; Beschi, M; Boni, E; Castellano, M; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
| Chiaramida, A; DeMaria, AN; Giles, TD; Hackshaw, B; Hart, W; Haugland, M; Johnston, R; Katz, R; Kirlin, P; Powers, ER | 1 |
| Anand, IS; Lipkin, DP; Poole-Wilson, PA; Scriven, AJ; Sutton, GC | 2 |
| Grom, E; Hauf, GF; Jähnchen, E; Roskamm, H | 1 |
| Coffman, JD; Creager, MA; Faxon, DP; Gavras, H; Rockwell, SM | 1 |
| Goldstein, S; Pitt, B | 1 |
| Khalil, A; Yadav, S | 1 |
| Blistanova, LS; Griaznov, VV; Kukes, VG | 1 |
| Capewell, S; Hannan, WJ; Muir, AL; Taverner, D | 1 |
| Cockcroft, JR; Webb, DJ | 1 |
| Hyun, J; Lahiri, B; Mesologites, D; Schatz, PL; Smith, GJ | 1 |
| de Graeff, PA; Kingma, JH; Lie, KI; Viersma, JW; Wesseling, H | 1 |
| Bolli, R; Charlat, ML; O'Neill, PG; Rajan, N | 1 |
| Cowley, AJ; Hampton, JR; Rowley, JM; Stainer, K; Wynne, RD | 2 |
| Goldman, S; Lee, RW; Raya, TE; Westhoff, T | 1 |
| Clemens, G; Weigeldt, H | 1 |
| Ambrosioni, E; Borghi, C; Boschi, S; Capelli, M; Costa, FV; Magelli, C; Magnani, B; Varani, E | 1 |
| Boland, MJ; Cinquegrani, MP; Insel, J; Mirvis, DM; Rubin, SA; Shanes, J; Whalen, JJ | 1 |
| Chiaramida, A; Giles, TD; Hackshaw, B; Haugland, M; Katz, R; Kirlin, P; Powers, E; Rich, S; Sullivan, JM; Wolfson, P | 1 |
| Jessup, M | 1 |
| Feinstein, AR; Fisher, MB; Pigeon, JG | 1 |
| Carter, SM; Maisel, AS; Michel, MC; Phillips, C; Ziegler, MG | 1 |
| Frank, GJ | 1 |
| Gheorghiade, M; Goldstein, S; Hall, V; Lakier, JB | 1 |
| Hasegawa, K; Inoue, S; Kakumae, S; Kawahara, Y; Nakamura, T; Nakao, M; Nezuo, S; Sawayama, T; Tadaoka, S | 1 |
| Kawamura, K; Kubo, S; Kubota, J; Nishimura, H; Ueyama, M | 2 |
| Ambrosioni, E; Bassein, L; Liberatore, S; Magelli, C; Magnani, B; Ribani, MA | 1 |
| Biron, P; Davignon, A; Elie, R; Fournier, A; Fouron, JC; Montigny, M | 1 |
| Diver, MJ; Scammell, AM | 1 |
| Arnold, R; Scammell, AM | 1 |
| Punzengruber, C; Silberbauer, K; Stanek, B | 1 |
| Barnett, DB; Scott, RA | 1 |
| Esser, H; Heck, I; Lüderitz, B; Müller, HM | 1 |
| Fouad-Tarazi, FM; Hobbs, RE | 1 |
| Belz, GG; Erbel, R; Haude, M; Meyer, J; Steffen, W; Tschollar, W | 1 |
| Berni, A; Danesi, A; Mangieri, E; Martuscelli, E; Nigri, A; Sardella, F; Sardella, G | 1 |
| Cuccia, C; Dei Cas, L; Gargano, M; Gei, P; Metra, M; Moretti, R; Riva, S; Volpini, M | 1 |
| Cohn, JN; Francis, G; Goldsmith, SR | 1 |
| Barin, E; Hoschl, R; Nelson, GI; Stokes, GS; Wilkes, NP | 1 |
| Emchenko, IR; Iaremenko, OB; Kurochko, VB; Netiazhenko, VZ | 1 |
| Bertoni, T; Foresti, A; Gentile, G; Kheir, A; Lotto, A; Nardi, B | 1 |
| Banaszewski, M; Stepińska, J; Szajewski, T | 1 |
| Kerkovits, G; Palócz, E | 1 |
| Gottlieb, SS; Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 2 |
| Dolva, LO; Gullestad, L; Kjekshus, J; Søyland, E | 1 |
| Milnes, JP; Shaw, AJ | 1 |
| Francis, GS | 1 |
| Ikeda, Y; Kaneko, Y; Kimura, K; Minamisawa, K; Nomura, S; Oda, H; Onishi, T; Shionoiri, H; Takagi, N; Yoshimura, H | 1 |
| Breckenridge, A | 1 |
| Alicandri, C; Muiesan, G | 1 |
| Rydén, L | 1 |
| Jackson, B; Johnston, CI; Maher, D; Matthews, PG; McGrath, BP | 1 |
| Fisher, MB; Giles, TD; Rush, JE | 1 |
| Fukuzaki, H; Nakanishi, M; Yokota, Y | 1 |
| Schofer, J | 1 |
| Bilezikian, JP; Cannon, PJ; Chow, YK; Corwin, SJ; Horn, EM; Neuberg, GW; Powers, ER; Steinberg, SF | 1 |
| de Abajo, FJ; Lopo, CR | 1 |
| Bajaj, AK | 1 |
| Wyvratt, MJ | 1 |
| Dietz, R; Kübler, W; Manthey, J; Mikulaschek, K; Osterziel, KJ; Röhrig, N; Schmid, W | 1 |
| Scheler, F; Schilling, H | 1 |
| Wernze, H | 1 |
| Edwards, CR; Padfield, PL | 1 |
| Kaziulin, AN; Vorob'ev, LP | 1 |
| Riegger, AJ | 2 |
| Anakwenze, J; Britton, KE; Granowska, M; Horne, T; Petrosina, I | 1 |
| Graf, B; Urbaszek, W | 1 |
| Boyd, O; Pohl, JE | 1 |
| Boccanelli, A; Liberatore, SM; Prati, PL | 1 |
| Slany, J | 1 |
| Bayliss, J; Parameshwar, J; Poole-Wilson, PA; Richardson, A; Scriven, AJ; Sutton, GC | 1 |
| Coughlan, MG; Flynn, K; Luke, D; Neligan, M; Phelan, DM; Wood, AE | 1 |
| Factor, S; Le Jemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
| Lee, WH; Medina, N; Packer, M; Yushak, M | 5 |
| Fyhrquist, F; Tikkanen, I | 1 |
| Dietz, R; Hackenthal, E; Kübler, W; Manthey, J; Osterziel, KJ; Röhrig, N; Schmidt-Gayk, H | 1 |
| Bichet, D; Kortas, C; Rouleau, JL | 1 |
| Dietz, R; Haass, M; Kübler, W | 1 |
| Bichet, D; de Champlain, J; Kortas, C; Rouleau, JL | 1 |
| Esser, H; Heck, I; Kikis, D; Stumpe, KO | 1 |
| Chambers, S; Espiner, EA; Ikram, H; Livesey, JH; Nicholls, MG | 1 |
| Ferraro, N; Wilson, JR | 1 |
| Lee, WH; Packer, M | 2 |
| Bruckner, U; Silberbauer, K; Stanek, B | 1 |
| Dahan, M; Gourgon, R; Juliard, JM; Merillon, JP; Solal, AC | 1 |
| Jia, L | 1 |
| Crozier, IG; Ikram, H; Lewis, GR; Nicholls, MG; Richards, AM; Webster, MW | 1 |
| Chen, MX | 1 |
| Schultheiss, HP; Zähringer, J | 1 |
| Chadwick, B; Le Jemtel, TH; Maskin, CS | 1 |
| Kessler, PD; Lee, WH; Packer, M | 1 |
| Gottlieb, SS; Kessler, PD; Packer, M | 1 |
| Holt, P; Najm, J; Sowton, E | 1 |
| Mimran, A; Ribstein, J | 1 |
| Kessler, PD; Lee, WH; Medina, N; Packer, M; Yushak, M | 1 |
| Hes, I; Kozák, P; Salava, T; Spacek, A; Stárek, A | 1 |
| Chilton, RJ | 1 |
| Artman, M; Graham, TP | 1 |
| Cleland, JG; Dargie, HJ; East, BW; Ford, I; Inglis, CG; Leckie, BJ | 1 |
| Laragh, J | 1 |
| de Graeff, PA; Dunselman, PH; Kingma, JH; Lie, KI; Wesseling, H | 1 |
| Gans, RO; Hoorntje, SJ | 1 |
| Dzau, VJ | 1 |
| Marszal-Marciniak, M; Zambrzycki, J | 1 |
| Katz, S; LeJemtel, TH; Scortichini, D | 1 |
| Banhardt, U; Drexler, H; Hiroi, M; Just, H; Meinertz, T; Riede, U | 1 |
| Jessup, M; Meissner, MD; Wilson, AR | 1 |
| Kiriaev, AA; Merzon, AK; Zolotov, NA | 1 |
| Dietz, R; Hecht, J; Kübler, W; Manthey, J; Osterziel, KJ; Röhrig, N | 1 |
| Brogden, RN; Sorkin, EM; Todd, PA | 1 |
| Chen, X; Fang, YX; Hu, KL; Liu, ZQ; Su, Z; Wu, WJ; Xiong, WS | 1 |
| Cooper, WH; Dennick, LG; Hallows, BG; Maskin, CS; Meyer, JH; Newman, TJ | 1 |
| Pfeffer, JM; Pfeffer, MA | 1 |
| Massie, BM | 2 |
| Bumpus, FM; Fouad-Tarazi, FM; Healy, B; Khosla, M | 1 |
| Magnani, B | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Rodeanu, ME; Saggie, Y | 1 |
| Kiriaev, AA; Merzon, AK; Mukharliamov, NM; Zolotov, NA | 1 |
| Bendig, L; Temesvári, A | 1 |
| Bittar, AE; dos Santos, AA; Junges, F; Rodrigues, R; Vitola, D | 1 |
| Friedman, WF; George, BL | 2 |
| Malone-Lee, J; Murphy, PJ; Van der Cammen, T | 1 |
| Godtfredsen, J; Holm, S; Jarden, JO; Paulson, OB; Vorstrup, S | 1 |
| Bensaïd, J; Blanc, P; Bontemps, T; Chabanier, A; Pinaud, D; Richard, A; Tardieu, A; Vergnoux, H; Virot, P | 1 |
| Figulla, HR; Kreuzer, H; Luig, H; Nieschlag, F | 1 |
| Alunni, G; Boschetti, E; Bruni, B; Castellano, M; Cocchieri, M; Fortunati, F; Grassi, V; Tantucci, C | 1 |
| Hertrich, FF; Leinberger, H; Winkelmann, BR | 1 |
| Goodfield, MJ; Millard, LG | 1 |
| Brett, C; Shaddy, RE; Teitel, DF | 1 |
| Amaro Cendón, A; Gil de la Peña, M; González-Juanatey, JR; Vega Fernández, M | 1 |
| Al Mahdy, H; Boswell, GV | 1 |
| Collins-Nakai, RL; Ng, P; Pereira, CM; Tam, YK | 1 |
| Faxon, DP | 1 |
| Dickinson, DF; Shaw, NJ; Wilson, N | 1 |
| Andersen, AR; Barry, DI; Paulson, OB; Pedersen, EV; Schmidt, JF; Vorstrup, S; Waldemar, G | 1 |
| Zatuchni, J | 1 |
| Cohen, AI; Duchin, KL; McKinstry, DN; Migdalof, BH | 1 |
| Morozova, TE; Ol'binskaia, LI | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Rodeanu, ME; Rosenfeld, T; Saggie, Y; Schneider, H | 1 |
| Beaudry, MA; Coe, JY; McGonigle, LF | 1 |
| Alpert, E; Alpert, L; Tabibian, N | 1 |
| Arnold, R; Scammell, AM; Wilkinson, JL | 1 |
| Chadwick, B; Davis, L; LeJemtel, TH; Mancini, DM; Wexler, JP | 1 |
| Bílková, B; Chaloupka, V; Janousek, S; Lupínek, Z; Merta, Z; Toman, J; Vítovec, J; Zeman, K | 1 |
| Borkenstein, J | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| Gorb, IuG; Malaia, LT; Savchuk, AM | 1 |
| Dzau, VJ; Swartz, SL | 1 |
| Anand, IS; Gurden, J; Harris, P; Poole-Wilson, PA; Wanless, RB | 1 |
| Bojanowski, LM; Gosling, RG; Najm, YC; Nelson, DJ; Timmis, AD | 1 |
| Di Bianco, R | 1 |
| Daniels, AR | 1 |
| Ajzen, H; Draibe, SA; Ferreira, SR; Homsi, E; Ramos, OL; Ribeiro, AB; Saragoça, MA | 1 |
| Corrie, J; Duncan, FM; Edwards, CR; Eglen, A; Rademaker, M; Shaw, TR; Williams, BC | 1 |
| Chadwick, B; Gumbardo, D; LeJemtel, TH; Rutman, HI; Sonnenblick, EH | 1 |
| Sutton, FJ | 1 |
| Bichet, D; Chatterjee, K; Kortas, C; Manzini, C; Mettauer, B; Rouleau, JL; Tremblay, G | 1 |
| Conti, A; De Alfieri, W; Di Bari, M; Ferrucci, L; Lombardi, A; Marchionni, N; Moschi, G; Vannucci, A | 1 |
| Bayliss, J; Canepa-Anson, R; Norell, MS; Poole-Wilson, P; Sutton, G | 1 |
| Grant, PK; Reuben, SR; Singh, SP | 1 |
| Creager, MA; Cutler, SS; Faxon, DP; Gavras, H; Kohlmann, O; Ryan, TJ | 1 |
| Fiori, G; Fogari, R; Gabba, L; Pasotti, C; Zoppi, A | 1 |
| Cody, RJ; Covit, AB; Feldschuh, J; Laragh, JH; Schaer, GL; Sealey, JE | 1 |
| Cleland, JG; Dargie, HJ; Gillen, G; Pettigrew, A; Robertson, JI | 1 |
| Burgess, JH; Chatterjee, K; Cousineau, D; Daly, P; Rouleau, JL | 1 |
| Baum, R; Hör, G; Jungmann, E; Kaltenbach, M; Klepzig, H; Maul, FD; Mildenberger, D; Siede, WH; Standke, R | 1 |
| Kochsiek, K; Riegger, GA | 1 |
| Bichet, DG; Kortas, C; Manzini, C; Marc-Aurèle, J; Mettauer, B; Rouleau, JL; Schrier, RW | 1 |
| Iudichev, IS; Makolkin, VI; Pomerantsev, EV; Syrkin, AL; Vakhliaev, VD | 1 |
| Bhatia, ML; Gopinath, PG; Kaul, U; Kaushik, SK; Malhotra, A | 1 |
| Magelli, C; Magnani, B | 1 |
| Brusoni, B; Caroli, A; Gronda, E; Inglese, E; Mangiavacchi, M; Oppizzi, M; Rovelli, F | 1 |
| Cappello, C; Fusaro, MT; Mattioli, G; Ricci, S; Rigo, R | 1 |
| Alicandri, C; Boni, E; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
| Crozier, IG; Fitzpatrick, MA; Ikram, H; Nicholls, MG | 1 |
| Boccanelli, A; Carboni, GP; Liberatore, SM; Prati, PL; Zachara, E | 1 |
| Bortz, J | 1 |
| Braunwald, E; Pfeffer, JM; Pfeffer, MA | 1 |
| Lemberg, L; Valle, GA | 1 |
| Irani, RM | 1 |
| Agababian, IR; Akhmed, Kh; Ataullakhanova, DM; Mareev, VIu; Sazonova, LN | 1 |
| Haeske, W; Kochsiek, K; Kraus, C; Kromer, EP; Riegger, GA | 1 |
| Kornberg, B | 1 |
| Manoria, PC; Mehrotra, Y; Misra, NP; Pandey, P; Trivedi, HH | 1 |
| Creager, MA; Faxon, DP; Ryan, TJ; Weiner, DA | 1 |
| Althoff, PH; Bussmann, WD; Fassbinder, W; Hadler, D; Jungmann, E; Kaltenbach, M; Schöffling, K; Störger, H | 1 |
| Drexler, H; Just, H; Truog, AG; Zelis, R | 1 |
| Chadwick, B; Feld, H; LeJemtel, TH; Mancini, D; Maskin, CS; Sinoway, L | 1 |
| Finn, P; Pfeffer, JM; Pfeffer, MA; Steinberg, C | 1 |
| Bassein, L; Galiè, N; Magelli, C; Magnani, B; Ribani, MA; Sanguinetti, M | 1 |
| Greminger, P; Hess, OM; Krayenbühl, HP; Maire, R; Turina, J | 1 |
| Crichton, E; Davis, JR; Duncan, FM; Edwards, CR; Rademaker, M; Shaw, TR; Thomson, SA; Williams, BC | 1 |
| Awan, NA; Chatterjee, K; Cohn, JN; Creager, M; Faxon, DP; Fouad, FM; Gavras, HP; Levine, TB; Mason, DT; Parmley, WW | 1 |
| Arcavi, L; Caspi, A; Estrov, Z; Resnitzky, P | 1 |
| Ball, SG; Cleland, JG; Dargie, HJ; East, BW; Gillen, G; Hodsman, GP; Morton, JJ; Robertson, I; Robertson, JI | 1 |
| Al-Mufti, HI; Arieff, AI | 1 |
| de Roquefeuil, F; Goupil, C | 1 |
| Gorb, IuG | 1 |
| Rubin, SA; Shellock, FG | 1 |
| Bielak, J; Hanzlik, J; Klimczak, W; Krawczyk, A; Ostrowski, S; Sodolski, W; Wojnicz, A | 1 |
| Ageev, FT; Evdokimova, NKh; Mareev, VIu; Mukharliamov, NM; Novikov, SV | 1 |
| Cattan, S; Degeorges, M; Guérin, F; Pailleret, JJ; Weber, S | 1 |
| Abrams, J | 1 |
113 review(s) available for captopril and Cardiac Failure
| Article | Year |
|---|---|
Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Humans; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
Topics: Administration, Cutaneous; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Diabetic Nephropathies; Enalapril; Heart Failure; Humans; Hypertension; Indoles; Lisinopril; Perindopril; Skin | 2014 |
[The use of angiotensin converting enzyme inhibitors in patients after myocardial infarction].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Complications; Enalapril; Heart Failure; Humans; Indoles; Middle Aged; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Ventricular Dysfunction | 2008 |
The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Signaling; Captopril; Cyclic GMP; Gene Expression; Heart Failure; Humans; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myosin-Light-Chain Phosphatase; Vasoconstriction | 2008 |
[Efficiancy Angiotensin -converting enzyme inhibitors for the clinical practice].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Diabetic Cardiomyopathies; Heart Failure; Humans; Hypertension; Myocardial Infarction | 2011 |
Long-term clinical experience with zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspirin; Captopril; Coronary Artery Disease; Drug Interactions; Evidence-Based Medicine; Heart Failure; Humans; Hypertension; Myocardial Infarction; Platelet Aggregation Inhibitors | 2012 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
[Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Survival Rate; Treatment Outcome | 2003 |
A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Drug Therapy, Combination; Drug Tolerance; Heart Failure; Humans; Losartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Captopril; Cardiovascular Diseases; Enalapril; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Ventricular Dysfunction | 2005 |
[Angiotensin converting enzyme inhibitors in acute period of myocardial infarction: the place of zofenopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Follow-Up Studies; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Time Factors; Treatment Outcome | 2006 |
Early imaging in heart failure: exploring novel molecular targets.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Fluorine Radioisotopes; Heart Failure; Humans; Imidazoles; Lisinopril; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Renin-Angiotensin System; Ventricular Remodeling | 2007 |
Should we inhibit angiotensin-converting enzymes in acute heart failure?
Topics: Acute Disease; Administration, Sublingual; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Practice Guidelines as Topic; Pulmonary Edema; Treatment Outcome; Vasodilator Agents | 2007 |
[Clinical trials of ACE inhibitors and ARB for treatment of patients with hypertension, heart failure, and diabetic nephropathy in Japan--special reference to the dosage schedule and adverse effects].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Cough; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Japan; Losartan; Randomized Controlled Trials as Topic; Tetrazoles | 2008 |
Clinical applications of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascites; Bartter Syndrome; Captopril; Drug Evaluation; Edema; Heart Failure; Humans; Hypertension; Hypertension, Pulmonary; Liver Cirrhosis; Proline; Renin-Angiotensin System | 1984 |
Current concepts in the treatment of congestive heart failure.
Topics: Calcium Channel Blockers; Captopril; Digitalis Glycosides; Dipeptides; Diuretics; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hydralazine; Hypernatremia; Isosorbide Dinitrate; Nitroprusside; Prazosin; Vasoconstriction | 1984 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
The role of hormones in congestive heart failure: new frontiers in therapy?
Topics: Animals; Antihypertensive Agents; Captopril; Dogs; Guinea Pigs; Heart Failure; Humans; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 1982 |
[New drug preparations used for treating congestive heart failure: converting enzyme inhibitors, nitroprusside, nitrates and calcium channel blockers].
Topics: Calcium Channel Blockers; Captopril; Dose-Response Relationship, Drug; Ferricyanides; Heart Failure; Hemodynamics; Humans; Nitrates; Nitroprusside; Oligopeptides; Teprotide; Time Factors | 1982 |
Drug suppression of the angiotensin system in congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Renin-Angiotensin System; Saralasin; Teprotide | 1983 |
Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Kinetics; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Renin; Renin-Angiotensin System; Teprotide | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
[Captopril in congestive heart failure (author's transl)].
Topics: Acute Kidney Injury; Agranulocytosis; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Drug Eruptions; Enzyme Inhibitors; Glomerulonephritis; Heart Failure; Humans; Peptide Hydrolases; Proline; Pruritus; Pulmonary Wedge Pressure; Taste Disorders | 1982 |
Captopril--an overview.
Topics: Aged; Animals; Captopril; Cats; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dogs; Drug Eruptions; Female; Guinea Pigs; Haplorhini; Heart Failure; Humans; Hypertension; Kinetics; Neutropenia; Proline; Proteinuria; Rabbits; Rats | 1982 |
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
Topics: Animals; Blood; Captopril; Clinical Trials as Topic; Coronary Circulation; Drug Eruptions; Heart Failure; Hemodynamics; Humans; Kidney; Kinins; Oxygen Consumption; Physical Exertion; Proline; Prostaglandins; Renin-Angiotensin System; Taste Disorders | 1983 |
Angiotensin converting enzyme (ACE) inhibitors.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Heart Failure; Humans; Hypertension; Kallikreins; Kidney; Kinins; Prostaglandins; Renin | 1982 |
Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Heart Failure; Hemodynamics; Humans; Hypertension; Kinetics; Natriuresis; Renin; Vasodilator Agents | 1984 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocarditis, Bacterial; Furosemide; Heart; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Hydralazine; Isoproterenol; Nitroprusside; Physical Examination; Radionuclide Imaging; Rheumatic Heart Disease | 1983 |
[Treatment of refactory heart failure].
Topics: Adult; Aged; Aminopyridines; Amrinone; Captopril; Diet, Sodium-Restricted; Digitalis Glycosides; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Female; Heart Failure; Humans; Male; Medication Errors; Middle Aged; Oxygen Inhalation Therapy; Sodium | 1983 |
[Use of captopril in cardiology practice].
Topics: Adult; Captopril; Cardiomyopathies; Cardiovascular Diseases; Child; Dinoprostone; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Proline; Prostaglandins E; Renal Artery Obstruction; Renin-Angiotensin System; Stimulation, Chemical | 1983 |
Vasodilator therapy in chronic congestive heart failure.
Topics: Captopril; Chronic Disease; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine; Minoxidil; Nitrates; Piperazines; Vasodilator Agents | 1983 |
Vasodilator therapy of heart failure. Has the promissory note been paid?
Topics: Calcium Channel Blockers; Captopril; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Minoxidil; Pyridazines; Vasodilator Agents | 1984 |
[Captopril in the treatment of chronic congestive heart failure].
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Muscle, Smooth, Vascular; Proline; Prostaglandins E | 1984 |
Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agent.
Topics: Captopril; Chronic Disease; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1984 |
Southwestern Internal Medicine Conference: chronic congestive heart failure--the nature of the problem and its management in 1984.
Topics: Administration, Oral; Captopril; Cardiotonic Agents; Digitalis Glycosides; Diuretics; Female; Heart Failure; Heart Transplantation; Heart, Artificial; Hemodynamics; Humans; Male; Prognosis; Vasodilator Agents | 1984 |
[Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
Topics: Blood Pressure; Captopril; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Hypertension; Proline | 1984 |
Vasodilators in acute circulatory failure.
Topics: Albuterol; Captopril; Chlorpromazine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroglycerin; Nitroprusside; Phentolamine; Vasodilator Agents | 1983 |
[Vasodilator agents in the treatment of cardiac insufficiency].
Topics: Captopril; Dihydralazine; Heart Failure; Humans; Hydralazine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1984 |
Captopril--indications and clinical problems.
Topics: Animals; Blood Pressure; Bradykinin; Brain; Captopril; Cats; Dogs; Female; Guinea Pigs; Haplorhini; Heart Failure; Humans; Hypertension; Kallikreins; Kinetics; Pregnancy; Proline; Prostaglandins; Rabbits; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Scleroderma, Systemic | 1984 |
[Treatment of heart failure with vasodilators].
Topics: Captopril; Cardiomegaly; Cardiotonic Agents; Coronary Disease; Heart Failure; Heart Function Tests; Heart Valve Diseases; Humans; Hydralazine; Nitroglycerin; Phentolamine; Prazosin; Vasodilator Agents | 1980 |
[Use of captopril in circulatory failure].
Topics: Angiotensin II; Animals; Captopril; Chronic Disease; Drug Evaluation; Heart Failure; Hemodynamics; Humans; Proline; Renin; Renin-Angiotensin System | 1982 |
Vasodilator therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Nitroglycerin; Physical Exertion; Prazosin; Vasodilator Agents | 1980 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
Topics: Aldosterone; Angiotensin II; Captopril; Drug Interactions; Heart Failure; Hemodynamics; Humans; Hypertension; Kallikreins; Kinetics; Kinins; Proline; Prostaglandins; Renin; Scleroderma, Systemic | 1980 |
Drug therapy. Captopril.
Topics: Animals; Blood Pressure; Captopril; Drug Interactions; Heart Failure; Hematologic Diseases; Hemodynamics; Humans; Hypertension; Intestinal Absorption; Kidney; Pressoreceptors; Proline; Rats; Reflex; Renin-Angiotensin System | 1982 |
The discovery of captopril: from large animals to small molecules.
Topics: Animals; Captopril; Dogs; Guinea Pigs; Heart Failure; History, 19th Century; History, 20th Century; Research | 1995 |
[Lisinopril in the treatment of heart insufficiency].
Topics: Captopril; Clinical Trials as Topic; Digoxin; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Lisinopril; Quality of Life | 1995 |
Optimizing the treatment of heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume | 1994 |
Postmyocardial infarction patients: experience from the SAVE trial.
Topics: Captopril; Decision Trees; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 1995 |
Angiotensin-converting enzyme inhibitor and spironolactone combination therapy. New objectives in congestive heart failure treatment.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart; Heart Failure; Humans; Spironolactone | 1993 |
Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney; Renin-Angiotensin System | 1993 |
[Therapeutic effectiveness of Crataegus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Medicine, Traditional; Plants, Medicinal | 1996 |
[Use of captopril in therapeutic combinations].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Myocardial Ischemia | 1997 |
[Captopril in the treatment of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents | 1997 |
Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Economics, Pharmaceutical; Fosinopril; Heart Failure; Hospital Charges; Humans; Ventricular Dysfunction, Left | 1997 |
[Effect of combined captopril-spironolactone therapy of cardiac insufficiency on kidney function and serum electrolyte values].
Topics: Captopril; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Humans; Kidney; Spironolactone; Water-Electrolyte Balance | 1998 |
Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Renin-Angiotensin System | 1998 |
[Pathophysiological function of angiotensin II AT1 and AT2 receptors and clinical application of AT1 antagonists].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Cardiovascular System; Clinical Trials as Topic; Heart Failure; Humans; Kidney; Losartan; Protein Kinase C; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction | 1998 |
Captopril and angiotensin II receptor antagonist therapy in a pacing model of heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Heart Failure; Humans | 1998 |
[ACE inhibitors or AT1 receptor antagonists?].
Topics: Age Factors; Aged; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Clinical Trials as Topic; Death, Sudden, Cardiac; Enalapril; Heart Failure; Humans; Losartan; Prodrugs; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Time Factors | 1999 |
STOPPING at the CAPPP of good HOPE.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Ischemia; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2000 |
[Angiotensin-II-receptor antagonists for cardiac insufficiency].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Tetrazoles | 2000 |
Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Myocardial Ischemia; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 2001 |
Management of asymptomatic left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Heart Failure; Humans; Hypertension; Indoles; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ramipril; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Heart Failure; Humans; Hypertension; Losartan; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System; Spironolactone; Tetrazoles; Valine; Valsartan | 2001 |
[Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2001 |
[The ACE inhibitor, captopril, in the light of new clinical studies].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Heart Failure; Humans; Myocardial Infarction | 2002 |
Captopril in the treatment of clinical hypertension and cardiac failure.
Topics: Administration, Oral; Angiotensin II; Blood Pressure; Captopril; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Hypertension, Renal; Hyponatremia; Kidney Failure, Chronic; Proline; Renal Artery Obstruction | 1979 |
Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart.
Topics: Animals; Captopril; Cardiography, Impedance; Dogs; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypertension; Phenylephrine; Plethysmography, Impedance; Renin; Stroke Volume; Teprotide; Vasoconstriction | 1979 |
Remodeling and reparation of the cardiovascular system.
Topics: Animals; Blood Pressure; Captopril; Cardiomegaly; Collagen; Coronary Circulation; Diabetic Angiopathies; Endothelins; Endothelium, Vascular; Fibrosis; Heart; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Muscle, Smooth, Vascular; Myocardium; Peptidyl-Dipeptidase A; Rats; Vascular Resistance | 1992 |
Angiotensin-converting enzyme inhibition, the sympathetic nervous system, and congestive heart failure. The Australian Zestril (Lisinopril) Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Catecholamines; Dipeptides; Heart Failure; Humans; Lisinopril; Sympathetic Nervous System | 1992 |
[The place of new therapies in the treatment of congestive heart failure. The combination of digitalis and diuretics is always in good place].
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Digoxin; Dihydralazine; Dopamine; Female; Furosemide; Heart Defects, Congenital; Heart Failure; Humans; Infant; Infant, Newborn; Male | 1992 |
Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Enalapril; Follow-Up Studies; Heart Failure; Humans; Indoles; Meta-Analysis as Topic; Perindopril; Survival Rate | 1992 |
Studies of left ventricular dysfunction following myocardial infarction.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Substance Withdrawal Syndrome; Ventricular Function, Left | 1991 |
Comparison of lisinopril and captopril in the treatment of left ventricular congestive heart failure--influence of duration of action on efficacy and safety.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Ventricular Function, Left | 1991 |
[ACE inhibitors and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Isoquinolines; Lisinopril; Quinapril; Tetrahydroisoquinolines | 1990 |
[Modification of hemodynamics by angiotensin converting enzyme inhibitors in heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction | 1990 |
Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Humans | 1990 |
Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Multicenter Studies as Topic; Renin-Angiotensin System | 1990 |
[Captopril--new additional applications].
Topics: Animals; Captopril; Diabetic Nephropathies; Heart Failure; Humans; Hypertension; Lipids | 1990 |
[Heart insufficiency and life expectancy--the role of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic | 1990 |
When is it useful to inhibit the renin-angiotensin system for treating hypertension?
Topics: Antihypertensive Agents; Captopril; Diuretics; Drug Resistance; Heart Failure; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Sodium; Vasoconstriction | 1985 |
The Captopril-Digoxin Multicenter Research Group study on the comparative steps of captopril and digoxin in patients with mild-moderate heart failure: implications for therapy.
Topics: Captopril; Digoxin; Heart Failure; Humans | 1989 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Quinapril; Tetrahydroisoquinolines; Time Factors | 1989 |
Hypertension revisited: the concept of relative hypertension in congestive heart failure.
Topics: Blood Pressure; Captopril; Heart Failure; Heart Ventricles; Humans; Hypertension | 1989 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
Angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
[When and how to use angiotensin-converting enzyme inhibitors in heart failure].
Topics: Captopril; Enalapril; Heart Failure; Humans; Prognosis | 1987 |
When and how to use angiotensin-converting enzyme inhibition in congestive heart failure.
Topics: Captopril; Enalapril; Heart Failure; Humans; Renin-Angiotensin System | 1988 |
[Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Male; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors | 1988 |
[Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo].
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Enalapril; Evaluation Studies as Topic; Heart Failure; Humans; Multicenter Studies as Topic; Placebos; Random Allocation | 1988 |
Enalapril: a second-generation angiotensin converting enzyme inhibitor.
Topics: Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
[Angiotensin-converting enzyme inhibition: side effects and risks].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension; Risk Factors | 1988 |
[Angioneurotic edema caused by angiotensin-converting enzyme inhibitors: incidence, clinical characteristics, mechanisms of action].
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Angiotensin-converting enzyme inhibitors: past, present, and bright future.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Eruptions; Drug Interactions; Enalapril; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Neutropenia; Proline; Taste Disorders | 1985 |
[Drug treatment of patients with the chronic form of atrial fibrillation in counterindications for cardioversion (a review)].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anabolic Agents; Atrial Fibrillation; Calcium Channel Blockers; Captopril; Cardiac Glycosides; Chronic Disease; Electric Countershock; Heart Failure; Heart Rate; Humans; Molsidomine; Myocardial Contraction; Recurrence; Sydnones; Vasodilator Agents | 1985 |
Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Blood Pressure; Calcium Channel Blockers; Captopril; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Hypotension; Lung; Oxygen; Oxygen Inhalation Therapy; Parasympathomimetics; Prostaglandins; Pulmonary Artery; Vascular Resistance; Vasodilator Agents | 1985 |
Central and peripheral components of cardiac failure.
Topics: Aminopyridines; Amrinone; Animals; Captopril; Cardiac Output; Cardiomegaly; Cardiotonic Agents; Catecholamines; Coronary Circulation; Diuretics; Drug Therapy, Combination; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Isotonic Contraction; Microcirculation; Muscles; Norepinephrine; Oxygen Consumption; Renal Circulation; Vasodilator Agents | 1986 |
Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperkalemia; Hypotension; Proline; Renin-Angiotensin System; Risk; Time Factors; Vasodilator Agents | 1985 |
Clinical pharmacology and therapeutic applications of the new oral converting enzyme inhibitor, enalapril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperaldosteronism; Hypertension; Kinetics; Oligopeptides; Renin; Teprotide | 1985 |
[Some advances in angiotensin converting enzyme inhibitors].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Prostaglandins; Scleroderma, Systemic; Structure-Activity Relationship; Teprotide | 1985 |
Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Glomerular Filtration Rate; Heart Failure; Humans; Renin-Angiotensin System; Risk | 1987 |
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hypertension | 1988 |
New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1988 |
Survival in patients with heart failure: focus on captopril.
Topics: Captopril; Heart Failure; Humans; Survival Rate | 1988 |
ACE inhibition for the failing heart: experience with captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Random Allocation | 1988 |
Role of angiotensin in autoregulation of cerebral blood flow.
Topics: Angiotensin II; Animals; Captopril; Cerebrovascular Circulation; Heart Failure; Homeostasis; Humans; Renin-Angiotensin System | 1988 |
Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.
Topics: Age Factors; Animals; Captopril; Drug Administration Routes; Drug Interactions; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Kinetics | 1988 |
Captopril in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans | 1987 |
Vasodilator therapy.
Topics: Administration, Oral; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitrates; Physical Exertion; Prazosin; Random Allocation; Stroke Volume; Time Factors; Vasodilator Agents | 1986 |
264 trial(s) available for captopril and Cardiac Failure
| Article | Year |
|---|---|
Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Renin-Angiotensin System; Sympathetic Nervous System; Treatment Outcome | 2017 |
Effect of zofenopril and ramipril on cardiovascular mortality in patients with chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Endpoint Determination; Female; Heart Failure; Humans; Male; Proportional Hazards Models; Prospective Studies; Ramipril; Survival Rate; Treatment Outcome | 2013 |
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Death, Sudden, Cardiac; Drug Therapy, Combination; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Myocardial Infarction; Quality of Life; Recurrence; Stroke; Survivors; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2014 |
Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk; Risk Factors; Sex Factors; Valsartan; Ventricular Dysfunction, Left | 2015 |
Angiotensin-Converting Enzyme Inhibitor Initiation and Dose Uptitration in Children With Cardiovascular Disease: A Retrospective Review of Standard Clinical Practice and a Prospective Randomized Clinical Trial.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Cardiovascular Diseases; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Heart Failure; Humans; Infant; Infant, Newborn; Male; Prospective Studies; Retrospective Studies; Time Factors; Ventricular Dysfunction | 2016 |
Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Comorbidity; Female; Heart Failure; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction | 2008 |
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
Topics: Age Factors; Aged; Captopril; Cause of Death; Confidence Intervals; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2011 |
Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European stud
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Platelet Aggregation Inhibitors; Prospective Studies; Ramipril; Risk Assessment; Risk Factors; Stroke Volume; Systole; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure.
Topics: Animals; Captopril; Cholesterol; Clinical Trials as Topic; Diiodothyronines; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Pilot Projects; Propionates; Rabbits; Randomized Controlled Trials as Topic; Rats; Treatment Outcome; Triglycerides | 2002 |
Effects of furosemide versus captopril on postprandial and orthostatic blood pressure and on cerebral oxygenation in patients > or = 70 years of age with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cerebral Cortex; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Heart Rate; Hemoglobins; Humans; Male; Oxygen Consumption; Oxyhemoglobins; Postprandial Period; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Long-term survival of non-elderly patients with severe heart failure treated with angiotensin-converting enzyme inhibitors assessment of treatment with captopril and enalapril survival study (ACESS).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Dose-Response Relationship, Drug; Drug Evaluation; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Survivors; Treatment Outcome | 2002 |
[Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional Chinese medicine combined with captopril on severe viral myocarditis complicated heart failure].
Topics: Adult; Captopril; Diagnosis, Differential; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Medicine, Chinese Traditional; Myocarditis; Phytotherapy | 2001 |
Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatine Kinase; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Smoking; Survival Analysis; Time Factors | 2003 |
Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Drug Interactions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prostaglandins | 2003 |
[Comparative effectiveness of lotensin and capoten in patients with chronic cardiac failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Exercise; Heart Failure; Humans; Platelet Aggregation; Treatment Outcome | 2003 |
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzopyrans; Captopril; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nebivolol; Treatment Outcome | 2004 |
Heart attack patients with complications. Treat with valsartan, captopril, or both?
Topics: Aged; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Soluble CD40 ligand in acute and chronic heart failure.
Topics: Acute Disease; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; CD40 Ligand; Chronic Disease; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Treatment Outcome | 2005 |
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Fibrinolytic Agents; Fosinopril; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Recurrence; Risk Factors; Survival Analysis; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2005 |
Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Losartan; Male; Survival | 2005 |
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Topics: Ambulatory Care; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Costs; Global Health; Health Care Costs; Health Resources; Heart Failure; Hospital Costs; Hospitalization; Humans; Myocardial Infarction; Prospective Studies; Quality of Life; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Fibrinolytic Agents; Forearm; Heart Failure; Humans; Platelet Aggregation Inhibitors; Plethysmography; Vasodilation; Veins | 2005 |
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarct
Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Captopril; Cardiovascular Diseases; Cause of Death; Heart Failure; Humans; Middle Aged; Morbidity; Mortality; Myocardial Infarction; Systole; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2005 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 2006 |
[Effects of xinshuai mistura on plasma angiotensin II, atrial natriuretic peptide and N terminal pro-brain natriuretic peptide in patients with heart failure].
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phytotherapy; Single-Blind Method; Treatment Outcome | 2006 |
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Research Design; Risk Factors; Stroke Volume; Survival Analysis; Survivors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality.
Topics: Aged; Amiodarone; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction | 2008 |
The use of captopril in the management of cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; Proline | 1984 |
Angiotensin converting enzyme inhibition in heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Proline | 1984 |
Tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Drug Eruptions; Enalapril; Enzyme Inhibitors; Heart Failure; Humans; Hypertension; Leukocyte Count; Proteinuria; Taste; Uremia | 1984 |
Safety and efficacy of enalapril. Summing up the evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1983 |
Overall tolerance and safety of enalapril.
Topics: Captopril; Clinical Trials as Topic; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Global Health; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Leukopenia; Skin Diseases; Taste Disorders | 1984 |
Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
Topics: Aged; Angiotensin II; Captopril; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Middle Aged; Potassium; Proline; Renin; Sodium | 1981 |
Captopril therapy for heart failure. A placebo controlled study.
Topics: Aged; Captopril; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Proline; Vascular Resistance | 1982 |
[Long-term drug treatment of chronic heart failure].
Topics: Adrenergic beta-Antagonists; Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Nitroglycerin; Physical Exertion; Prazosin; Prognosis; Regional Blood Flow; Renal Circulation | 1984 |
Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.
Topics: Acute Disease; Blood Circulation; Captopril; Clinical Trials as Topic; Forearm; Heart Failure; Humans; Leg; Male; Middle Aged; Oxygen Consumption; Physical Exertion; Proline; Respiration; Time Factors | 1984 |
Monotherapy of hypertension with angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline; Racial Groups; Teprotide; Time Factors | 1984 |
Captopril--an overview.
Topics: Aged; Animals; Captopril; Cats; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dogs; Drug Eruptions; Female; Guinea Pigs; Haplorhini; Heart Failure; Humans; Hypertension; Kinetics; Neutropenia; Proline; Proteinuria; Rabbits; Rats | 1982 |
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
Topics: Animals; Blood; Captopril; Clinical Trials as Topic; Coronary Circulation; Drug Eruptions; Heart Failure; Hemodynamics; Humans; Kidney; Kinins; Oxygen Consumption; Physical Exertion; Proline; Prostaglandins; Renin-Angiotensin System; Taste Disorders | 1983 |
Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output; Clinical Trials as Topic; Female; Heart Failure; Humans; Kidney; Liver Circulation; Male; Middle Aged; Norepinephrine; Proline; Renin; Sodium; Splanchnic Circulation; Vascular Resistance | 1981 |
Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Prazosin; Proline; Quinazolines; Renin; Vasodilator Agents | 1982 |
Hemodynamic effects of vasodilators and long-term response in heart failure.
Topics: Antihypertensive Agents; Captopril; Dipeptides; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Minoxidil; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1984 |
Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Proline; Stroke Volume; Vascular Resistance | 1983 |
A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group.
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Physical Exertion; Proline; Random Allocation; Stroke Volume; Time Factors | 1983 |
Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Kidney; Male; Middle Aged; Natriuresis; Potassium; Proline; Renal Circulation | 1984 |
Captopril in heart failure. A double blind controlled trial.
Topics: Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Proline; Random Allocation; Time Factors | 1984 |
[Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
Topics: Blood Pressure; Captopril; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Hypertension; Proline | 1984 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Pulmonary Wedge Pressure; Quinazolines; Random Allocation; Renin; Stroke Volume; Vascular Resistance | 1982 |
Captopril - an oral angiotensin-converting enzyme inhibitor in CHF.
Topics: Captopril; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Long-Term Care; Myocardium; Oxygen Consumption; Physical Exertion; Proline | 1981 |
Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Topics: Aged; Captopril; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Prazosin; Proline; Quinazolines | 1982 |
Captopril (Capoten, E.R. Squibb & Sons).
Topics: Captopril; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Heart Failure; Humans; Hypertension; Kinetics; Proline | 1981 |
Failure of "effective" treatment for heart failure to improve normal customary activity.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Treatment Failure; Vasodilator Agents | 1995 |
[Acute hemodynamic effects of ibopamine, captopril, and placebo in patients with severe heart failure].
Topics: Adolescent; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Deoxyepinephrine; Diuretics; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Rest; Severity of Illness Index | 1995 |
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arm; Aspirin; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Drug Interactions; Female; Heart Failure; Hemodynamics; Humans; Indocyanine Green; Leg; Male; Middle Aged; Prostaglandins; Regional Blood Flow | 1994 |
Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure.
Topics: Aged; Aged, 80 and over; Captopril; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Heart Failure; Humans; Hypotension; Kidney; Renal Circulation | 1995 |
[Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Clinical Protocols; Deoxyepinephrine; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged | 1994 |
Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Chronic Disease; Cilazapril; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged | 1995 |
A comparative study of captopril and enalapril on endothelial cell function in congestive heart failure patients.
Topics: Aged; Antigens; Captopril; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Heart Failure; Humans; Male; Middle Aged; Plasminogen Inactivators; Time Factors; Tissue Plasminogen Activator | 1995 |
[Cost-effectiveness analysis of captopril treatment after myocardial infarction].
Topics: Captopril; Cost-Benefit Analysis; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Placebos; Prospective Studies; Recurrence; Treatment Outcome | 1994 |
Effect of captopril on myocardial beta-adrenoceptor density and Gi alpha-proteins in patients with mild to moderate heart failure due to dilated cardiomyopathy.
Topics: Adenosine Diphosphate Ribose; Adolescent; Adult; Aged; Captopril; Cardiomyopathy, Dilated; Female; GTP-Binding Proteins; Heart Failure; Humans; Male; Middle Aged; Myocardium; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1995 |
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Captopril; Cerebrovascular Circulation; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Leg; Liver Circulation; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Renal Circulation | 1995 |
Long-term evaluation of treatment for chronic heart failure: a 1 year comparative trial of flosequinan and captopril.
Topics: Blood Pressure; Captopril; Chronic Disease; Diuretics; Double-Blind Method; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Long-Term Care; Male; Middle Aged; Quinolines; Time Factors; Treatment Outcome; Vasodilator Agents | 1994 |
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
Topics: Administration, Oral; Aged; Aldosterone; Captopril; Cross-Over Studies; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypertension; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuresis; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Sodium; Ultrasonography; Ventricular Dysfunction, Left | 1995 |
Comparison of the safety and efficacy of delapril with captopril in outpatients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Indans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 1995 |
Congestive heart failure in elderly patients: controlled study of delapril versus captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Test; Female; Heart Failure; Humans; Indans; Male; Quality of Life; Severity of Illness Index; Treatment Outcome; Ventricular Function, Left | 1995 |
Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Dinoprostone; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Homeostasis; Humans; Indomethacin; Kidney; Leg; Male; Middle Aged; Regional Blood Flow; Vascular Resistance | 1995 |
Combined therapy of captopril and spironolactone for refractory congestive heart failure.
Topics: Adult; Aged; Aldosterone; Captopril; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Spironolactone | 1994 |
[Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Flow Velocity; Blood Pressure; Captopril; Creatinine; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Male; Middle Aged; Renal Circulation | 1994 |
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Wedge Pressure; Time Factors; Vascular Resistance | 1994 |
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Aspirin; Captopril; Cardiac Output, Low; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Morbidity; Myocardial Infarction; Prognosis; Recurrence; Risk Factors; Stroke Volume; Survival Rate; Time Factors; Ventricular Function, Left | 1993 |
Symptomatic hemodynamic and hormonal effects of intravenous captopril in patients with heart failure.
Topics: Adult; Aged; Captopril; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Renin-Angiotensin System | 1994 |
Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Topics: Aged; Captopril; Double-Blind Method; Echocardiography; Electrocardiography; Female; Heart Failure; Humans; Isoquinolines; Male; Middle Aged; Physical Exertion; Quinapril; Tetrahydroisoquinolines | 1994 |
The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Confidence Intervals; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Morbidity; Myocardial Infarction; Treatment Outcome | 1995 |
Comparison of two methods of determining renal perfusion with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
Topics: Aged; Blood Flow Velocity; Captopril; Cardiac Output, Low; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Iodine Radioisotopes; Iodohippuric Acid; Kidney; Male; Middle Aged; Myocardial Infarction; p-Aminohippuric Acid; Premedication; Regional Blood Flow; Single-Blind Method | 1994 |
Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuresis; Drug Synergism; Female; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged | 1994 |
Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome | 1994 |
First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Captopril; Double-Blind Method; Drug Tolerance; Enalapril; Heart Failure; Humans; Middle Aged; Peptidyl-Dipeptidase A; Safety | 1994 |
[The benefit of combined therapy with captopril and nitrates in severe congestive heart failure].
Topics: Acute Disease; Administration, Oral; Administration, Sublingual; Captopril; Drug Therapy, Combination; Dyspnea; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Statistics as Topic; Time Factors | 1994 |
Experiences with ACE inhibitors early after acute myocardial infarction. Rationale and design of the German Multicenter Study on the Effects of Captopril on Cardiopulmonary Exercise parameters post myocardial infarction (ECCE).
Topics: Adult; Aged; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Pilot Projects; Recurrence; Survival Rate | 1993 |
Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.
Topics: Adult; Aged; Angina Pectoris; Captopril; Coronary Disease; Digoxin; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Quality of Life; Survival Rate | 1993 |
Effects of angiotensin-converting enzyme inhibitor therapy on presence of late potentials detected using signal-averaged electrocardiography in patients with congestive heart failure.
Topics: Action Potentials; Adult; Aged; Captopril; Cardiomyopathy, Hypertrophic; Coronary Disease; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Function, Left | 1993 |
N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.
Topics: Atrial Natriuretic Factor; Captopril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Peptide Fragments; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Risk Factors; Time Factors | 1994 |
Determinants of the initial effects of captopril on blood pressure, glomerular filtration rate, and natriuresis in mild-to-moderate chronic congestive heart failure secondary to coronary artery disease.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Coronary Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Natriuresis; Norepinephrine; Placebos; Renal Plasma Flow; Sodium | 1994 |
Acute effects of captopril on the renal actions of furosemide in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Captopril; Chronic Disease; Diuresis; Double-Blind Method; Drug Interactions; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Tablets; Time Factors; Urodynamics | 1993 |
Effect of vasodilator therapy on mortality in chronic congestive heart failure.
Topics: Adult; Aged; Captopril; Chi-Square Distribution; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilation; Vasodilator Agents | 1993 |
Acute haemodynamic effects of lisinopril and captopril in patients with severe congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Female; Heart Failure; Hemodynamics; Humans; Lisinopril; Male; Middle Aged | 1993 |
Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril; Prodrugs | 1993 |
Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose.
Topics: Acetylcholinesterase; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Enalapril; Enalaprilat; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Perindopril | 1993 |
Sustained hemodynamic response to flosequinan in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
Topics: Adult; Aged; Captopril; Catheterization, Swan-Ganz; Digitalis Glycosides; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Quinolines; Severity of Illness Index; Thermodilution; Time Factors; Vasodilator Agents; Ventricular Function, Left | 1993 |
[Do ACE inhibitors help prevent heart failure? Results of 3 clinical trials].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans | 1993 |
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Electrocardiography; Female; Fourier Analysis; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Parasympathetic Nervous System; Signal Processing, Computer-Assisted; Time Factors | 1993 |
Long-term survival in the Munich Mild Heart Failure Trial (MHFT).
Topics: Captopril; Follow-Up Studies; Heart Failure; Humans; Odds Ratio; Stroke Volume; Survival Rate; Time Factors | 1993 |
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
Topics: Captopril; Confidence Intervals; Digoxin; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Endurance; Systole | 1993 |
Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Digoxin; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1993 |
[Treatment of heart failure in dogs with ACe inhibitors: comparison of quinapril and captopril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Isoquinolines; Male; Quinapril; Tetrahydroisoquinolines | 1995 |
[Therapeutic effectiveness of Crataegus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Medicine, Traditional; Plants, Medicinal | 1996 |
Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Cardiotonic Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Echocardiography; Electrocardiography, Ambulatory; Half-Life; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydrazones; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Pyridazines; Simendan | 1996 |
A pharmacokinetic and pharmacodynamic evaluation of buffered sublingual captopril in patients with congestive heart failure.
Topics: Administration, Sublingual; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cross-Over Studies; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Phosphates; Potassium Compounds; Renin; Single-Blind Method | 1996 |
Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Male; Predictive Value of Tests; Prospective Studies; Renin; Safety | 1996 |
Which patient benefits from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS).
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Female; Fibrinolytic Agents; Follow-Up Studies; Heart Failure; Humans; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Myocardial Infarction; Streptokinase; Thrombolytic Therapy; Time Factors; Treatment Outcome | 1996 |
Effects of the early administration of zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction. The SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prevalence; Prospective Studies; Time Factors | 1996 |
[Cost effectiveness of captopril after myocardial infarct; comment].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1996 |
Captopril does not acutely modulate plasma endothelin-1 concentration in human congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Radioimmunoassay; Renin; Stroke Volume | 1996 |
Circadian variation in blood pressure and heart rate in nonhypertensive congestive heart failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Circadian Rhythm; Digoxin; Diuretics; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Middle Aged; Norepinephrine | 1996 |
[The effectiveness and tolerance of ramipril in comparison to captopril for heart failure in dogs].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Dog Diseases; Dogs; Female; Heart Failure; Male; Ramipril; Treatment Outcome | 1996 |
Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clonidine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Renin-Angiotensin System; Single-Blind Method; Sympathetic Nervous System; Sympatholytics | 1997 |
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Creatinine; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Imidazoles; Kidney; Losartan; Male; Mortality; Prospective Studies; Stroke Volume; Survival Analysis; Tetrazoles | 1997 |
[When does the treatment with captopril show a better improvement in physical performance in patients with heart failure?].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Physical Endurance; Stroke Volume; Time Factors; Ventricular Dysfunction | 1996 |
Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Quality of Life; Stroke Volume | 1997 |
Vasodilation by urapidil in the treatment of chronic congestive heart failure in addition to angiotensin-converting enzyme inhibitors is not beneficial: results of a placebo-controlled, double-blind study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Odds Ratio; Oxygen Consumption; Piperazines; Quality of Life; Survival Analysis; Vasodilation; Vasodilator Agents | 1997 |
Low-dose but not high-dose captopril increases parasympathetic activity in patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Parasympathetic Nervous System; Stimulation, Chemical | 1997 |
Angiotensin-converting enzyme inhibitors in preventing remodeling and development of heart failure after acute myocardial infarction: results of the German multicenter study of the effects of captopril on cardiopulmonary exercise parameters (ECCE).
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Carbon Dioxide; Cardiomegaly; Double-Blind Method; Echocardiography; Exercise Test; Female; Germany; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen Consumption; Treatment Outcome | 1997 |
An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Female; Heart Failure; Humans; Isoquinolines; Male; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines; Walking | 1997 |
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Renin | 1997 |
Comparison of captopril and ibopamine in mild to moderate heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Deoxyepinephrine; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies | 1997 |
[Does captopril decrease endothelial production of endothelin?].
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Endothelin-1; Endothelin-2; Female; Heart Failure; Humans; Male; Middle Aged; Radioimmunoassay; Renin-Angiotensin System; Stroke Volume; Vascular Resistance | 1997 |
[Clinical course of patients treated with partial left ventriculectomy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Enalapril; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Terminally Ill | 1997 |
Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arteries; Atrial Natriuretic Factor; Baroreflex; Blood Pressure; Body Weight; Captopril; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Renin; Tilt-Table Test; Ventricular Function, Left | 1998 |
Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cross-Over Studies; Female; Gene Deletion; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Lisinopril; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Pressoreceptors; Prospective Studies; Single-Blind Method; Treatment Outcome | 1998 |
Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cilazapril; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life | 1998 |
Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiotonic Agents; Digoxin; Disease Progression; Diuretics; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Neurosecretory Systems; Nicardipine; Norepinephrine; Renin; Severity of Illness Index; Stroke Volume; Treatment Outcome | 1998 |
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Captopril; Coronary Disease; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Israel; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Risk Factors; Survival Rate | 1999 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Double-Blind Method; Electrocardiography; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Vasodilator Agents | 1999 |
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heart Failure; Humans; Losartan; Male; Middle Aged; Research Design; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1999 |
Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Incidence; Italy; Male; Middle Aged; Myocardial Infarction; Survival Rate; Treatment Outcome; Ventricular Function, Left | 1999 |
Effects of losartan and captopril on QT dispersion in elderly patients with heart failure. ELITE study group.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiotonic Agents; Death, Sudden, Cardiac; Electrocardiography; Heart Failure; Humans; Long QT Syndrome; Losartan; Survival Rate; Treatment Outcome | 1999 |
ACE inhibitors still the drug of choice for heart failure--and more.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Death, Sudden, Cardiac; Heart Failure; Humans; Losartan | 1999 |
Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Belgium; Captopril; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 2000 |
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Survival Analysis | 2000 |
Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Volume; Double-Blind Method; Female; Heart Failure; Humans; Losartan; Male; Myocardial Contraction; Radionuclide Ventriculography; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2000 |
[Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Female; Heart Failure; Humans; Losartan; Male; Survival Rate | 1999 |
[A-II blocker or ACE inhibitor in heart failure? Captopril can't be beat].
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Female; Heart Failure; Humans; Losartan; Male; Survival Rate; Treatment Outcome | 1999 |
The value of repeated echocardiographic evaluation in patients with idiopathic dilated cardiomyopathy during treatment with metoprolol or captopril.
Topics: Adult; Captopril; Cardiomyopathy, Dilated; Double-Blind Method; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Prospective Studies; Reproducibility of Results; Treatment Outcome; Ventricular Function, Left | 2000 |
Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Chronic Disease; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Losartan; Male; Neurotransmitter Agents; Norepinephrine; Renin | 1999 |
Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indans; Male; Middle Aged; Propionates; Protease Inhibitors | 1999 |
Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Prospective Studies | 2000 |
[The ELITE 2 study].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Follow-Up Studies; Heart Failure; Humans; Losartan; Middle Aged; Prospective Studies; Time Factors | 2000 |
[Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aortic Valve Insufficiency; Atenolol; Captopril; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis; Rheumatic Heart Disease | 2000 |
Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life substudy.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Losartan; Male; Quality of Life | 2000 |
Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiote
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate | 2001 |
Exercise-induced ventricular arrhythmias in congestive heart failure and role of ACE inhibitors.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Physical Endurance; Prospective Studies; Reference Values; Tachycardia, Ventricular | 1998 |
Comparison of the first dose response of fosinopril and captopril in congestive heart failure: a randomized, double-blind, placebo controlled study.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fosinopril; Heart Failure; Humans; Male; Middle Aged | 2001 |
Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Diuretics; Double-Blind Method; Heart Failure; Humans; Isosorbide Dinitrate; Middle Aged; Myocardial Infarction; Substance Withdrawal Syndrome; Vasodilator Agents | 2001 |
Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Cardiac Catheterization; Carvedilol; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Remodeling | 2001 |
Effects of acute and chronic alacepril treatment on exercise capacity and hemodynamics in patients with heart failure: a preliminary study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption | 2002 |
A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Perindopril; Ventricular Dysfunction, Left | 2001 |
Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypotension; Male; Perindopril; Risk Factors | 2001 |
Left ventricular filling dynamics by Doppler echocardiography in dilated cardiomyopathy: one-year follow-up in patients treated with captopril compared to placebo.
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Ventricular Function, Left | 1992 |
Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
Topics: Atrial Natriuretic Factor; Captopril; Cardiac Catheterization; Cardiac Volume; Double-Blind Method; Epinephrine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Prospective Studies; Renin-Angiotensin System; Ventricular Function, Left | 1992 |
Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
Topics: Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Radioimmunoassay; Single-Blind Method | 1992 |
Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output, Low; Circadian Rhythm; Creatinine; Dipeptides; Female; Heart Failure; Heart Rate; Humans; Kidney; Lisinopril; Male; Middle Aged; Potassium; Renin | 1992 |
Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Captopril; Cardiac Output, Low; Creatinine; Digitalis Glycosides; Dipeptides; Diuretics; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Placebos; Potassium; Urea | 1992 |
[Treatment of mild and moderate cardiac failure with captopril. A multicenter study].
Topics: Adult; Aged; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged | 1992 |
[Captopril in the treatment of patients with congestive heart failure. Its bicycle ergometry evaluation].
Topics: Analysis of Variance; Captopril; Chronic Disease; Digitoxin; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 1992 |
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
Topics: Adult; Captopril; Cardiomegaly; Cardiovascular Diseases; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Stroke Volume; Survival Rate; Ventricular Function, Left | 1992 |
Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.
Topics: Adolescent; Adult; Aged; Captopril; Chronic Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Germany; Heart; Heart Failure; Humans; Male; Middle Aged | 1992 |
Comparison of captopril with enalapril in the treatment of heart failure: influence on hemodynamics and measures of renal function.
Topics: Captopril; Catecholamines; Electrolytes; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged | 1992 |
Comparison of three methods of glomerular filtration rate measurement with and without captopril pretreatment in groups of patients with left ventricular dysfunction.
Topics: Captopril; Chromium Radioisotopes; Chronic Disease; Creatinine; Edetic Acid; Glomerular Filtration Rate; Heart Failure; Humans; Inulin; Kidney Function Tests; Myocardial Infarction; Renal Circulation; Single-Blind Method; Ventricular Function, Left | 1992 |
[Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
Topics: Arrhythmias, Cardiac; Captopril; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Nitroglycerin; Vasodilator Agents | 1992 |
[Results of conventional treatment of severe congestive heart failure with vasodilators].
Topics: Adult; Aged; Captopril; Digoxin; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Time Factors; Vasodilator Agents | 1992 |
A comparison of the effects of captopril and flosequinan in patients with severe heart failure.
Topics: Aged; Captopril; Exercise Test; Heart Failure; Humans; Middle Aged; Quinolines; Vasodilator Agents | 1992 |
Practical issues when initiating captopril therapy in chronic heart failure. What is the appropriate dose and how long should patients be observed?
Topics: Aged; Ambulatory Care; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Humans; Male; Time Factors | 1992 |
[Effect of captopril on the exercise performance in patients with congestive heart failure].
Topics: Adult; Aged; Angiotensin II; Captopril; Dinoprostone; Double-Blind Method; Epoprostenol; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1992 |
The prevention of heart failure--a new agenda.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiovascular Diseases; Enalapril; Follow-Up Studies; Heart Failure; Humans; Myocardial Infarction; Ventricular Function, Left | 1992 |
Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
Topics: Actuarial Analysis; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Time Factors | 1992 |
Acute hemodynamics of pimobendan in chronic heart failure. A comparative crossover study of captopril and pimobendan.
Topics: Aged; Captopril; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pyridazines; Vasodilator Agents | 1992 |
Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure.
Topics: Aged; Angiotensin II; Captopril; Double-Blind Method; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Male; Natriuresis; Renal Circulation; Renin-Angiotensin System | 1992 |
Chagas cardiomyopathy and captopril.
Topics: Adult; Captopril; Chagas Cardiomyopathy; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Single-Blind Method | 1992 |
Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Chronic Disease; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Rate; Humans; Indoles; Male; Middle Aged; Peptidyl-Dipeptidase A; Perindopril; Renin | 1991 |
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril | 1991 |
Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Female; Heart Failure; Humans; Male; Myocardial Infarction; Placebos; Stroke Volume; Thrombolytic Therapy; Time Factors; Ventricular Function, Left | 1991 |
The safety and tolerability of quinapril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypotension; Isoquinolines; Kidney; Male; Middle Aged; Potassium; Quinapril; Tetrahydroisoquinolines | 1990 |
Enalapril in the treatment of congestive heart failure.
Topics: Captopril; Double-Blind Method; Enalapril; Heart Failure; Hemodynamics; Humans; Physical Exertion; Randomized Controlled Trials as Topic | 1990 |
[The effect of captopril on the progression of heart insufficiency].
Topics: Captopril; Death, Sudden, Cardiac; Heart Failure; Humans | 1992 |
Influence of severity of heart failure on the efficacy of angiotensin-converting enzyme inhibition.
Topics: Age Factors; Captopril; Cardiac Output, Low; Cause of Death; Coronary Disease; Digitalis Glycosides; Diuretics; Double-Blind Method; Female; Heart Arrest; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Placebos; Regression Analysis; Risk Factors; Systole; Thorax | 1991 |
Posture determines the nature of the interaction between angiotensin converting enzyme inhibitors and loop diuretics in patients with chronic cardiac failure.
Topics: Aged; Captopril; Chronic Disease; Creatinine; Drug Interactions; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Middle Aged; Posture; Renin-Angiotensin System; Supine Position | 1991 |
[Different changes in the adrenergic system with nitrendipine and captopril and different therapeutic aspects in treatment of hypertension and heart failure].
Topics: Adult; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Norepinephrine | 1991 |
Functional status in the treatment of heart failure by captopril: a multicentre, controlled, double-blind study in family practice.
Topics: Aged; Captopril; Double-Blind Method; Family Practice; Female; Health Status; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1991 |
Circadian rhythm of blood pressure in congestive heart failure and effects of ACE inhibitors.
Topics: Blood Pressure; Captopril; Circadian Rhythm; Drug Administration Schedule; Enalapril; Female; Heart Failure; Humans; Kidney; Male; Middle Aged | 1991 |
Studies of left ventricular dysfunction following myocardial infarction.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Substance Withdrawal Syndrome; Ventricular Function, Left | 1991 |
[Prognosis of mild chronic heart failure: effects of the ACE inhibitor captopril].
Topics: Captopril; Cause of Death; Chronic Disease; Death, Sudden, Cardiac; Double-Blind Method; Epinephrine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Potassium; Survival Rate; Ventricular Function, Left | 1991 |
Skeletal muscle depressed calcium and phosphofructokinase in chronic heart failure are upregulated by captopril--a double-blind, placebo-controlled study.
Topics: Aged; Angiotensin II; Calcium; Captopril; Chronic Disease; Double-Blind Method; Heart Failure; Humans; Middle Aged; Muscles; Phosphofructokinase-1; Serum Albumin | 1991 |
[Acute effect of enoximone and captopril in patients with heart failure].
Topics: Adult; Captopril; Cardiac Output; Cardiotonic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure | 1991 |
[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide].
Topics: Angiotensin II; Atrial Natriuretic Factor; Captopril; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Renin; Ventricular Function, Left | 1991 |
[Comparison of lisinopril and captopril in treatment of severe heart failure (NYHA III-IV) in high risk patients. Preliminary results of the trial].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Lisinopril; Male; Middle Aged | 1991 |
Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Creatine; Diuretics; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Magnesium | 1991 |
Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients.
Topics: Aged; Captopril; Deoxyepinephrine; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Time Factors; Vasodilator Agents | 1991 |
A large-scale trial of captopril for mild to moderate heart failure in the primary care setting.
Topics: Activities of Daily Living; Aged; Captopril; Digoxin; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Office Visits; Physicians, Family; Prospective Studies; Walking | 1991 |
Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Topics: Adult; Aged; Aldosterone; Captopril; Catecholamines; Child; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Middle Aged; Neurotransmitter Agents; Nisoldipine; Randomized Controlled Trials as Topic; Renin | 1990 |
Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.
Topics: Aged; Angina Pectoris; Captopril; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Radionuclide Ventriculography; Stroke Volume | 1991 |
Clinical efficacy of flosequinan in heart failure.
Topics: Aged; Captopril; Drug Evaluation; Exercise; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolines; Vasodilator Agents | 1991 |
Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
Topics: Adult; Aged; Captopril; Cardiomyopathy, Dilated; Chronic Disease; Coronary Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Radionuclide Ventriculography; Random Allocation; Vasodilator Agents | 1991 |
[Enalapril versus captopril in heart failure--effect on blood pressure and kidney function].
Topics: Blood Pressure; Captopril; Creatinine; Electrolytes; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged | 1991 |
Effects of captopril on glucose tolerance in elderly patients with congestive cardiac failure.
Topics: Aged; Aged, 80 and over; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Heart Failure; Humans; Male; Prospective Studies | 1991 |
Mechanocardiographic effects of ACE-inhibitors.
Topics: Captopril; Carotid Arteries; Double-Blind Method; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Kinetocardiography; Male; Middle Aged; Phonocardiography; Pulmonary Wedge Pressure; Pulse; Stroke Volume | 1990 |
Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure.
Topics: Administration, Sublingual; Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Vascular Resistance | 1990 |
Captopril does not prevent nitroglycerin tolerance in heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Nitroglycerin; Renin-Angiotensin System | 1990 |
Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Long-Term Care; Middle Aged; Tachycardia; Vasodilator Agents | 1990 |
Effects of enoximone in patients with heart failure uncontrolled by captopril and diuretics.
Topics: Aged; Captopril; Diuretics; Enoximone; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors | 1990 |
Effects of captopril versus milrinone therapy in modulating the adrenergic nervous system response to exercise in congestive heart failure.
Topics: Aged; Captopril; Cardiotonic Agents; Double-Blind Method; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Pyridones; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Time Factors | 1990 |
[Right ventricular function and effort tolerance in patients with chronic congestive heart insufficiency. A cross-over double-blind study].
Topics: Adult; Captopril; Chronic Disease; Digoxin; Double-Blind Method; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Random Allocation; Stroke Volume; Time Factors | 1990 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output; Coronary Disease; Digoxin; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Furosemide; Heart Block; Heart Failure; Heart Valve Diseases; Heart Ventricles; Humans; Isosorbide; Male; Middle Aged; Nifedipine; Tachycardia; Vasodilator Agents | 1990 |
Captopril improves hemodynamic response to static exercise in patients with congestive heart failure: a double-blind, placebo-controlled, randomized trial.
Topics: Blood Pressure; Captopril; Double-Blind Method; Exercise; Female; Forearm; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Muscle Contraction; Muscles; Myocardial Contraction; Placebos; Randomized Controlled Trials as Topic; Vascular Resistance | 1990 |
[Comparison of enalapril and captopril in the treatment of chronic heart failure].
Topics: Blood Pressure; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Coronary Disease; Enalapril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Humans | 1990 |
[24-hour blood pressure and renal function in cardiac failure during the titration phase of captopril and enalapril].
Topics: Adult; Aged; Blood Pressure; Captopril; Circadian Rhythm; Enalapril; Female; Heart Failure; Heart Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Regression Analysis | 1990 |
[Heart insufficiency and life expectancy--the role of ACE inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Heart Failure; Humans; Prognosis; Randomized Controlled Trials as Topic | 1990 |
Long-term treatment of severe chronic heart failure with captopril: a double-blind, randomized, placebo-controlled, long-term study.
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Placebos; Pulmonary Artery; Random Allocation; Time Factors | 1987 |
Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study.
Topics: Adult; Aged; Aldosterone; Captopril; Clinical Trials as Topic; Digoxin; Epinephrine; Heart Failure; Humans; Isometric Contraction; Middle Aged; Norepinephrine; Osmolar Concentration; Renin | 1987 |
A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Female; Heart Failure; Heart Function Tests; Humans; Lisinopril; Male; Middle Aged; Physical Exertion; Random Allocation | 1987 |
Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.
Topics: Aged; Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Random Allocation | 1988 |
Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
Topics: Adult; Captopril; Cardiotonic Agents; Chronic Disease; Exercise; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Artery; Pyridazines; Random Allocation; Time Factors | 1989 |
The Captopril-Digoxin Multicenter Research Group study on the comparative steps of captopril and digoxin in patients with mild-moderate heart failure: implications for therapy.
Topics: Captopril; Digoxin; Heart Failure; Humans | 1989 |
Acute and chronic effects of ramipril and captopril in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Electrolytes; Female; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Ramipril; Random Allocation | 1989 |
Comparison of the effects of captopril and enoximone in patients with severe heart failure: a placebo controlled double-blind study.
Topics: Adult; Aged; Captopril; Double-Blind Method; Enoximone; Exercise Test; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase Inhibitors; Pulmonary Gas Exchange; Random Allocation; Vascular Resistance | 1989 |
A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Multicenter Studies as Topic; Peptidyl-Dipeptidase A; Renin; Time Factors | 1989 |
Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1989 |
Lisinopril in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Lisinopril; Random Allocation | 1989 |
The effect of the first dose of captopril on blood pressure in infants in heart failure.
Topics: Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Heart Defects, Congenital; Heart Failure; Humans; Infant, Newborn; Renin; Sodium | 1989 |
[Captopril versus digoxin in the treatment of mild to moderately severe heart failure].
Topics: Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Stroke Volume | 1989 |
Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure.
Topics: Blood Pressure; Captopril; Digoxin; Diuretics; Exercise Test; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Renin; Time Factors | 1989 |
[Angiotensin-converting enzyme inhibitors in heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Hemodynamics; Humans; Prognosis | 1987 |
Heart failure management: the impact of drug therapy on survival.
Topics: Captopril; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Time Factors | 1988 |
Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
Topics: Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Lisinopril; Male; Random Allocation; Stroke Volume; Time Factors | 1988 |
[Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Male; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors | 1988 |
[Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo].
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Enalapril; Evaluation Studies as Topic; Heart Failure; Humans; Multicenter Studies as Topic; Placebos; Random Allocation | 1988 |
Enalapril: a second-generation angiotensin converting enzyme inhibitor.
Topics: Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
Evolution of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Design; Enalapril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1988 |
[Comparison of captopril with enalapril in the therapy of heart failure: effect on hemodynamics and kidney function].
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Electrolytes; Enalapril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Random Allocation | 1988 |
Angiotensin-converting-enzyme inhibitors in treatment of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans | 1985 |
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.
Topics: Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Furosemide; Heart Failure; Humans; Male; Middle Aged; Random Allocation | 1986 |
Captopril versus frusemide in moderate heart failure.
Topics: Captopril; Furosemide; Heart Failure; Humans | 1986 |
[Do vasodilators help in chronic heart failure?].
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1987 |
Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
Topics: Amiloride; Captopril; Chronic Disease; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Combinations; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Random Allocation | 1987 |
Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
Topics: Adult; Aged; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Ramipril; Random Allocation; Renin; Vasoconstriction; Vasopressins | 1987 |
A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failure.
Topics: Administration, Oral; Aged; Captopril; Cardiotonic Agents; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Random Allocation; Time Factors | 1987 |
Role of vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Clinical Trials as Topic; Dipeptides; Double-Blind Method; Enalapril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Prazosin; Random Allocation; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1985 |
Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Dipeptides; Enalapril; Heart Failure; Hemodynamics; Humans; Hyperkalemia; Hypotension; Proline; Renin-Angiotensin System; Risk; Time Factors; Vasodilator Agents | 1985 |
ACE inhibitors: enalapril and captopril compared.
Topics: Captopril; Clinical Trials as Topic; Double-Blind Method; Enalapril; Heart Failure; Humans; Hypertension | 1985 |
Comparison of captopril and enalapril in patients with severe chronic heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Creatinine; Digoxin; Diuretics; Drug Therapy, Combination; Electrolytes; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Random Allocation | 1986 |
Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Chronic Disease; Heart Failure; Humans; Middle Aged; Ramipril; Random Allocation; Renin-Angiotensin System | 1987 |
Effects of captopril on survival in patients with heart failure.
Topics: Captopril; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation | 1988 |
Converting enzyme inhibition and heart failure.
Topics: Captopril; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged | 1988 |
[Clinical and hemodynamic effects of nisoldipine and captopril in heart failure: a double-blind comparative study of long and short-term effects].
Topics: Adult; Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Nifedipine; Nisoldipine; Random Allocation; Vasodilator Agents | 1987 |
ACE inhibition for the failing heart: experience with captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Random Allocation | 1988 |
Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle.
Topics: Captopril; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Leg; Male; Middle Aged; Muscles; Oxygen Consumption; Random Allocation; Regional Blood Flow | 1987 |
[Effect of captopril on the life expectancy of patients with chronic heart failure].
Topics: Captopril; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Heart Failure; Humans; Life Expectancy; Random Allocation | 1987 |
Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance.
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Milrinone; Oxygen Consumption; Physical Exertion; Pyridones; Time Factors | 1986 |
Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Prazosin; Renin; Time Factors; Vasopressins; Water-Electrolyte Balance | 1986 |
Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
Topics: Aged; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Renin-Angiotensin System; Rest; Vasodilation; Vasopressins | 1986 |
The effects of captopril on serum digoxin and urinary urea and digoxin clearances in patients with congestive heart failure.
Topics: Captopril; Clinical Trials as Topic; Creatinine; Digoxin; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Tubules; Male; Middle Aged; Potassium; Urea; Urodynamics | 1986 |
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure.
Topics: Aged; Arginine Vasopressin; Blood Platelets; Captopril; Diuresis; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Sodium; Water-Electrolyte Balance | 1986 |
Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
Topics: Adult; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Muzolimine; Radionuclide Imaging; Random Allocation; Time Factors | 1986 |
Comparison of captopril and digoxin in mild to moderate heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Chronic Disease; Digoxin; Heart Failure; Humans; Isometric Contraction; Middle Aged; Physical Exertion; Random Allocation | 1986 |
Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.
Topics: Aged; Captopril; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Random Allocation; Time Factors | 1986 |
Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
Topics: Adult; Aged; Aldosterone; Captopril; Dexamethasone; Electrolytes; Epinephrine; Female; Heart Failure; Humans; Hydrocortisone; Male; Metoclopramide; Middle Aged; Norepinephrine; Prolactin; Proline; Renin; Time Factors | 1985 |
Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study.
Topics: Captopril; Clinical Trials as Topic; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypotension; Isosorbide Dinitrate; Proline; Pulmonary Circulation; Vascular Resistance | 1985 |
[Hemodynamic and clinical effects of captopril in congestive heart failure].
Topics: Adolescent; Adult; Aged; Captopril; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1985 |
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Output; Clinical Trials as Topic; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Proline; Renin; Time Factors; Vascular Resistance | 1985 |
Total body and serum electrolyte composition in heart failure: the effects of captopril.
Topics: Aged; Calcium; Captopril; Chlorides; Creatinine; Double-Blind Method; Female; Heart Failure; Hormones; Humans; Male; Middle Aged; Nitrogen; Phosphorus; Potassium; Renin; Sodium; Urea; Water-Electrolyte Balance | 1985 |
[Clinical studies of the effectiveness of captopril in the treatment of chronic circulatory insufficiency].
Topics: Adult; Aged; Captopril; Chronic Disease; Clinical Trials as Topic; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1985 |
656 other study(ies) available for captopril and Cardiac Failure
| Article | Year |
|---|---|
Effects of the angiotensin-converting enzyme inhibitor captopril on occlusal-disharmony-induced cardiac dysfunction in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enzyme Inhibitors; Heart; Heart Failure; Humans; Mice; Myocardium | 2023 |
Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Lipopolysaccharides; Mice; Porphyromonas gingivalis; Stroke Volume; Ventricular Function, Left | 2023 |
Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclic AMP-Dependent Protein Kinases; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Telmisartan | 2019 |
Angiotensin converting enzyme inhibition improves cerebrovascular control during exercise in male rats with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cerebrovascular Circulation; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Physical Conditioning, Animal; Rats; Rats, Inbred Lew | 2021 |
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Captopril; Chronic Disease; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Models, Biological; Pharmacokinetics; Renal Insufficiency, Chronic; Reproducibility of Results; Young Adult | 2021 |
Captopril Versus Hydralazine-Isosorbide Dinitrate Vasodilator Protocols in Patients With Acute Decompensated Heart Failure Transitioning From Sodium Nitroprusside.
Topics: Adult; Aftercare; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Patient Discharge; Retrospective Studies; Vasodilator Agents | 2021 |
Cardioprotection of Sheng Mai Yin a classic formula on adriamycin induced myocardial injury in Wistar rats.
Topics: Animals; Captopril; Cardiomyopathies; Cardiotonic Agents; Doxorubicin; Drug Combinations; Drugs, Chinese Herbal; Female; Heart Failure; Interleukin-6; Male; Matrix Metalloproteinases; Microscopy, Electron, Scanning; Myocardium; Rats, Wistar; Tumor Necrosis Factor-alpha | 2018 |
Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Comorbidity; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Kidney; Male; Metabolic Syndrome; Rats, Zucker; Renal Circulation; Renal Insufficiency, Chronic; Renin-Angiotensin System; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 2018 |
Arrhythmogenic right ventricular dysplasia, cutaneous manifestations and desmoplakin mutation: Carvajal syndrome.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arrhythmogenic Right Ventricular Dysplasia; Captopril; Cardiomyopathies; Cardiomyopathy, Dilated; Child, Preschool; Defibrillators, Implantable; Desmoplakins; Diuretics; Echocardiography; Electrocardiography; Furosemide; Hair Diseases; Heart Failure; Humans; Keratoderma, Palmoplantar; Magnetic Resonance Imaging, Cine; Male; Metoprolol; Mutation | 2018 |
Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apoptosis; beta Catenin; Blotting, Western; Captopril; Enzyme-Linked Immunosorbent Assay; Heart Failure; In Situ Nick-End Labeling; Janus Kinase 2; Male; Mice; Mice, Inbred C57BL; Myocardium; Signal Transduction; STAT3 Transcription Factor; Wnt3A Protein | 2019 |
Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.
Topics: Angiotensin II; Animals; Captopril; Drugs, Chinese Herbal; Fibrosis; Heart Failure; Heart Ventricles; Hemodynamics; Inflammation; Interleukin-6; Ligation; Male; Matrix Metalloproteinases; NADPH Oxidases; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Ventricular Remodeling | 2014 |
Regression of a large congenital hepatic arteriovenous malformation.
Topics: Arteriovenous Malformations; Captopril; Diuretics; Female; Furosemide; Heart Failure; Hepatic Veins; Humans; Hypertrophy; Infant, Newborn; Liver; Persistent Fetal Circulation Syndrome; Remission, Spontaneous | 2015 |
Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echocardiography; Heart Failure; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Nifedipine; Random Allocation; Rats, Inbred SHR; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
[Effects of Salvianolate on Myosin Heavy Chain in Cardiomyocytes of Congestive Heart Failure Rats].
Topics: Animals; Captopril; Doxorubicin; Drugs, Chinese Herbal; Heart Failure; Male; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Plant Extracts; Rats; Rats, Sprague-Dawley | 2015 |
Apamin-Sensitive Small Conductance Calcium-Activated Potassium Channels were Negatively Regulated by Captopril in Volume-Overload Heart Failure Rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apamin; Calcium; Captopril; Disease Models, Animal; Echocardiography; Gene Expression; Heart Failure; Hemodynamics; Male; Myocytes, Cardiac; Rats; Small-Conductance Calcium-Activated Potassium Channels | 2016 |
Responsive mesoporous silica nanoparticles for sensing of hydrogen peroxide and simultaneous treatment toward heart failure.
Topics: alpha-Cyclodextrins; Animals; Animals, Genetically Modified; Captopril; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Heart Failure; Hydrogen Peroxide; Nanoparticles; Porosity; Silicon Dioxide; Zebrafish | 2017 |
Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Female; Heart Defects, Congenital; Heart Failure; Humans; Hypotension; Infant; Infant, Newborn; Kidney Diseases; Male; Retrospective Studies; Treatment Outcome | 2008 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Positive Airway Pressure; Diagnosis, Differential; Diuretics; Emergency Medicine; Furosemide; Heart Failure; Humans; Nitroglycerin; Pulmonary Edema; Treatment Outcome; Vasodilator Agents | 2008 |
L-arginine fails to prevent ventricular remodeling and heart failure in the spontaneously hypertensive rat.
Topics: Animals; Arginine; Captopril; Cardiomegaly; Heart; Heart Failure; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2009 |
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines | 2008 |
Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Erythropoietin; Female; Heart Failure; Humans; Losartan; Male; Myocardial Infarction; Prognosis; Retrospective Studies | 2009 |
The effect of cardiovascular drugs on pro-inflammatory cytokine secretion and natural killer activity of peripheral blood mononuclear cells of patients with chronic heart failure in vitro.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cytokines; Diuretics; Female; Furosemide; Heart Failure; Humans; In Vitro Techniques; Inflammation Mediators; Killer Cells, Natural; Leukocytes, Mononuclear; Male | 2007 |
Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Enzyme Activation; Heart Failure; Humans; Isoenzymes; Losartan; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocardial Infarction; p38 Mitogen-Activated Protein Kinases; Protein Phosphatase 1; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 2009 |
[Effects of Astragalus membranaccus on cardiac function and SERCA2a gene expression in myocardial tissues of rats with chronic heart failure].
Topics: Animals; Astragalus propinquus; Captopril; Chronic Disease; Disease Models, Animal; Drugs, Chinese Herbal; Gene Expression Regulation; Heart; Heart Failure; Heart Ventricles; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2009 |
Optimising management of chronic heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Heart Failure; Humans; Losartan; Renin-Angiotensin System | 2009 |
Use of captopril in paediatric congestive cardiac failure: early effects on blood pressure and renal function.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Child; Heart Failure; Humans; Hypotension; Kidney | 2010 |
Transcriptional changes associated with recovery from heart failure in the SHR.
Topics: Animals; Antihypertensive Agents; Biomarkers; Blotting, Western; Captopril; Drug Combinations; Echocardiography; Fibroblasts; Gene Expression Profiling; Heart Failure; Hypertension; Male; Oligonucleotide Array Sequence Analysis; Phenylbutyrates; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2010 |
A consistency-adjusted alpha-adaptive strategy for sequential testing.
Topics: Algorithms; Biostatistics; Captopril; Clinical Trials as Topic; Data Interpretation, Statistical; Diabetic Angiopathies; Endpoint Determination; Epidemiologic Research Design; Heart Failure; Humans; Losartan; Pioglitazone; Randomized Controlled Trials as Topic; Thiazolidinediones | 2010 |
Captopril induced reversible acute renal failure in a premature neonate with double outlet right ventricle and congestive heart failure.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double Outlet Right Ventricle; Heart Failure; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Monitoring, Physiologic | 2011 |
Mutation of the calmodulin binding motif IQ of the L-type Ca(v)1.2 Ca2+ channel to EQ induces dilated cardiomyopathy and death.
Topics: Amino Acid Motifs; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Binding Sites; Calcium; Calcium Channels, L-Type; Calmodulin; Captopril; Cardiomyopathy, Dilated; Cells, Cultured; Heart Failure; Metoprolol; Mice; Mice, Mutant Strains; Myocardial Contraction; Myocytes, Cardiac; Protein Structure, Tertiary; Survival Rate | 2012 |
Microcirculatory effects of angiotensin II inhibitors in patients with severe heart failure.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Prospective Studies; Renin-Angiotensin System | 2013 |
[Effects of captopril on the protein expression of Bax and Bcl-2 in chronic pressure overload rats].
Topics: Animals; bcl-2-Associated X Protein; Captopril; Heart Failure; Male; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2012 |
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Captopril; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Heart Failure; Hypertension; Male; MicroRNAs; Natriuretic Peptide, Brain; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Sodium Chloride; Treatment Outcome | 2013 |
Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cross-Over Studies; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents; Patients; Statistics, Nonparametric | 2002 |
[Is it real to replace angiotensin converting enzyme inhibitors as basic remedy in the treatment of chronic heart failure?].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Heart Failure; Humans; Losartan | 2002 |
[Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Austria; Bisoprolol; Captopril; Cardiac Care Facilities; Data Interpretation, Statistical; Diuretics; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Practice Guidelines as Topic; Regression Analysis; Spironolactone; Stroke Volume | 2002 |
[Chronopharmacological approaches to the therapeutic prophylaxis of chronic cardiac insufficiency in type I diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Fosinopril; Glucose; Heart Failure; Hemodynamics; Humans; Immunologic Factors; Male; Oligopeptides; Ramipril; Time Factors | 2003 |
What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Heart Failure; Humans; Losartan; Myocardial Infarction; Randomized Controlled Trials as Topic | 2003 |
Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure.
Topics: Administration, Oral; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Diuresis; Drug Therapy, Combination; Fibrosis; Heart Failure; Heart Ventricles; Hypertension; Hypertrophy; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Spironolactone; Time Factors; Ultrasonography | 2003 |
The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiotonic Agents; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Treatment Failure; Ventricular Remodeling | 2003 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diuretics; Dose-Response Relationship, Drug; Endothelin-1; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radioimmunoassay; Time Factors | 2003 |
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance | 2003 |
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
Topics: Aged; Angiotensin Receptor Antagonists; Captopril; Double-Blind Method; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptide Fragments; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
Congestive heart failure: guidelines for the primary care physician.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Diagnosis, Differential; Diuretics; Heart Failure; Humans; Losartan; Primary Health Care; Risk Factors | 2003 |
Angiotensin-receptor blockade in acute myocardial infarction--a matter of dose.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[Value in heart failure proven again. AT II blocker soon also for post-infarct patients?].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Survival Rate; Tetrazoles; Valine; Valsartan | 2003 |
Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cells, Cultured; DNA; Electrophoresis, Agar Gel; Enzyme Inhibitors; Fibrosis; Heart Failure; Hemodynamics; Hydrogen Peroxide; Inhibitory Concentration 50; Male; Myocytes, Cardiac; Protease Inhibitors; Pyridines; Rats; Rats, Wistar; Thiazepines; Time Factors | 2003 |
[When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2003 |
[New options against undertreatment].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Heart Failure; Hospitalization; Humans; Losartan; Myocardial Infarction; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan | 2003 |
Valsartan, captopril, or both in myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Ethics, Clinical; Heart Failure; Humans; Myocardial Infarction; Placebos; Research Design; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
VALIANT and EUROPA.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Perindopril; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Valsartan in acute myocardial infarction trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Male; Myocardial Infarction; Tetrazoles; Valine; Ventricular Dysfunction, Left | 2004 |
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Comorbidity; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Medical Records; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan; Ventricular Dysfunction, Left | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
Topics: Age Distribution; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benchmarking; Captopril; Cohort Studies; Contraindications; Creatinine; Dose-Response Relationship, Drug; Drug Utilization; Female; Guideline Adherence; Heart Failure; Hospital Mortality; Hospitalization; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Multivariate Analysis; United States; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
[Peripartum heart failure: the underestimated role of frequent diseases in the Sudan-Sahelian area].
Topics: Adult; Africa, Northern; Anemia; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Causality; Developing Countries; Digoxin; Diuretics; Echocardiography; Female; Furosemide; Heart Failure; Humans; Hypertension; Incidence; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Rheumatic Fever; Sudan | 2000 |
Clinical implications of an accurate problem list on heart failure treatment.
Topics: Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Community Health Centers; Cross-Sectional Studies; Drug Utilization Review; Evidence-Based Medicine; Female; Heart Failure; Humans; Logistic Models; Male; Medical Records, Problem-Oriented; Middle Aged; Oregon; Practice Patterns, Physicians'; Retrospective Studies | 2005 |
Captopril-furosemide survival study in experimental heart failure.
Topics: Animals; Captopril; Diuresis; Drug Therapy, Combination; Echocardiography; Furosemide; Heart Failure; Male; Natriuresis; Potassium; Rats; Rats, Wistar; Renin | 2005 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
AT1 receptor in paraventricular nucleus mediates the enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Blotting, Western; Bradykinin; Captopril; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Hemodynamics; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reflex; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sympathetic Nervous System | 2005 |
Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials.
Topics: Aged; Captopril; Clinical Trials as Topic; Confidence Intervals; Data Interpretation, Statistical; Follow-Up Studies; Heart Failure; Humans; Incidence; Losartan; Middle Aged; Models, Statistical; Poisson Distribution; Proportional Hazards Models | 2006 |
Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Captopril; Cardiomyopathy, Dilated; Cell Adhesion Molecules; Cricetinae; Disease Models, Animal; Female; Guanylate Cyclase; Heart Failure; Male; Mesocricetus; Microfilament Proteins; Myocardium; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Size; Oxidative Stress; Phosphoproteins; Receptors, Cytoplasmic and Nuclear; Renin-Angiotensin System; Soluble Guanylyl Cyclase; Superoxides | 2005 |
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Captopril; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Heart Failure; Humans; Hypokalemia; Hypotension; Losartan; Meta-Analysis as Topic; Myocardial Infarction; Renal Insufficiency; Tetrazoles; Valine | 2005 |
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemokine CCL2; Creatinine; Female; Heart Failure; Humans; Immunoenzyme Techniques; Interleukin-6; Losartan; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Assessment; Solubility | 2005 |
[Successful mega studies with heart patients. Valsartan possesses cardioprotective action].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Long-Term Care; Myocardial Infarction; Secondary Prevention; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2006 |
Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Biomarkers; Captopril; Cardiomyopathy, Dilated; Gene Expression; Heart; Heart Failure; Integrases; Male; Metoprolol; Mice; Mice, Inbred Strains; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Organ Size; Survival Analysis; Up-Regulation | 2006 |
Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation.
Topics: Animals; Antihypertensive Agents; Captopril; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Heart Failure; Male; Myosin-Light-Chain Phosphatase; Myosins; Nitric Oxide; Protein Isoforms; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2006 |
Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
Topics: Aged; Body Mass Index; Captopril; Cardiovascular Agents; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Male; Middle Aged; Multivariate Analysis; Oxygen Consumption; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis | 2006 |
Congenital right ventricular diverticulum associated with a ventricular septal defect: a rare echocardiographic finding.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Surgical Procedures; Digoxin; Diuretics; Diverticulum; Echocardiography; Furosemide; Heart Failure; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Infant, Newborn; Male; Myocardial Contraction; Osteogenesis Imperfecta; Stroke Volume | 2006 |
[Isolated non-compaction of the left ventricular myocardium in a neonate--a case report].
Topics: Antihypertensive Agents; Captopril; Cardiotonic Agents; Echocardiography; Heart Defects, Congenital; Heart Failure; Humans; Infant, Newborn; Male; Medigoxin; Myocardium; Shock, Cardiogenic; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriovenous Shunt, Surgical; Captopril; Compliance; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Lisinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Myocardial Contraction; Myocardium; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Time Factors; Venae Cavae; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2007 |
Left bundle branch block is not good for your heart.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bundle-Branch Block; Captopril; Heart Failure; Humans; Myocardial Infarction; Risk Factors; Stroke Volume; Tetrazoles; Time Factors; Valine; Valsartan; Ventricular Dysfunction, Left | 2007 |
Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chemistry, Pharmaceutical; Child; Drug Approval; Drug Stability; Drug Utilization; Health Care Surveys; Heart Defects, Congenital; Heart Failure; Humans; Pharmaceutical Solutions; Pharmacy Service, Hospital; Professional Practice; Tablets; United Kingdom | 2007 |
Heart failure treatment profile at the beta blockers era.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index | 2007 |
Role of renin-angiotensin system in development of heart failure induced by myocardial infarction in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Echocardiography; Electrocardiography; Heart Failure; Myocardial Infarction; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 2007 |
Tailored hormonal therapy in secretory adrenocortical cancer.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Aged; Aldosterone; Alkalosis; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Captopril; Cisplatin; Diarrhea; Doxorubicin; Etoposide; Female; Heart Failure; Humans; Hydrocortisone; Hyperaldosteronism; Hypertension; Hypokalemia; Ketoconazole; Mineralocorticoid Receptor Antagonists; Mitotane; Neoplasm Recurrence, Local; Potassium; Rhabdomyolysis; Spironolactone; Tachycardia | 2007 |
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors; Stroke; Tetrazoles; Valine; Valsartan; Ventricular Dysfunction, Left | 2008 |
Regulation of gene expression in rats with heart failure treated with the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) and the combination of DITPA and captopril.
Topics: Animals; Captopril; Cardiotonic Agents; Diiodothyronines; Drug Therapy, Combination; Gene Expression Regulation; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Heart Failure; Heart Rate; Male; Mitochondrial Proteins; Mitochondrial Proton-Translocating ATPases; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transcriptional Activation; Ventricular Function, Left | 2007 |
Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Drug Therapy, Combination; Endothelin-1; Epinephrine; Female; Heart Failure; Models, Animal; Renin; Renin-Angiotensin System; Sheep; Urocortins; Vascular Resistance | 2008 |
Recovery of heart function in children with acute severe heart failure.
Topics: Acute Disease; Captopril; Carbazoles; Cardiotonic Agents; Carvedilol; Child; Child, Preschool; Databases, Factual; Digoxin; Enalapril; Enoximone; Female; Heart Failure; Heart Function Tests; Humans; Infant; Infant, Newborn; Male; Propanolamines; Treatment Outcome | 2008 |
Gene expression profiles of vascular smooth muscle show differential expression of mitogen-activated protein kinase pathways during captopril therapy of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Captopril; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Heart Failure; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Portal Vein; Rats; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2008 |
From black and white to shades of gray: race and renin-angiotensin system blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Captopril; Heart Failure; Humans; Myocardial Infarction; Renin-Angiotensin System; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Black or African American; Captopril; Female; Heart Failure; Hospitalization; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Systole; Tetrazoles; United States; Valine; Valsartan; Ventricular Dysfunction, Left; White People | 2008 |
Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arterioles; Captopril; Enalapril; Enalaprilat; Heart Failure; Humans; Hypertension; Kinetics; Male; Nifedipine; Renin; Renin-Angiotensin System; Sodium; Teprotide; Vascular Resistance | 1983 |
The action of converting enzyme inhibitors in cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Prazosin; Renin-Angiotensin System | 1984 |
[Angiotensin-converting enzyme inhibition: a pathophysiologically based concept for the therapy of hypertension and heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hypertension; Kinetics; Time Factors | 1984 |
Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Exercise Test; Furosemide; Heart Failure; Hemodynamics; Humans; Hypertension | 1984 |
Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Proline; Renin; Vascular Resistance | 1984 |
Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Heart Failure; Humans; Hypertension; Proline | 1984 |
Pressure dependence of renal hemodynamics and function during converting-enzyme inhibition in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Proline; Renal Circulation; Renin | 1984 |
Regulation of angiotensin converting enzyme.
Topics: Adult; Animals; Captopril; Enalapril; Endothelium; Female; Heart Failure; Humans; Hypertension, Renovascular; Kinetics; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; Pregnancy; Rats; Umbilical Arteries | 1983 |
Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Topics: Adrenalectomy; Angiotensin II; Animals; Blood Pressure; Captopril; Dogs; Enalapril; Female; Heart Failure; Heart Ventricles; Hindlimb; Hypertension; Hypertension, Renal; Kidney; Male; Muscles; Rats; Rats, Inbred SHR; Renin; Sodium; Vasoconstriction | 1983 |
Eosinophilia during captopril treatment.
Topics: Captopril; Eosinophilia; Heart Failure; Humans; Proline; Skin Manifestations | 1980 |
Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.
Topics: Adult; Aged; Blood Pressure; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Time Factors | 1980 |
Absence of rebound deterioration in cardiac function upon withdrawal of captopril for heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Proline; Substance Withdrawal Syndrome | 1981 |
Haemodynamic, hormonal, and electrolyte responses to withdrawal of long-term captopril treatment for heart failure.
Topics: Aged; Angiotensin II; Captopril; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Male; Middle Aged; Potassium; Proline; Sodium; Substance Withdrawal Syndrome; Time Factors | 1981 |
[Vasodilators in heart failure? Basic principles and its role in practice].
Topics: Adrenergic alpha-Antagonists; Captopril; Diazoxide; Furosemide; Heart Failure; Humans; Hydralazine; Minoxidil; Phentolamine; Prazosin; Vasodilator Agents | 1981 |
[Long-term treatment with captopril in arterial hypertension complicated by renal failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Captopril; Female; Furosemide; Heart Failure; Heart Rate; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Proline | 1982 |
Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prazosin; Proline; Vasodilator Agents | 1982 |
[The use of vasodilator agents in the therapy of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diuretics; Heart Failure; Humans; Methyldopa; Nitrates; Nitroprusside; Prazosin; Vasodilator Agents | 1982 |
Alpha-blockers and converting enzyme inhibitors.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Indoramin; Kinetics; Labetalol; Prazosin | 1983 |
[Cardiology 1983--results, problems, developments].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon; Arrhythmias, Cardiac; Bundle of His; Captopril; Cardiac Glycosides; Coronary Disease; Coronary Vessels; Dihydroergotamine; Echocardiography; Electrocoagulation; Fibrinolysis; Heart Failure; Heparin; Humans; Myocardial Infarction; Pacemaker, Artificial; Thromboembolism | 1983 |
Clinical use of captopril in Takayasu's disease.
Topics: Adult; Angiography; Aortic Arch Syndromes; Captopril; Child; Female; Heart Failure; Humans; Hypertension, Renovascular; Male; Proline; Renal Artery Obstruction; Takayasu Arteritis | 1984 |
Extended use of captopril.
Topics: Captopril; Drug Eruptions; Heart Failure; Humans; Proline | 1984 |
Angiotensin-converting enzyme inhibitors.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Renin; Teprotide | 1980 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
Angiotensin converting enzyme inhibition: a new therapeutic modality.
Topics: Captopril; Heart Failure; Humans; Hypertension; Oligopeptides; Proline; Teprotide | 1981 |
The effect of captopril on plasma histamine and histamine release in vitro.
Topics: Adult; Aged; Captopril; Heart Failure; Histamine; Histamine Release; Humans; Hypersensitivity; Hypertension; Mast Cells; Middle Aged; Proline; Skin Tests | 1981 |
Renal response to angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; Dogs; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Kinins; Rabbits; Rats; Renal Circulation; Renin-Angiotensin System; Saralasin; Sodium; Teprotide; Water-Electrolyte Balance | 1982 |
Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Creatinine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Oligopeptides; Proline; Renin; Renin-Angiotensin System; Sodium; Teprotide; Water-Electrolyte Balance | 1982 |
Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oligopeptides; Proline; Renin; Teprotide; Vasodilator Agents | 1982 |
Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Oligopeptides; Oxygen Consumption; Proline; Renin-Angiotensin System; Stroke Volume; Teprotide; Vascular Resistance | 1982 |
Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment.
Topics: Aged; Amylases; Captopril; Cholestasis, Intrahepatic; Female; Heart Failure; Humans; Proline | 1983 |
The management of congestive heart failure.
Topics: Aged; Arrhythmias, Cardiac; Calcium Channel Blockers; Captopril; Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Diuretics; Echocardiography; Female; Heart Failure; Heart Transplantation; History, 17th Century; Humans; Middle Aged; Nitroprusside; Teprotide; Vasodilator Agents | 1984 |
Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output; Coronary Circulation; Forearm; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Oligopeptides; Proline; Regional Blood Flow; Renal Circulation; Renin; Renin-Angiotensin System; Splanchnic Circulation; Teprotide; Vascular Resistance | 1984 |
Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Aprotinin; Blood Pressure; Body Weight; Captopril; Drug Interactions; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Kinetics; Male; Middle Aged; Potassium; Proline; Renin; Renin-Angiotensin System; Sodium | 1984 |
Exfoliative dermatitis from captopril.
Topics: Captopril; Dermatitis, Exfoliative; Drug Eruptions; Heart Failure; Humans; Male; Middle Aged; Proline; Pulmonary Edema | 1982 |
Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.
Topics: Age Factors; Animals; Captopril; Cardiomegaly; Female; Heart Failure; Hemodynamics; Hypertension; Male; Proline; Rats; Rats, Mutant Strains | 1982 |
Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat.
Topics: Age Factors; Animals; Captopril; Cardiomegaly; Female; Heart Failure; Hemodynamics; Hypertension; Proline; Rats; Rats, Inbred Strains; Remission, Spontaneous | 1983 |
[Side effects induced by captopril. Comparison of a series of hypertensive patients with renal failure and a series with cardiac failure].
Topics: Captopril; Drug Eruptions; Eosinophilia; Heart Failure; Humans; Hypertension, Renal; Kidney Failure, Chronic; Proline; Proteinuria; Taste Disorders | 1983 |
Long-term captopril therapy for chronic congestive heart failure.
Topics: Aged; Captopril; Cardiomegaly; Chronic Disease; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Proline; Stroke Volume; Time Factors | 1984 |
Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Proline; Vascular Resistance | 1980 |
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Urea Nitrogen; Captopril; Cardiac Output; Creatinine; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Length of Stay; Male; Middle Aged; Proline; Renin; Vascular Resistance | 1980 |
Progress in vasodilator therapy for heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Proline; Vasodilator Agents | 1980 |
Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Vascular Resistance | 1980 |
Captopril: an oral angiotension converting enzyme inhibitor active in man.
Topics: Adolescent; Adult; Aged; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Heart Failure; Hemodynamics; Humans; Hypertension; Kidney; Male; Middle Aged; Proline; Renal Dialysis | 1980 |
Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Cardiovascular System; Chronic Disease; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Plethysmography; Proline; Radionuclide Imaging; Renin; Stroke Volume | 1981 |
[Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Proline | 1981 |
[Captopril inhibits angiotensin converting enzyme. New principles for therapy in hypertension and heart failure].
Topics: Captopril; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Proline | 1981 |
Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
Topics: Administration, Oral; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Captopril; Heart Failure; Heart Rate; Humans; Hypokalemia; Male; Middle Aged; Natriuresis; Potassium; Proline; Renin; Renin-Angiotensin System; Stroke Volume | 1981 |
Thou, gentle viper: an introduction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Proline | 1982 |
Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Erythrocytes; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Proline; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium; Vascular Resistance | 1982 |
[Captopril in refractory advanced cardiac insufficiency].
Topics: Captopril; Enzyme Inhibitors; Exanthema; Heart Failure; Heart Ventricles; Humans; Peptidyl-Dipeptidase A; Proline; Taste Disorders; Vascular Resistance | 1982 |
Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Catheterization; Echocardiography; Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Nitroprusside; Plethysmography; Prazosin; Proline; Radionuclide Imaging; Renin; Vasodilator Agents | 1982 |
Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Hypotension; Myocardium; Oxygen Consumption; Prazosin; Proline; Vasodilator Agents | 1982 |
Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.
Topics: Acute Kidney Injury; Adult; Aged; Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Proline; Radionuclide Imaging; Renin; Vasodilator Agents | 1982 |
Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Test; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Rest; Vasodilator Agents | 1982 |
Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Proline; Renin; Vasodilator Agents | 1982 |
Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Renin-Angiotensin System; Sodium; Vasoconstriction; Vasodilator Agents | 1982 |
The effect of captopril on postural hemodynamics and autonomic responses in chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cold Temperature; Heart Failure; Hemodynamics; Humans; Middle Aged; Norepinephrine; Posture; Proline; Reflex; Valsalva Maneuver; Vasodilator Agents | 1982 |
Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Catheterization; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Proline; Radionuclide Imaging; Vasodilator Agents | 1982 |
Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Topics: Aldosterone; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Proline; Receptors, Cell Surface; Vascular Resistance; Venous Pressure | 1982 |
Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Captopril; Cardiac Output; Depression, Chemical; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen; Peptidyl-Dipeptidase A; Renin; Stroke Volume | 1982 |
Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin-Angiotensin System | 1982 |
Inhibition of angiotensin-converting enzyme: therapeutic implications.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Hypertension; Male; Proline | 1982 |
Converting enzyme inhibitors in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1983 |
The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dipeptides; Enalapril; Epinephrine; Heart Failure; Hemodynamics; Humans; Norepinephrine; Proline; Renin; Renin-Angiotensin System | 1983 |
[Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Chronic Disease; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Time Factors | 1983 |
[Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Male; Middle Aged; Proline | 1983 |
Clinical application of orally active angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Renin | 1983 |
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Heart Failure; Norepinephrine; Proline; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Vascular Resistance | 1984 |
Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Proline; Renin; Sodium | 1984 |
[Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Hypertension; Proline | 1984 |
[Effects of prostaglandins and kinin-kallikrein system in heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Epoprostenol; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Platelet Aggregation; Proline | 1983 |
Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition.
Topics: Adult; Aged; Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hyponatremia; Male; Middle Aged; Prazosin; Proline | 1984 |
Estimation of angiotensin II receptor activity in chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Receptors, Angiotensin; Receptors, Cell Surface; Renin; Saralasin; Sodium | 1984 |
Cerebral blood flow in patients with congestive heart failure treated with captopril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Brain; Captopril; Cerebrovascular Circulation; Heart Failure; Humans; Middle Aged; Proline; Pulmonary Gas Exchange; Tomography, Emission-Computed; Xenon Radioisotopes | 1984 |
Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Autoradiography; Blood Pressure; Captopril; Cerebrovascular Circulation; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Pulmonary Gas Exchange; Stimulation, Chemical; Xenon Radioisotopes | 1984 |
Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Topics: Adult; Aged; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Female; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Proline; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance | 1983 |
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Topics: Aged; Aldosterone; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Proline; Renin | 1983 |
Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Myocardial Infarction; Prazosin; Regional Blood Flow; Vasoconstriction; Vasodilator Agents | 1983 |
Hypertension and congestive heart failure: benefits of converting enzyme inhibition (captopril).
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hypertension; Proline | 1983 |
New approaches to managing congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Combined vasodilator therapy for chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Proline; Renin-Angiotensin System | 1983 |
The renin-angiotensin system in congestive cardiac failure: a selective review.
Topics: Aldosterone; Angiotensin II; Animals; Captopril; Heart Failure; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Sodium | 1983 |
Captopril in heart failure with renal disease.
Topics: Captopril; Heart Failure; Humans; Kidney Failure, Chronic; Male; Proline | 1983 |
[Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
Topics: Adult; Aged; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Quinazolines | 1983 |
Converting-enzyme inhibitor therapy for chronic heart failure.
Topics: Captopril; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Heart Failure; Hemodynamics; Humans; Hydralazine; Proline; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance | 1983 |
Increased plasma arginine vasopressin levels in patients with congestive heart failure.
Topics: Arginine Vasopressin; Captopril; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Radioimmunoassay; Renin; Renin-Angiotensin System; Vascular Resistance; Vasomotor System; Water-Electrolyte Balance | 1983 |
Azotemia in patients with congestive heart failure treated with captopril.
Topics: Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Uremia | 1983 |
Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Hypotension; Male; Middle Aged; Proline; Pulmonary Wedge Pressure; Risk; Time Factors | 1983 |
Beneficial effect of captopril in a patient with congestive heart failure and ischemic interventricular septal rupture.
Topics: Captopril; Drug Therapy, Combination; Heart Failure; Heart Rupture; Heart Septum; Humans; Male; Middle Aged; Myocardial Infarction; Proline; Vasodilator Agents | 1983 |
[Captopril therapy in chronic congestive heart failure].
Topics: Adult; Aged; Captopril; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Vasodilator Agents | 1983 |
Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Catheterization; Cardiac Output; Drug Tolerance; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Stroke Volume; Time Factors; Vascular Resistance | 1983 |
Further experience with long-term captopril therapy in severe refractory congestive heart failure.
Topics: Adolescent; Adult; Aged; Captopril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Proline | 1983 |
[Alternatives to digitalis therapy].
Topics: Aminopyridines; Amrinone; Captopril; Catecholamines; Diuretics; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance.
Topics: Angiotensin II; Blood Urea Nitrogen; Captopril; Creatinine; Drug Tolerance; Extracellular Space; Heart Failure; Humans; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasodilator Agents | 1983 |
Captopril.
Topics: Captopril; Heart Failure; Humans; Hypertension; Kidney; Proline | 1983 |
Chronic afterload reduction in the treatment of congestive heart failure.
Topics: Captopril; Drug Evaluation; Heart Failure; Humans; Hydralazine; Prazosin; Proline; Quinazolines | 1983 |
Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
Topics: Adolescent; Captopril; Cardiac Catheterization; Child; Child, Preschool; Digoxin; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Mitral Valve Insufficiency; Prazosin; Time Factors; Vasodilator Agents | 1984 |
[Irreversible cardiogenic shock after captopril in a patient with refractory congestive cardiac insufficiency. Case report].
Topics: Adult; Captopril; Heart Failure; Humans; Hypotension; Male; Proline; Shock, Cardiogenic; Ventricular Fibrillation | 1983 |
[Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature].
Topics: Blood Pressure; Captopril; Chlorine; Female; Heart Failure; Heart Rate; Humans; Male; Proline; Renin | 1983 |
[Captopril (Capoten) in the treatment of heart insufficiency].
Topics: Captopril; Heart Failure; Humans; Kinetics; Myocardial Infarction; Proline | 1984 |
Renin, renin substrate, angiotensin II, and vasopressin in plasma during treatment with captopril in hypertension and heart failure.
Topics: Adult; Aged; Angiotensin II; Angiotensinogen; Angiotensins; Blood Pressure; Captopril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Proline; Renin; Time Factors; Vasopressins | 1983 |
Captopril in congestive heart failure resistant to other vasodilators.
Topics: Aldosterone; Captopril; Catecholamines; Drug Resistance; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Vasodilator Agents | 1984 |
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Topics: Adult; Aged; Angiotensin II; Captopril; Chronic Disease; Coronary Disease; Dinoprostone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Proline; Prostaglandins E; Renin; Renin-Angiotensin System | 1983 |
Captopril in refractory heart failure: clinical and hemodynamic observations.
Topics: Adult; Aged; Captopril; Female; Follow-Up Studies; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Proline | 1983 |
Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
Topics: Aged; Captopril; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Organ Size; Physical Exertion; Proline; Stroke Volume; Time Factors | 1984 |
[A clinical study on treatment of refractory heart failure with oral captopril].
Topics: Administration, Oral; Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Rheumatic Heart Disease | 1983 |
[Renin-angiotensin system antagonists].
Topics: Captopril; Cardiac Output; Heart Failure; Heart Rate; Hemodynamics; Humans; Hypertension; Proline | 1983 |
Sodium, water, and congestive heart failure.
Topics: Captopril; Diuretics; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Plasma; Renin-Angiotensin System; Thirst; Vasopressins | 1984 |
Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Output; Female; Forearm; Heart Failure; Hemodynamics; Humans; Liver Circulation; Male; Middle Aged; Proline; Regional Blood Flow; Renin-Angiotensin System; Time Factors; Vascular Resistance | 1984 |
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Natriuresis; Proline; Time Factors | 1984 |
[Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
Topics: Adult; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin-Angiotensin System | 1983 |
[Captopril in congestive heart failure].
Topics: Captopril; Heart Failure; Humans; Proline | 1984 |
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
Topics: Aged; Angiotensin II; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Proline; Renin | 1984 |
Vasodilators for chronic congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Vasodilator Agents | 1984 |
Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia.
Topics: Aged; Captopril; Drug Interactions; Drug Therapy, Combination; Female; Heart Failure; Humans; Hyperkalemia; Hypertension; Male; Middle Aged; Potassium; Proline | 1984 |
[Severe circulatory insufficiency in congestive cardiomyopathy treated successfully with captopril].
Topics: Adult; Blood Circulation; Captopril; Cardiomyopathy, Dilated; Chronic Disease; Heart Failure; Humans; Male; Proline | 1984 |
[Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Proline; Renin-Angiotensin System; Respiration; Vasodilator Agents | 1984 |
[Treatment of congestive heart failure with captopril].
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin | 1984 |
[Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Digoxin; Dihydralazine; Drug Resistance; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Middle Aged; Proline | 1984 |
[The role of vasodilator agents in the emergency treatment of heart failure].
Topics: Aged; Captopril; Emergencies; Female; Heart Failure; Humans; Male; Nitroglycerin; Nitroprusside; Phentolamine; Vasodilator Agents | 1983 |
Vasodilators in the treatment of congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1983 |
[Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
Topics: Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Proline; Renin-Angiotensin System | 1983 |
Vasodilator drugs.
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Humans; Hydralazine; Minoxidil; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Thiocyanates; Vasodilator Agents | 1984 |
[Captopril (Tensobon) in practical use in hypertension and heart failure].
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Proline | 1984 |
[Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
Topics: Aged; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1984 |
[Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Topics: Adult; Aged; Captopril; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Nitroglycerin; Proline; Time Factors; Vasodilator Agents | 1984 |
[Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].
Topics: Adult; Aged; Captopril; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Proline; Vascular Resistance; Vasodilator Agents | 1984 |
Long-term captopril therapy in congestive heart failure: serial hemodynamic and echocardiographic changes.
Topics: Adult; Aged; Captopril; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1982 |
A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Topics: Aldosterone; Blood Pressure; Captopril; Catecholamines; Chronic Disease; Heart Failure; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance | 1982 |
New strategies in the management of severe chronic heart failure: captopril.
Topics: Captopril; Heart Failure; Humans; Proline | 1982 |
Therapy of severe chronic congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Proline | 1982 |
The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Creatinine; Female; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Male; Potassium; Proline; Sodium; Vasodilation; Vasodilator Agents | 1982 |
Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Proline; Vasodilator Agents | 1982 |
Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Lung; Male; Middle Aged; Nitroprusside; Prazosin; Proline; Vascular Resistance; Vasodilation; Vasodilator Agents | 1982 |
Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
Topics: Adult; Aged; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Terbutaline; Vasodilator Agents | 1982 |
"First dose" effect of captopril.
Topics: Adult; Captopril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Proline | 1982 |
Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topics: Aged; Captopril; Exercise Test; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Endurance; Physical Exertion; Proline | 1982 |
Acute and chronic effects of captopril therapy in patients with refractory heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Captopril; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin | 1982 |
Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
Topics: Adult; Aged; Captopril; Chronic Disease; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1982 |
Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Physical Endurance; Proline; Renin | 1982 |
Regional circulatory response to converting-enzyme inhibition in congestive heart failure.
Topics: Aged; Captopril; Coronary Circulation; Female; Forearm; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Regional Blood Flow; Renal Circulation | 1982 |
Beneficial effects of captopril in left ventricular failure in patients with myocardial infarction.
Topics: Aged; Captopril; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Proline | 1982 |
Captopril in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Volume; Coronary Circulation; Female; Heart Failure; Humans; Male; Middle Aged; Proline | 1982 |
Long-term captopril therapy in severe refractory congestive heart failure.
Topics: Adolescent; Adult; Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Proline | 1982 |
Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Topics: Adult; Aged; Captopril; Heart Failure; Hemodynamics; Humans; Hydralazine; Physical Endurance; Proline | 1982 |
Captopril: worldwide clinical experience.
Topics: Captopril; Heart Failure; Humans; Hypertension; Proline | 1982 |
Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
Topics: Aged; Aldosterone; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin; Time Factors | 1982 |
Long-term treatment of congestive heart failure with captopril.
Topics: Adult; Aged; Aldosterone; Captopril; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Proline; Renin | 1982 |
Captopril kinetics in chronic congestive heart failure.
Topics: Adult; Aged; Captopril; Half-Life; Heart Failure; Hemodynamics; Humans; Kinetics; Middle Aged; Proline | 1982 |
Captopril in patients with terminal cardiac failure.
Topics: Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Proline | 1982 |
[Therapy of cardiac insufficiency: vasodilator agents].
Topics: Captopril; Heart Failure; Humans; Nitrates; Phentolamine; Prazosin; Vasodilator Agents | 1982 |
[Experiences with captopril in severe heart ventricular failure].
Topics: Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Vasodilator Agents | 1982 |
Captopril--a new treatment for severe congestive heart failure.
Topics: Agranulocytosis; Animals; Captopril; Echocardiography; Heart Failure; Hemodynamics; Humans; Kinetics; Physical Endurance; Proline; Proteinuria | 1982 |
[Favorable hemodynamic effects of captopril in chronic refractory cardiac decompensation].
Topics: Adult; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1982 |
[Favorable hemodynamic effects of captopril in chronic refractory congestive heart failure].
Topics: Adult; Captopril; Chronic Disease; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1982 |
Sustained effectiveness of minoxidil in heart failure after development of tolerance to other vasodilator drugs.
Topics: Administration, Oral; Aged; Captopril; Cardiac Catheterization; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Hydralazine; Long-Term Care; Male; Minoxidil; Nitroprusside; Pyrimidines; Vasodilator Agents | 1981 |
[Captopril - profile of a new antihypertensive (author's transl)].
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertension, Renovascular; Proline; Rats; Rats, Inbred Strains; Renin | 1981 |
[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
Topics: Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Plethysmography; Proline; Time Factors | 1981 |
Immediate effects of captopril in acute left ventricular failure secondary to myocardial infarction.
Topics: Acute Disease; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Proline; Renin | 1981 |
Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
Topics: Aged; Ambulatory Care; Blood Pressure; Captopril; Cardiac Catheterization; Chronic Disease; Echocardiography; Exercise Test; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Proline; Radionuclide Imaging | 1982 |
Severe hyponatraemia and cardiac failure successfully treated with captopril.
Topics: Adult; Captopril; Heart Defects, Congenital; Heart Failure; Humans; Hyponatremia; Male; Proline | 1982 |
Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Topics: Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Hypertension, Renal; Hypertension, Renovascular; Long-Term Care; Male; Middle Aged; Proline; Renal Artery Obstruction; Renin; Water-Electrolyte Balance | 1982 |
Long-term control of congestive heart failure with captopril.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Volume; Captopril; Cardiac Output; Creatinine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Proline; Renin | 1982 |
Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Topics: Aged; Aldosterone; Angiotensin II; Captopril; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Hydrocortisone; Long-Term Care; Male; Middle Aged; Proline; Renin; Substance Withdrawal Syndrome | 1982 |
Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition.
Topics: Adult; Aged; Aldosterone; Captopril; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Norepinephrine; Posture; Pressoreceptors; Proline; Reflex; Renin | 1982 |
[Therapy of severe chronic cardiac congestive insufficiency with captopril. Short and long-term clinical, hemodynamic and biological effects].
Topics: Angiotensins; Captopril; Child; Child, Preschool; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Proline; Renin | 1982 |
[Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
Topics: Adult; Aged; Captopril; Carbon Dioxide; Catecholamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen; Proline; Renin-Angiotensin System | 1982 |
[Management of congestive heart failure (2). Diuretic administration and vasodilator therapy of cardiac asthma and pulmonary edema (cardiac load reduction) with special reference to SQ 14225 (captopril)].
Topics: Captopril; Diuretics; Dyspnea, Paroxysmal; Female; Heart Failure; Humans; Middle Aged; Proline; Pulmonary Edema; Vasodilator Agents | 1980 |
The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Catecholamines; Chronic Disease; Heart Failure; Heart Rate; Humans; Middle Aged; Norepinephrine; Proline; Renin; Sympathetic Nervous System; Time Factors; Vascular Resistance | 1980 |
Hyponatraemia in congestive heart failure during treatment with captopril.
Topics: Aged; Captopril; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Proline | 1980 |
Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Topics: Administration, Oral; Adult; Aged; Aldosterone; Angiotensin II; Captopril; Cardiac Output; Female; Heart Failure; Hemodynamics; Humans; Leg; Male; Middle Aged; Norepinephrine; Proline; Pulmonary Wedge Pressure; Regional Blood Flow; Renin; Vascular Resistance | 1981 |
Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Topics: Aged; Aldosterone; Angiotensin II; Captopril; Heart Failure; Humans; Kinetics; Male; Middle Aged; Potassium; Proline | 1981 |
Ulceration of the tongue: a complication of captopril therapy.
Topics: Aged; Captopril; Heart Failure; Humans; Male; Proline; Stomatitis, Aphthous; Taste Disorders; Tongue Diseases | 1981 |
Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.
Topics: Adolescent; Adult; Captopril; Female; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Proline | 1981 |
Hyperkinetic circulation associated with captopril therapy for congestive heart failure.
Topics: Adult; Captopril; Female; Heart Failure; Hemodynamics; Humans; Proline | 1981 |
Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects.
Topics: Aged; Captopril; Cardiac Catheterization; Chronic Disease; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1981 |
[Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
Topics: Adult; Captopril; Drug Synergism; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hypertension, Malignant; Kidney Failure, Chronic; Labetalol; Male; Middle Aged; Proline | 1981 |
[Long-term treatment of severe cardiac failure with captopril (author's transl)].
Topics: Adult; Captopril; Cardiomyopathies; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline; Renin | 1981 |
[Results of the treatment of heart failure with captopril].
Topics: Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Proline | 1981 |
Effect of captopril on renal function in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Captopril; Heart Failure; Humans; Kidney; Male; Middle Aged; Proline; Renin; Sodium | 1981 |
Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
Topics: Aged; Captopril; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Proline | 1981 |
[Role of the renin-angiotensin system in the regulation of the vascular resistance of chronic heart failure (author's transl)].
Topics: Captopril; Chronic Disease; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Renin-Angiotensin System; Vascular Resistance | 1981 |
Captopril therapy for severe CHF: hypotensive response in presence of markedly elevated PRA.
Topics: Aged; Captopril; Heart Failure; Humans; Hypotension; Male; Proline; Renin | 1982 |
Evidence against an interaction of angiotensin II with the sympathetic nervous system in man.
Topics: Adult; Aged; Angiotensin II; Captopril; Epinephrine; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Renin; Sympathetic Nervous System | 1981 |
Hyponatraemia as a marker for high renin heart failure.
Topics: Captopril; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Renin; Sodium | 1982 |
Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
Topics: Aged; Captopril; Chronic Disease; Coronary Disease; Dose-Response Relationship, Drug; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Proline | 1982 |
Clinical use of captopril. Illustrative cases.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Proline | 1982 |
Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Captopril; Chronic Disease; Creatinine; Diuretics; Heart Failure; Hemodynamics; Humans; Hypotension, Orthostatic; Middle Aged; Proline; Renin | 1982 |
Renin, the heart and hypertension.
Topics: Aldosterone; Captopril; Heart Failure; Humans; Hypertension; Renin | 1982 |
Hemodynamic effects of captopril in patients with severe chronic heart failure.
Topics: Blood Pressure; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Proline; Renin; Vascular Resistance | 1982 |
The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Topics: Aged; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Proline; Quinazolines; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance | 1982 |
Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Posture; Proline; Sympathetic Nervous System | 1982 |
[Captopril therapy of severe heart failure after carditis].
Topics: Adult; Captopril; Heart Failure; Humans; Male; Myocarditis; Proline | 1982 |
Captopril (capoten) for heart failure.
Topics: Captopril; Heart Failure; Humans; Proline | 1982 |
[Pharmaclinics. Drug of the month. Captopril (Capoten) in diabetic nephropathies].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetic Nephropathies; Heart Failure; Humans; Hypertension, Renovascular | 1995 |
Modulation of norepinephrine release in adriamycin-induced heart failure in rabbits: role of presynaptic alpha 2-adrenoceptors and presynaptic angiotensin II receptors.
Topics: Anesthesia; Angiotensin II; Animals; Captopril; Catecholamines; Decerebrate State; Doxorubicin; Electric Stimulation; Female; Heart Failure; Male; Nitroprusside; Norepinephrine; Pentobarbital; Rabbits; Receptors, Adrenergic, alpha-2; Receptors, Angiotensin; Receptors, Presynaptic; Sympathetic Nervous System; Yohimbine | 1994 |
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents | 1994 |
Effect of captopril treatment on total and central vascular capacitance in dogs with chronic heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Blood Volume; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Wedge Pressure; Vascular Resistance | 1994 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Captopril; Cardiovirus Infections; Enalapril; Encephalomyocarditis virus; Female; Heart; Heart Failure; Hypertrophy, Left Ventricular; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Organ Size; Random Allocation; Tetrazoles; Therapeutic Equivalency | 1995 |
Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Hyponatremia; Kidney Concentrating Ability; Male; Middle Aged; Potassium; Prognosis; Prospective Studies; Sodium | 1995 |
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Heart Failure; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins | 1995 |
[Exercise capacity evaluation in patients with mild to moderate left ventricular dysfunction. Influence of captopril].
Topics: Adult; Captopril; Clinical Protocols; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Time Factors; Ventricular Dysfunction, Left; Walking | 1995 |
Captopril attenuates pacing-induced acute heart failure by increasing total vascular capacitance.
Topics: Acute Disease; Animals; Blood Vessels; Captopril; Compliance; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Pacemaker, Artificial; Vasodilator Agents | 1993 |
[Heart failure--difficult to diagnose. Can a point system identify the patients?].
Topics: Aged; Captopril; Diagnosis, Differential; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Patient Identification Systems; Pilot Projects; Primary Health Care; Sweden | 1995 |
[Comparative assessment of digoxin and captopril in the treatment of chronic congestive circulatory failure, NYHA grade II].
Topics: Adult; Aged; Captopril; Chronic Disease; Digoxin; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Treatment Outcome | 1994 |
Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure.
Topics: Captopril; Combined Modality Therapy; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen; Oxygen Inhalation Therapy; Polysomnography; Sleep Apnea Syndromes | 1995 |
Zofenopril after anterior myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Myocardial Infarction | 1995 |
[Captopril in the treatment of heart failure].
Topics: Captopril; Heart Failure; Humans | 1995 |
Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Dioxolanes; Dipeptides; Disease Models, Animal; Enzyme Induction; Heart Failure; Kidney; Ligation; Lung; Male; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Radioimmunoassay; Rats; Rats, Wistar; Regression Analysis; Renin | 1994 |
[The efficacy of isolated ultrafiltration and Capoten in the combined treatment of chronic heart failure].
Topics: Aged; Captopril; Chronic Disease; Combined Modality Therapy; Drug Evaluation; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Ultrafiltration | 1994 |
[A study of captopril enhancement of nitrate effect coronary arterial disease patients associated with heart failure].
Topics: Adult; Aged; Animals; Captopril; Coronary Circulation; Drug Therapy, Combination; Female; Heart Failure; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Prospective Studies; Rats; Rats, Sprague-Dawley | 1994 |
Captopril treatment does not restore either the renal or the ANF release response during volume expansion in moderate to severe high output heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cardiac Volume; Heart Failure; Kidney; Male; Rats; Rats, Sprague-Dawley | 1994 |
[Influence of prolonged application of captopril upon pulmonary ventilation in patients with chronic congestive heart failure].
Topics: Aged; Captopril; Chronic Disease; Drug Administration Schedule; Heart Failure; Humans; Male; Middle Aged; Respiration; Respiratory Function Tests | 1994 |
Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Topics: Alanine; Amino Acid Sequence; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Bradykinin; Captopril; Cardiomegaly; Dioxoles; Disease Models, Animal; Heart Failure; Hormones; Male; Molecular Sequence Data; Myocardial Infarction; Myocardium; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin | 1994 |
Tumour necrosis factor alpha in severe congestive cardiac failure.
Topics: Body Weight; Captopril; Epinephrine; Heart Failure; Humans; Middle Aged; Prospective Studies; Quinolines; Renin; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1993 |
Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure.
Topics: Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Pulmonary Wedge Pressure | 1994 |
Low-dose combination therapy with metoprolol and captopril for congestive heart failure in mice.
Topics: Animals; Captopril; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Metoprolol; Mice; Mice, Inbred C3H; Myocardium; Necrosis; Organ Size | 1993 |
[Comparative analysis of several treatment methods for severe congestive heart failure].
Topics: Adult; Aged; Aged, 80 and over; Captopril; Digoxin; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Nifedipine | 1993 |
[Acute mitral insufficiency in osteogenesis imperfecta].
Topics: Aortic Valve; Captopril; Cardiac Catheterization; Drug Therapy, Combination; Dyspnea; Echocardiography; Electrocardiography; Female; Furosemide; Glycosaminoglycans; Heart Failure; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Osteogenesis Imperfecta; Pulmonary Edema; Radiography; Rupture, Spontaneous | 1994 |
Beneficial effect of ACE inhibitor in congestive heart failure.
Topics: Animals; Captopril; Drug Administration Schedule; Heart Failure; Humans; Male; Rats; Rats, Wistar; Time Factors; Ventricular Function, Left | 1993 |
Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Creatinine; Endothelins; Female; Heart Failure; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Norepinephrine; Pulmonary Artery; Pulmonary Wedge Pressure; Quinapril; Renin; Stroke Volume; Tetrahydroisoquinolines; Vascular Resistance | 1994 |
Are ACE inhibitors equal in congestive heart failure?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1993 |
Quality control of extemporaneously prepared microdose captopril capsules: weight variation versus content uniformity.
Topics: Capsules; Captopril; Chromatography, High Pressure Liquid; Drug Compounding; Heart Failure; Humans; Quality Control; Random Allocation | 1994 |
[A clinical study of intravenous captopril in heart failure].
Topics: Adult; Angiotensin II; Blood Urea Nitrogen; Captopril; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged | 1993 |
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors.
Topics: Captopril; Chronic Disease; Digoxin; Enalapril; Heart Failure; Humans | 1993 |
ED management of acute congestive heart failure in renal dialysis patients.
Topics: Acute Disease; Administration, Cutaneous; Administration, Oral; Administration, Sublingual; Captopril; Clinical Protocols; Clonidine; Emergency Medical Services; Emergency Medicine; Heart Failure; Humans; Infusions, Intravenous; Intubation, Intratracheal; Kidney Failure, Chronic; Morphine; Nifedipine; Nitroglycerin; Nitroprusside; Oxygen Inhalation Therapy; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Severity of Illness Index; Transportation of Patients | 1993 |
Captopril-induced bone marrow suppression in two cardiac patients with trisomy 21.
Topics: Bone Marrow; Captopril; Down Syndrome; Female; Heart Defects, Congenital; Heart Failure; Humans; Hypertension; Infant; Male; Neutropenia; Postoperative Care | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
[Captopril].
Topics: Captopril; Heart Failure; Humans; Hypertension; Renin-Angiotensin System | 1993 |
Elevated breath pentane in heart failure reduced by free radical scavenger.
Topics: Aged; Captopril; Enalapril; Female; Free Radical Scavengers; Free Radicals; Heart Failure; Humans; Lipid Peroxidation; Male; Middle Aged; Pentanes; Reactive Oxygen Species; Respiration | 1993 |
Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure.
Topics: Animals; Captopril; Cardiac Output; Cattle; Diiodothyronines; Heart Failure; Hemodynamics; Humans; Propionates; Rats; Receptors, Thyroid Hormone; Triiodothyronine | 1993 |
[Captopril in the treatment of congestive heart failure in acute myocardial infarct].
Topics: Aged; Captopril; Heart Failure; Humans; Middle Aged; Myocardial Infarction | 1993 |
Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy.
Topics: Adolescent; Adult; Captopril; Cardiomyopathy, Dilated; Child; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prognosis; Survival Analysis | 1993 |
Combination treatment with captopril and the thyroid hormone analogue 3,5-diiodothyropropionic acid. A new approach to improving left ventricular performance in heart failure.
Topics: Animals; Captopril; Diiodothyronines; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Propionates; Rats; Rats, Sprague-Dawley; Ventricular Function, Left | 1993 |
ACE inhibitor first dose effect.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dipeptides; Heart Failure; Humans; Hypotension; Indoles; Lisinopril; Middle Aged; Perindopril | 1993 |
Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Cardiac Pacing, Artificial; Cyclic GMP; Dogs; Female; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Renin | 1993 |
[Treatment of congestive heart failure complicating chronic Keshen disease with magnesium sulfate and captopril].
Topics: Adolescent; Adult; Captopril; Cardiac Output; Cardiomyopathies; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Humans; Magnesium Sulfate; Male; Selenium; Vascular Resistance | 1993 |
Captopril and spironolactone therapy for refractory congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Captopril; Drug Therapy, Combination; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Potassium; Sodium; Spironolactone | 1993 |
Clinical and neurohumoral response of patients with severe congestive heart failure treated with two different captopril dosages.
Topics: Aldosterone; Atrial Natriuretic Factor; Captopril; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renin; Retrospective Studies; Treatment Outcome | 1993 |
A patient with congestive heart failure.
Topics: Adult; Captopril; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Male; Postoperative Complications; Transposition of Great Vessels | 1993 |
[Angiotensin converting enzyme inhibitor-induced cough: patterns and incidence. Consequences for continuation of therapy].
Topics: Aged; Captopril; Cilazapril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Long-Term Care; Male; Middle Aged | 1993 |
Acute renal failure associated with use of angiotensin converting enzyme inhibitor--a report of two children with Down's syndrome.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child, Preschool; Down Syndrome; Enalapril; Female; Heart Failure; Humans; Infant; Male | 1996 |
Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
Topics: Adenine Nucleotides; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Energy Metabolism; Heart Failure; Hemodynamics; Indoles; Lactates; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Phosphocreatine; Rats; Rats, Wistar | 1995 |
Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiac Output; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Growth Hormone; Heart Failure; Heart Rate; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1995 |
Renal artery stenosis in infants: long-term medical treatment before surgery.
Topics: Antihypertensive Agents; Blood Pressure; Captopril; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension, Renal; Hypertrophy, Left Ventricular; Infant; Male; Renal Artery Obstruction; Retrospective Studies; Treatment Outcome; Urography; Vascular Surgical Procedures | 1996 |
Abnormal left ventricular systolic and diastolic functional response to isometric exercise in idiopathic dilated cardiomyopathy: beneficial effect of captopril.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiomyopathy, Dilated; Echocardiography, Doppler, Pulsed; Exercise; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Systole; Ventricular Function, Left | 1995 |
Congestive cardiac failure following laxative withdrawal.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cathartics; Diuretics; Female; Furosemide; Heart Failure; Humans; Middle Aged; Substance Withdrawal Syndrome; Water-Electrolyte Imbalance | 1996 |
[Economical treatment of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cost-Benefit Analysis; Heart Failure; Humans; Myocardial Infarction | 1996 |
Increase of plasma digoxin levels after withdrawal from therapy in an elderly patient.
Topics: Aged; Captopril; Digoxin; Drug Interactions; Heart Failure; Humans; Male | 1995 |
Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding, Competitive; Biphenyl Compounds; Captopril; Dogs; Heart Failure; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Pyridines; Reference Values; Renin-Angiotensin System; Tetrazoles | 1995 |
Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dipeptides; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hemodynamics; Neprilysin; Sheep | 1996 |
ACE inhibitors unmask incoordinate diastolic wall motion in restrictive left ventricular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Echocardiography; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Middle Aged; Signal Processing, Computer-Assisted; Ventricular Dysfunction, Left | 1996 |
A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Hospital Mortality; Humans; Hyponatremia; Length of Stay; Male; Nigeria; Prognosis; Retrospective Studies | 1996 |
Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Amiodarone; Blood Pressure; Captopril; Coronary Circulation; Digitalis Glycosides; Diuretics; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Nitroprusside; Predictive Value of Tests; Prognosis; Pulmonary Circulation; Vascular Resistance; Vasodilator Agents | 1997 |
[Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Male; Microcirculation; Middle Aged; Treatment Outcome | 1997 |
Effects of afterload-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats.
Topics: Animals; Captopril; Catalase; Glutathione Peroxidase; Heart; Heart Failure; Hemodynamics; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Prazosin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vasodilator Agents; Ventricular Function, Left | 1997 |
Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts).
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Dose-Response Relationship, Drug; Female; Geriatric Assessment; Health Status; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Sensitivity and Specificity; Treatment Outcome | 1997 |
Losartan versus captopril in elderly patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Heart Failure; Humans; Imidazoles; Losartan; Mortality; Randomized Controlled Trials as Topic; Tetrazoles | 1997 |
Losartan versus captopril in elderly patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Heart Failure; Humans; Imidazoles; Kidney; Losartan; Middle Aged; Tetrazoles | 1997 |
Losartan versus captopril in elderly patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Heart Failure; Humans; Imidazoles; Losartan; Mortality; Tetrazoles | 1997 |
Losartan versus captopril in elderly patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Captopril; Heart Failure; Humans; Imidazoles; Losartan; Mortality; Randomized Controlled Trials as Topic; Tetrazoles | 1997 |
Digoxin in patients with heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Digoxin; Heart Failure; Hospitalization; Humans | 1997 |
Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Angiotensin-Converting Enzyme Inhibitors; Animals; beta-Cyclodextrins; Blood Pressure; Captopril; Cardiac Pacing, Artificial; Cyclodextrins; Dipeptides; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Male; Morpholines; Regional Blood Flow; Renal Circulation; Renin | 1997 |
Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Cardiac Output; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Vasodilator Agents; Ventricular Pressure | 1997 |
Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats.
Topics: Aging; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Atrial Natriuretic Factor; Captopril; Cardiomegaly; Gene Expression Regulation; Heart; Heart Failure; Hypertension; Male; Myosin Heavy Chains; Polymerase Chain Reaction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta | 1997 |
Hemodynamic action of captopril in coronary patients with heart failure tolerant to nitroglycerin.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Drug Administration Routes; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Reproducibility of Results; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
Evaluation of Losartan in the Elderly (ELITE) Trial: clinical implications.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Treatment Outcome | 1997 |
Changes in collagen phenotypes during progression and regression of cardiac hypertrophy.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cardiomegaly; Collagen; Heart Failure; Hydroxyproline; Lisinopril; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA | 1997 |
Cardiac amyloidosis and the use of diuretic and ACE inhibitor therapy in severe heart failure.
Topics: Aged; Amyloidosis; Captopril; Cardiomyopathies; Diuretics; Fatal Outcome; Heart Failure; Humans; Male | 1997 |
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular Enlargement.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
[Pheochromocytoma and cardiac insufficiency].
Topics: Adrenal Gland Neoplasms; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Catecholamines; Digitalis; Diuretics; Echocardiography; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Middle Aged; Pheochromocytoma; Plants, Medicinal; Plants, Toxic; Time Factors | 1998 |
Patterns of angiotensin-converting enzyme inhibitor prescriptions, educational interventions, and outcomes among hospitalized patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Prescriptions; Enalapril; Female; Heart Failure; Hospitalization; Humans; Male; Patient Discharge; Patient Education as Topic; Retrospective Studies; Treatment Outcome; Ventricular Function, Left | 1998 |
The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain; Captopril; Evaluation Studies as Topic; Heart Failure; Hemodynamics; Losartan; Male; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley | 1998 |
Angiotensin II receptor antagonists for heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin; Captopril; Clinical Trials as Topic; Heart Failure; Humans; Losartan; Receptors, Angiotensin | 1998 |
[Pregnancy in corrected transposition of great arteries and therapy with ACE inhibitors].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cesarean Section; Dihydralazine; Female; Heart Failure; Heart Septal Defects, Ventricular; Humans; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pregnancy, High-Risk; Pulmonary Valve Stenosis; Transposition of Great Vessels | 1998 |
Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Radioisotope Renography; Renal Artery Obstruction; Sensitivity and Specificity | 1998 |
Simultaneous mucosal and small bowel angioedema due to captopril.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Coronary Disease; Heart Failure; Humans; Hypertension; Intestinal Diseases; Intestinal Obstruction; Intestine, Small; Male; Middle Aged; Mouth Mucosa | 1998 |
Partial left ventriculectomy: preoperative risk factors for perioperative mortality.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Surgical Procedures; Cardiomyopathy, Dilated; Diuretics; Echocardiography; Electrocardiography; Enalapril; Female; Furosemide; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Preoperative Care; Risk Factors; Shock, Cardiogenic | 1998 |
Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Gene Expression; Heart Failure; Irbesartan; Isoenzymes; Male; Myosin Heavy Chains; Organ Size; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger; Systole; Tetrazoles | 1999 |
Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Bradykinin; Captopril; CD13 Antigens; Dipeptides; Female; Glycopeptides; Heart Failure; Humans; Kallidin; Leucine; Male; Membrane Proteins; Middle Aged; Myocardium; Neprilysin; Peptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Substrate Specificity | 1999 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; Digoxin; Diuretics; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Heart Ventricles; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Papillary Muscles | 1999 |
AT1-receptor antagonists for the treatment of chronic heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Dogs; Heart Failure; Humans; Irbesartan; Losartan; Rats; Tetrazoles | 1999 |
An interaction between digoxin and acarbose.
Topics: Acarbose; Aged; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Captopril; Diabetes Mellitus, Type 1; Digoxin; Drug Interactions; Female; Furosemide; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Trisaccharides | 1999 |
The circulating renin-angiotensin system during treatment with metoprolol or captopril in patients with heart failure due to non-ischaemic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Cardiomyopathy, Dilated; Exercise; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Renin; Rest | 1999 |
Chronic eosinophilic pneumonia with pleural effusion.
Topics: Aged; Biopsy; Captopril; Chronic Disease; Dyspnea; Female; Furosemide; Heart Failure; Humans; Lung; Pleural Effusion; Prednisone; Pulmonary Eosinophilia; Radiography, Thoracic; Treatment Outcome | 1999 |
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enalapril; Female; Fosinopril; Heart Failure; Humans; Indoles; Lisinopril; Male; Peptidyl-Dipeptidase A; Perindopril; Treatment Failure | 1999 |
Captopril treatment improves the sarcoplasmic reticular Ca(2+) transport in heart failure due to myocardial infarction.
Topics: Animals; Blood Pressure; Calcium; Calcium-Transporting ATPases; Captopril; Gene Expression Regulation; Heart Failure; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 18S; RNA, Ribosomal, 28S; Sarcoplasmic Reticulum; Ventricular Function, Left | 1999 |
Effects of stimulation frequency on calcium transients in noninfarcted myocardium: modulation by chronic captopril treatment.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium Signaling; Captopril; Disease Models, Animal; Electric Stimulation; Heart Failure; Hydrogen-Ion Concentration; In Vitro Techniques; Intracellular Fluid; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley | 1999 |
Effect of ED management on ICU use in acute pulmonary edema.
Topics: Acute Disease; Aged; Analgesics, Opioid; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Emergency Treatment; Heart Failure; Humans; Intensive Care Units; Logistic Models; Morphine; New Jersey; Nitroglycerin; Odds Ratio; Pulmonary Edema; Respiratory Therapy; Retrospective Studies; Vasodilator Agents | 1999 |
Percutaneous transluminal angioplasty of renal artery stenosis in a 9-month-old hypertensive girl with congestive heart failure.
Topics: Angioplasty, Balloon; Aortography; Captopril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension, Renovascular; Infant; Radionuclide Imaging; Renal Artery Obstruction; Technetium Tc 99m Diethyl-iminodiacetic Acid; Treatment Outcome | 1999 |
Role of basal nitric oxide synthesis in vasoconstrictor hyporeactivity in the perfused rat hindlimb after myocardial infarction: effect of captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelium, Vascular; Heart Failure; Hindlimb; Male; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Rats; Rats, Wistar; Vasoconstriction | 1999 |
ACE inhibitor dosage at the time of listing predicts survival.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Lisinopril; Male; Middle Aged; Prognosis; Ramipril; Survival Analysis | 2000 |
ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Losartan; Male; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2000 |
Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Exercise Tolerance; Heart Failure; Humans; Losartan; Pyridines; Randomized Controlled Trials as Topic; Thiazepines | 2000 |
[Sublingual captopril: indications and advantages?].
Topics: Administration, Oral; Administration, Sublingual; Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Emergencies; Heart Failure; Humans; Hypertension; Nifedipine; Prazosin; Time Factors; Vasodilator Agents | 2000 |
All that glitters is not gold.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Ventricular Dysfunction, Left | 2000 |
Anthracycline induced cardiomyopathy: successful treatment with angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Captopril; Child; Child, Preschool; Daunorubicin; Heart Failure; Humans | 2000 |
Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Female; Heart Failure; Humans; Longitudinal Studies; Male; Peptidyl-Dipeptidase A; Renin | 1999 |
MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.
Topics: Adenine Nucleotides; Animals; Calcium; Captopril; Cardiovascular Agents; Energy Metabolism; Enzyme Inhibitors; gamma-Butyrobetaine Dioxygenase; Heart; Heart Failure; In Vitro Techniques; Male; Methylhydrazines; Mixed Function Oxygenases; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2000 |
Left ventricular dysfunction: causes, natural history, and hopes for reversal.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Coronary Disease; Female; Heart; Heart Failure; Humans; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Randomized Controlled Trials as Topic; Spironolactone; Ventricular Dysfunction, Left; Ventricular Remodeling | 2000 |
Comparison of losartan and captopril in ELITE II.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Heart Failure; Humans; Losartan | 2000 |
Comparison of losartan and captopril in ELITE II.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Heart Failure; Humans; Losartan | 2000 |
Comparison of losartan and captopril in ELITE II.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Dose-Response Relationship, Drug; Drug Administration Schedule; Heart Failure; Humans; Losartan | 2000 |
Comparison of losartan and captopril in ELITE II.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Administration Schedule; Heart Failure; Humans; Losartan; Middle Aged | 2000 |
Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Captopril; Cardiovascular System; Disease Models, Animal; Female; Heart Failure; Hormones; Kidney; Methionine; Myocardial Infarction; Neprilysin; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Water | 2000 |
[Current role of angiotensin II antagonists in the treatment of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Clinical Trials as Topic; Drug Evaluation; Heart Failure; Humans; Losartan | 2000 |
Captopril inhibits the production of tumor necrosis factor-alpha by human mononuclear cells in patients with congestive heart failure.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Monocytes; Tumor Necrosis Factor-alpha | 2001 |
[Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Hyperkalemia; Kidney Failure, Chronic; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Risk Factors; Spironolactone | 2000 |
Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cause of Death; Chronic Disease; Heart Failure; Humans; Losartan; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Survival Rate; Treatment Outcome | 2001 |
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Lisinopril; Male; Retrospective Studies; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
What are 'tissue ACE inhibitors,' and should they be used instead of other ACE inhibitors?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Isoquinolines; Myocardial Infarction; Perindopril; Prodrugs; Quinapril; Ramipril; Stroke; Stroke Volume; Tetrahydroisoquinolines; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
The effects of captopril on serum digoxin levels in patients with severe congestive heart failure.
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiotonic Agents; Digoxin; Drug Administration Schedule; Drug Interactions; Female; Heart Failure; Humans; Male; Middle Aged | 2001 |
[Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].
Topics: Aldosterone; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Heart Failure; Humans; Radioimmunoassay; Ramipril; Renin; Renin-Angiotensin System; Tuberculosis, Pulmonary | 2001 |
Angiotensin II type 1 receptor blockers and congestive heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Heart Failure; Humans; Losartan; Receptor, Angiotensin, Type 1; Sample Size; Selection Bias; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2001 |
Bradykinin infusion in chronic cardiac failure and the effects of captopril.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forearm; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Circulation; Treatment Outcome; Vasodilation | 2001 |
Are angiotensin II receptor blockers indicated in chronic heart failure?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Tetrazoles; Valine; Valsartan | 2002 |
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2001 |
Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure.
Topics: Age Factors; Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Captopril; Cardiomegaly; Coronary Disease; Disease Models, Animal; Heart Failure; Heart Septum; Ligation; Male; Mice; Mice, Inbred C57BL; Multivariate Analysis; Myocardial Infarction; Survival Rate | 2002 |
[Clinical study on treatment of mild-middle degree congestive heart failure with integrated traditional Chinese and Western medicine].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Captopril; Coronary Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Metoprolol; Middle Aged | 2000 |
Reversibility of ventricular dysfunction. Clinical experience in a medical office.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Captopril; Digoxin; Diuretics; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Blood pressure reduction after the first dose of captopril and perindopril.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hypotension; Male; Perindopril; Risk Factors | 2001 |
Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Hypotension; Lisinopril; Perindopril | 2001 |
Becker muscular dystrophy-related cardiomyopathy: a favorable response to medical therapy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Carbazoles; Cardiomyopathies; Carvedilol; Heart Failure; Humans; Male; Muscular Dystrophy, Duchenne; Propanolamines; Stroke Volume; Treatment Outcome | 2002 |
Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Topics: Adrenomedullin; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiotonic Agents; Creatinine; Disease Models, Animal; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Kidney; Peptides; Potassium; Sheep; Sodium; Vasodilator Agents | 2002 |
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Female; Heart Failure; Myocardium; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renin | 2002 |
The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Denervation; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Heart Failure; Injections, Intra-Arterial; Injections, Intravenous; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Neurons; Paraventricular Hypothalamic Nucleus; Pressoreceptors; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Spironolactone | 2002 |
Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure.
Topics: Adult; Aged; Aldosterone; Captopril; Coronary Circulation; Digitalis Glycosides; Diuretics; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Proline; Renin | 1979 |
[The effect of captopril on the immediate quality of life in patients with congestive heart failure].
Topics: Adult; Aged; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Quality of Life; Rheumatic Heart Disease | 1992 |
[Treatment of congestive heart failure using angiotensin I convertase inhibitors].
Topics: Aged; Captopril; Female; Heart Failure; Humans | 1992 |
Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.
Topics: Aged; Aspirin; Blood Flow Velocity; Captopril; Creatinine; Drug Therapy, Combination; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Myocardial Ischemia | 1992 |
Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure.
Topics: Animals; Calcium; Captopril; Heart; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1992 |
Angiotensin-converting enzyme inhibitors and renal function in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure; Captopril; Dipeptides; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Inulin; Kidney; Lisinopril; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Retrospective Studies | 1992 |
Comparison of the first-dose effect of captopril and lisinopril in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output, Low; Circadian Rhythm; Dipeptides; Female; Heart Failure; Heart Rate; Humans; Lisinopril; Male; Middle Aged | 1992 |
Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Topics: Angiotensinogen; Animals; Blood Pressure; Captopril; Enalapril; Heart Failure; Kidney; Male; Natriuresis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors | 1992 |
[Changes in lymphocyte beta-receptor density in patients with heart failure before and after metoprolol or captopril administration].
Topics: Adult; Aged; Captopril; Cardiomyopathy, Dilated; Female; Heart Failure; Humans; Lymphocytes; Male; Metoprolol; Middle Aged; Receptors, Adrenergic, beta; Rheumatic Heart Disease; Stroke Volume; Ventricular Function | 1992 |
[Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure].
Topics: Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pyridazines; Vasodilator Agents | 1992 |
First-dose hypotension, ACE inhibitors, and heart failure in the elderly.
Topics: Aged; Aged, 80 and over; Captopril; Female; Heart Failure; Humans; Hypotension; Male | 1992 |
Lichenoid eruption induced by low dose captopril.
Topics: Aged; Aged, 80 and over; Captopril; Drug Eruptions; Female; Heart Failure; Humans; Lichenoid Eruptions; Skin | 1992 |
Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cardiac Output; Enalaprilat; Heart Failure; Hemodynamics; Hypertension; Injections, Intravenous; Male; Myocardial Infarction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Vascular Resistance | 1992 |
Comparison of the effect of renin inhibition and angiotensin-converting enzyme inhibition in ovine heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Captopril; Catheterization; Heart Failure; Hemodynamics; Male; Oligopeptides; Renin; Sheep | 1992 |
Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy.
Topics: Aged; Atrial Function, Right; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Pressoreceptors; Pulmonary Wedge Pressure | 1992 |
Choice of ACE inhibitor for congestive heart failure.
Topics: Captopril; Dose-Response Relationship, Drug; Enalapril; Heart Failure; Humans | 1992 |
Constipation and colonic perforation complicating calcium resonium therapy.
Topics: Captopril; Colonic Diseases; Constipation; Dose-Response Relationship, Drug; Drug Administration Schedule; Fecal Impaction; Heart Failure; Humans; Hyperkalemia; Intestinal Perforation; Male; Middle Aged; Polystyrenes | 1992 |
Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition.
Topics: Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; beta 2-Microglobulin; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Reference Values; Renin | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Captopril; Cardiomyopathy, Dilated; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged | 1992 |
The influence of captopril on intrahospital mortality and duration of hospitalization in Nigerians with congestive heart failure.
Topics: Captopril; Digoxin; Diuretics; Drug Therapy, Combination; Heart Failure; Hospital Mortality; Hospitals, State; Humans; Length of Stay; Nigeria; Prazosin; Retrospective Studies | 1992 |
Contrasting patterns of arterial and venous dilatation after intravenous captopril in patients with chronic cardiac failure and their relationship to plasma angiotensin II concentrations.
Topics: Aged; Angiotensin II; Arteries; Blood Pressure; Captopril; Female; Heart Atria; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Renin; Vascular Resistance; Vasodilation; Veins | 1992 |
Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
Topics: Adult; Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure | 1992 |
Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril.
Topics: Acute Disease; Adrenal Gland Neoplasms; Adult; Captopril; Cardiomyopathies; Catecholamines; Drug Therapy, Combination; Heart Failure; Humans; Male; Phenoxybenzamine; Pheochromocytoma | 1992 |
Baroreflex control of heart rate in rats with heart failure after myocardial infarction: effects of captopril.
Topics: Animals; Blood Pressure; Captopril; Heart Failure; Heart Rate; Male; Myocardial Infarction; Norepinephrine; Pressoreceptors; Rats; Rats, Sprague-Dawley; Reflex | 1992 |
[Doppler echocardiographic evaluation of vasodilator treatments in patients with cardiac insufficiency. Contribution to the combination of isosorbide dinitrate and captopril].
Topics: Aged; Captopril; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Ventricular Function, Left | 1992 |
Decreased skeletal muscle vasodilation in patients with congestive heart failure.
Topics: Acetylcholine; Atrial Natriuretic Factor; Captopril; Endothelium, Vascular; Exercise; Forearm; Heart Failure; Humans; Male; Middle Aged; Muscles; Nitroglycerin; Nitroprusside; Vascular Resistance; Vasodilation | 1992 |
Perioperative management of a case of severe peripartum cardiomyopathy.
Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Heparin; Humans; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular | 1992 |
[Restrictive cardiomyopathy caused by cardiac amyloidosis in multiple myeloma].
Topics: Aged; Amyloidosis; Biopsy; Captopril; Cardiomyopathy, Restrictive; Diagnosis, Differential; Digitoxin; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Intestinal Mucosa; Myocardium; Rectum | 1992 |
Vasodilator therapy and survival in chronic congestive heart failure.
Topics: Captopril; Heart Failure; Humans; Hydralazine; Prospective Studies; Randomized Controlled Trials as Topic; Vasodilator Agents | 1992 |
Geriatrics nephrology.
Topics: Aged; Aging; Captopril; Digoxin; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases; Lung Diseases, Obstructive; Male | 1992 |
Captopril following acute myocardial infarction.
Topics: Captopril; Heart Failure; Humans; Myocardial Infarction | 1992 |
Sodium cromoglycate for ACE inhibitor cough.
Topics: Administration, Inhalation; Adult; Captopril; Cough; Cromolyn Sodium; Heart Failure; Humans; Male | 1992 |
Effect of captopril therapy on lymphocyte potassium and magnesium concentrations in patients with congestive heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Lymphocytes; Magnesium; Male; Middle Aged; Potassium | 1992 |
Impact of inhibition of angiotensin-converting enzyme on urinary excretion of proteins in chronic heart failure.
Topics: Aged; Aged, 80 and over; Albuminuria; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Retinol-Binding Proteins | 1992 |
[Observations on the natural history of heart failure. Changes due to the therapeutic use of captopril].
Topics: Age Factors; Captopril; Cause of Death; Chi-Square Distribution; Heart Failure; Humans; Incidence; Italy; Retrospective Studies; Sex Factors | 1992 |
The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Cardiac Output; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Renin | 1992 |
Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Captopril; Combined Modality Therapy; Coronary Disease; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Lisinopril; Male; Middle Aged; Recurrence | 1991 |
Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
Topics: Atrial Natriuretic Factor; Captopril; Cyclic GMP; Diuresis; Down-Regulation; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; Natriuresis; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Renal Circulation; Renin-Angiotensin System | 1991 |
The effect of captopril on pharmacokinetics of digoxin in patients with mild congestive heart failure.
Topics: Adult; Aged; Captopril; Creatinine; Digoxin; Female; Half-Life; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged | 1991 |
Response to editorial on antioxidant therapy for chronic heart failure.
Topics: Antioxidants; Captopril; Chronic Disease; Heart Failure; Humans | 1992 |
Response to editorial on antioxidant therapy for chronic heart failure.
Topics: Antioxidants; Captopril; Chronic Disease; Free Radicals; Heart Failure; Humans | 1992 |
Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease.
Topics: Adult; Aged; Captopril; Coronary Disease; Electrocardiography, Ambulatory; Female; Heart; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Parasympathetic Nervous System | 1992 |
Effect of drugs on a noninvasive index of arterial compliance in healthy and heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Captopril; Cardiography, Impedance; Drug Therapy, Combination; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Vascular Resistance | 1991 |
A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.
Topics: Angiotensin II; Captopril; Heart Failure; Humans; Male; Platelet Aggregation; Renin; Serotonin | 1991 |
Angiotensin I converting enzyme inhibitors and cardiac remodeling.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Collagen; DNA; Heart Failure; Male; Myocardial Infarction; Rats; Rats, Inbred Strains | 1991 |
[Clinical application of enzyme inhibitors--hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomegaly; Coronary Disease; Heart Failure; Humans; Hypertension; Male; Oligopeptides; Renin | 1991 |
[Morphofunctional state of the heart and activity of the kallikrein-kinin system in patients with chronic heart failure during treatment with captopril].
Topics: Aged; Captopril; Cardiomegaly; Echocardiography; Female; Heart; Heart Failure; Humans; Kallikrein-Kinin System; Kallikreins; Male; Middle Aged; Myocardial Contraction; Potassium; Sodium | 1991 |
All ACE Inhibitors are not alike.
Topics: Captopril; Heart Failure; Humans; Malondialdehyde; Sulfhydryl Compounds | 1991 |
[A case of successful use of captopril in severe congestive heart failure].
Topics: Captopril; Heart Failure; Humans; Male; Middle Aged; Time Factors | 1991 |
[Dry cough in the elderly patients treated with angiotensin converting enzyme inhibitor].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cough; Enalapril; Female; Heart Failure; Humans; Hypertension; Indans; Male; Smoking; Surveys and Questionnaires | 1991 |
Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Blood Pressure; Captopril; Creatinine; Diuresis; Drug Interactions; Furosemide; Heart Failure; Humans; Male; Middle Aged; Natriuresis | 1991 |
The pharmacokinetics of captopril in infants with congestive heart failure.
Topics: Administration, Oral; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infant; Male; Pilot Projects; Respiration; Vascular Resistance | 1991 |
Captopril.
Topics: Captopril; Heart Failure; Humans; Hypertension; Infant, Newborn; Renin-Angiotensin System | 1991 |
Chorea after cardiopulmonary bypass: exacerbation by captopril.
Topics: Captopril; Cardiopulmonary Bypass; Child; Chorea; Female; Heart Failure; Hemiplegia; Humans; Male; Postoperative Complications | 1991 |
The selection of optimal vasodilator drugs in heart failure based on noninvasive parameters.
Topics: Captopril; Cardiomyopathy, Dilated; Coronary Disease; Dihydralazine; Exercise Test; Heart Failure; Humans; Radionuclide Imaging; Ultrasonography | 1991 |
Modulation of venous tone in heart failure.
Topics: Captopril; Felodipine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Vasodilation; Vasodilator Agents | 1991 |
Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiac Output; Disease Models, Animal; Female; Heart Failure; Male; Rabbits; Vascular Resistance; Vasopressins | 1991 |
Angiotensin-converting inhibitors in patients with congestive heart failure: a class effect?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1991 |
[Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Renin | 1991 |
Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency.
Topics: Aged; Captopril; Contraindications; Enalapril; Female; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged | 1991 |
Effect of captopril on congestive heart failure.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Captopril; Epinephrine; Female; Half-Life; Heart Failure; Humans; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Renin | 1990 |
Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
Topics: Blood Pressure; Captopril; Forearm; Heart Failure; Heart Rate; Humans; Middle Aged; Oxygen Consumption; Physical Exertion; Regional Blood Flow; Renin-Angiotensin System; Vascular Resistance | 1990 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease.
Topics: Adult; Aged; Aldosterone; Captopril; Coronary Disease; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Renin | 1990 |
[Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes].
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Renin | 1990 |
Long- versus short-acting angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
[Blood platelet alpha adrenergic receptors in congestive heart failure. Effects of ACE inhibition].
Topics: Aged; Blood Platelets; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Receptors, Adrenergic, alpha; Time Factors | 1990 |
[The value of lysinopril in cardiac insufficiency].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril | 1990 |
Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Captopril; Diuretics; Drug Therapy, Combination; Female; Ferricyanides; Heart; Heart Atria; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Mitral Valve; Mitral Valve Insufficiency; Nitroprusside; Tricuspid Valve; Tricuspid Valve Insufficiency | 1990 |
[Metabolic and acid-base changes in intensive diuretic therapy in heart failure].
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Amiloride; Blood Glucose; Captopril; Creatinine; Electrolytes; Furosemide; Heart Failure; Humans; Middle Aged | 1990 |
Captopril in the treatment of chronic CHF.
Topics: Captopril; Heart Failure; Hemodynamics; Humans | 1990 |
[Angioneurotic edema of the tongue, induced by administration of ACE inhibitors].
Topics: Angioedema; Captopril; Enalapril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Risk Factors; Tongue Diseases | 1990 |
Intravenous captopril in congestive heart failure.
Topics: Aged; Blood Pressure; Captopril; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged | 1990 |
Marked spontaneous improvement in ejection fraction in patients with congestive heart failure.
Topics: Aged; Alcoholism; Captopril; Digoxin; Diuretics; Enalapril; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Remission Induction; Stroke Volume | 1990 |
[Long-term treatment of congestive heart failure with captopril].
Topics: Adult; Aged; Aged, 80 and over; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1990 |
Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction.
Topics: Animals; Body Weight; Captopril; Coenzymes; Drug Synergism; Energy Metabolism; Female; Heart Failure; Hemodynamics; Myocardial Infarction; Organ Size; Rats; Survival Rate; Ubiquinone | 1990 |
Captopril and systemic lupus erythematosus syndrome.
Topics: Captopril; Heart Failure; Humans; Hypertension; Lupus Erythematosus, Systemic; Male; Middle Aged | 1990 |
Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging?
Topics: Aged; Captopril; Chronic Disease; Female; Free Radical Scavengers; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction | 1990 |
Captopril in congestive heart failure.
Topics: Captopril; Heart Failure; Humans | 1990 |
[Neonatal cardiac insufficiency secondary to renovascular hypertension (report of a case treated with captopril)].
Topics: Captopril; Heart Failure; Humans; Hypertension, Renovascular; Infant, Newborn; Kidney; Kidney Function Tests; Male; Renal Veins; Thrombophlebitis; Ultrasonography | 1990 |
Restoration of cardiac function and structure by converting enzyme inhibition possibilities and limitations of long-term treatment in hypertension and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomegaly; Coronary Circulation; Enalapril; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Oligopeptides; Rats; Teprotide | 1986 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents | 1987 |
Haemodynamic effects of captopril in acute left ventricular failure complicating myocardial infarction.
Topics: Angiotensin II; Blood Pressure; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure; Renin | 1987 |
The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Captopril; Extremities; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Posture; Renin-Angiotensin System; Vascular Resistance | 1985 |
Captopril.
Topics: Captopril; Heart Failure; Humans; Hypertension | 1989 |
[Hemoglobin affinity to oxygen and its correction with captopril in chronic cardiac insufficiency].
Topics: 2,3-Diphosphoglycerate; Adult; Aged; Captopril; Carbon Dioxide; Chronic Disease; Diphosphoglyceric Acids; Female; Heart Failure; Humans; Hypoxia; Male; Middle Aged; Oxygen; Oxyhemoglobins | 1989 |
Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
Captopril in congestive cardiac failure.
Topics: Angiotensin II; Captopril; Heart Failure; Humans; Vasodilation | 1989 |
Captopril-induced hypersensitivity lung disease. An immune-complex-mediated phenomenon.
Topics: Aged; Captopril; Drug Hypersensitivity; Heart Failure; Humans; Hypertension; Immune Complex Diseases; Kidney Failure, Chronic; Male; Pulmonary Eosinophilia | 1989 |
Captopril-related exfoliative dermatitis.
Topics: Captopril; Drug Eruptions; Female; Heart Failure; Humans; Middle Aged | 1989 |
Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure.
Topics: Animals; Atrial Natriuretic Factor; Blood Volume; Captopril; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Premedication; Rats; Rats, Inbred Strains | 1989 |
[Severe generalized exanthema following long-term treatment with captopril].
Topics: Captopril; Drug Eruptions; Drug Therapy, Combination; Heart Failure; Humans; Long-Term Care; Male; Middle Aged | 1989 |
Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Angiotensin I; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Forearm; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Renin; Vasodilation; Veins | 1989 |
Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Lisinopril; Renin-Angiotensin System | 1989 |
Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Dyspnea; Enalapril; Fatigue; Heart Failure; Humans; Lisinopril; Quality of Life; Random Allocation | 1989 |
Regulation of cardiac beta-adrenergic receptors by captopril. Implications for congestive heart failure.
Topics: Adenylyl Cyclases; Animals; Captopril; Cyclic AMP; Drug Evaluation, Preclinical; Drug Interactions; Guinea Pigs; Heart; Heart Failure; Isoproterenol; Leukocytes, Mononuclear; Male; Myocardium; Norepinephrine; Radioligand Assay; Receptors, Adrenergic, beta; Renin-Angiotensin System; Sarcolemma | 1989 |
Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.
Topics: Adult; Aged; Aged, 80 and over; Captopril; Digoxin; Drug Therapy, Combination; Exercise; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Neurotransmitter Agents; Rest | 1989 |
[The effect of bunazosin vs captopril on hemodynamic and neurohumoral parameters in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines; Renin | 1989 |
Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Bradykinin; Captopril; Dinoprostone; Female; Forearm; Heart Failure; Hemodynamics; Humans; Indomethacin; Male; Middle Aged; Plethysmography; Regional Blood Flow; Renin-Angiotensin System | 1989 |
Lack of effect of captopril on serum digoxin in congestive heart failure.
Topics: Captopril; Digoxin; Drug Interactions; Heart Failure; Humans; Random Allocation | 1989 |
Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt.
Topics: Captopril; Ductus Arteriosus, Patent; Endocardial Cushion Defects; Heart Failure; Heart Septal Defects; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Infant | 1989 |
Plasma aldosterone and renin activity.
Topics: Aldosterone; Captopril; Heart Failure; Humans; Infant; Infant, Newborn; Renin; Renin-Angiotensin System | 1989 |
Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril.
Topics: Adult; Aged; Captopril; Dinoprostone; Heart Failure; Humans; Male; Middle Aged | 1989 |
Lower than conventional doses of captopril in the initiation of converting enzyme inhibition in patients with severe congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypotension; Male | 1989 |
[Hemodynamics after sublingual administration of captopril in severe heart failure. A pilot study].
Topics: Administration, Sublingual; Adult; Aged; Blood Pressure; Captopril; Evaluation Studies as Topic; Female; Heart; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Pulmonary Artery; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
[Cardiovascular protection using ACE inhibitors (captopril). Additional benefits for patients with hypertension and coronary insufficiency. Abstracts from the International Symposium on ACE-Inhibition London, 14-17 February 1989].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Hypertension | 1989 |
Hemodynamic and clinical effects of captopril in patients with severe congestive heart failure.
Topics: Adolescent; Adult; Captopril; Drug Evaluation; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1989 |
[Hemodynamic effects of the intravenous administration of captopril in patients with chronic congestive heart failure].
Topics: Adult; Aged; Captopril; Chronic Disease; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged | 1989 |
Attenuation of the pressor response to intravenous furosemide by angiotensin converting enzyme inhibition in congestive heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Female; Furosemide; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Renin | 1989 |
[The hemodynamic effect of Capoten in patients with myocardial infarct complicated by heart failure].
Topics: Aged; Captopril; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors | 1989 |
[Acute and long-term effects of captopril in patients with left ventricular dysfunction and dilatation: evaluation of function and work capacity].
Topics: Aged; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Exercise; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged | 1989 |
[Captopril-induced attacks of bronchial asthma].
Topics: Adult; Asthma; Captopril; Heart Failure; Humans; Male | 1989 |
Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.
Topics: Adult; Captopril; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Disease; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1989 |
Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Enalapril; Female; Heart Failure; Humans; Hyponatremia; Kidney Diseases; Male; Middle Aged; Renin; Risk Factors; Sodium | 1987 |
Angiotensin converting enzyme inhibitors in the elderly.
Topics: Aged; Captopril; Enalapril; Heart Failure; Humans | 1987 |
[A case of severe heart failure complicating chronic hemodialysis in which angiotensin converting enzyme inhibitor was markedly effective].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodialysis, Home; Humans; Indans; Male | 1987 |
Lack of cross sensitivity between captopril and enalapril.
Topics: Captopril; Drug Eruptions; Enalapril; Female; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Male; Middle Aged; Proteinuria; Taste Disorders | 1988 |
Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
Topics: Aged; Blood Pressure; Bucladesine; Captopril; Cardiac Output; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1988 |
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; GTP-Binding Proteins; Heart Failure; Heart Ventricles; Humans; Lisinopril; Lymphocytes; Male; Middle Aged; Myocardium; Receptors, Adrenergic, beta; Reference Values | 1988 |
ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hypertension | 1988 |
[Therapy of heart failure. Value of a causal approach].
Topics: Captopril; Heart Failure; Humans; Hypertension; Proline | 1985 |
Neurohumoral vasoconstrictor systems in heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Captopril; Cardiac Output; Dogs; Heart; Heart Failure; Neurotransmitter Agents; Norepinephrine; Osmolar Concentration; Prazosin; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Vascular Resistance; Vasoconstriction | 1985 |
Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Enalapril; Erythema; Heart Failure; Humans; Hypotension; Neutropenia; Renin-Angiotensin System; Taste | 1985 |
Angiotensin-converting-enzyme inhibitors and treatment of heart failure.
Topics: Aged; Captopril; Cerebrovascular Circulation; Heart Failure; Humans; Middle Aged; Pilot Projects | 1985 |
[Therapy of chronic heart failure with vasodilators].
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Clonidine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Prazosin; Saralasin; Vascular Resistance; Vasodilator Agents | 1986 |
Intravenous captopril for cardiac failure.
Topics: Captopril; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Rectal Neoplasms; Time Factors | 1986 |
Intravenous captopril in acute heart failure.
Topics: Acute Disease; Adult; Captopril; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged | 1988 |
Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.
Topics: Adult; Aged; Captopril; Creatinine; Drug Eruptions; Dysgeusia; Female; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Male; Middle Aged; Renal Circulation; Renin | 1986 |
Antidiuretic hormone and atrial natriuretic peptide in congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Renin; Tachycardia, Paroxysmal; Vasopressins | 1986 |
Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy.
Topics: Atrial Function; Atrial Natriuretic Factor; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Posture; Pressure; Pulmonary Wedge Pressure | 1988 |
[Does the measurement of plasma ANP have a diagnostic or prognostic value in patients with organic heart disease?].
Topics: Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiac Catheterization; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Prognosis | 1988 |
Neurohumoral and hemodynamic changes in congestive heart failure: lack of correlation and evidence of compensatory mechanisms.
Topics: Adaptation, Physiological; Adult; Aged; Aldosterone; Atrial Natriuretic Factor; Captopril; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Posture; Renin; Renin-Angiotensin System; Vascular Resistance; Vasopressins | 1988 |
[Acute and long-term effect of captopril in severe chronic heart failure].
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Captopril; Chronic Disease; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Proline; Time Factors | 1985 |
Hormone and haemodynamic effects of angiotensin II infusion during captopril treatment for heart failure.
Topics: Adrenocorticotropic Hormone; Aged; Angiotensin II; Captopril; Female; Heart Failure; Hemodynamics; Hormones; Humans; Hydrocortisone; Male; Middle Aged; Norepinephrine; Proline | 1985 |
Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Exercise Test; Heart Failure; Humans; Lactates; Lactic Acid; Leg; Male; Middle Aged; Muscles; Oxygen Consumption; Physical Exertion; Regional Blood Flow; Renin-Angiotensin System; Vascular Resistance | 1985 |
Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Female; Heart Failure; Humans; Hypotension; Male; Middle Aged; Nitroglycerin; Proline; Pulmonary Circulation; Renin-Angiotensin System; Stroke Volume; Time Factors; Vascular Resistance; Vasodilation | 1985 |
Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renin | 1985 |
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Sodium; Vasodilator Agents | 1986 |
The kidney in heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Volume; Captopril; Diuresis; Glomerular Filtration Rate; Heart Failure; Homeostasis; Humans; Hyponatremia; Kidney; Kidney Tubules; Natriuresis; Natriuretic Agents; Prostaglandins; Renal Circulation; Renin; Renin-Angiotensin System; Sodium; Sympathetic Nervous System | 1986 |
Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Renin-Angiotensin System | 1985 |
[Coronary and renal circulation in patients with cardiac failure after converting enzyme inhibitors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiac Output; Coronary Circulation; Enalapril; Heart Failure; Humans; Myocardium; Oxygen Consumption; Renal Circulation; Renin-Angiotensin System; Vasoconstriction | 1985 |
Provocation of hyper- and hypokalemic sudden death during treatment with and withdrawal of converting-enzyme inhibition in severe chronic congestive heart failure.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Death, Sudden; Enalapril; Heart Arrest; Heart Failure; Humans; Hyperkalemia; Hypokalemia; Male; Middle Aged; Potassium; Resuscitation; Substance Withdrawal Syndrome | 1986 |
Combined spironolactone and converting-enzyme inhibitor therapy for refractory heart failure.
Topics: Adult; Captopril; Diuresis; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Oligopeptides; Spironolactone; Teprotide | 1986 |
[The hemodynamic effects of captopril].
Topics: Adult; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System | 1985 |
[Therapy of chronic heart failure with vasodilator agents].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Enalapril; Heart Failure; Hemodynamics; Humans; Regional Blood Flow; Vascular Resistance; Vasodilator Agents | 1986 |
Effects of acute angiotensin converting enzyme inhibition on renal blood flow in patients with stable congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Enalaprilat; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renal Circulation; Thermodilution | 1986 |
Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Renal Circulation; Renin-Angiotensin System | 1986 |
Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans; Hyperkalemia; Hypotension; Sodium Chloride | 1986 |
Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Therapeutic Equivalency; Vascular Resistance | 1986 |
The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Catheterization; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoquinolines; Male; Middle Aged; Pulmonary Circulation; Quinapril; Tetrahydroisoquinolines | 1986 |
Acute renal effects of captopril in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renal Circulation; Renin; Sodium | 1986 |
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Captopril; Creatinine; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1987 |
Inhibition of angiotensin-converting enzyme in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Heart Failure; Humans | 1987 |
[Inhibitors of angiotensin convertase (inhibitory ACE) in chronic heart failure].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans; Middle Aged | 1987 |
Introduction to the symposium on practical aspects of angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension | 1987 |
Angiotensin-converting enzyme inhibition therapy in heart failure: practical guidelines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Hemodynamics; Humans | 1987 |
Guidelines for vasodilator therapy of congestive heart failure in infants and children.
Topics: Captopril; Child; Child, Preschool; Enalapril; Heart Diseases; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hydralazine; Infant; Nifedipine; Nitroglycerin; Nitroprusside; Phentolamine; Prazosin; Vasodilator Agents | 1987 |
Relation of arrhythmias and electrolyte abnormalities to survival in patients with severe chronic heart failure.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Captopril; Enalapril; Exercise Test; Female; Heart Failure; Heart Ventricles; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Prognosis; Prospective Studies | 1987 |
When to use ACE inhibitors in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans | 1986 |
[The treatment of chronic cardiac decompensation].
Topics: Captopril; Enalapril; Heart Failure; Humans | 1987 |
Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enalapril; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Rats; Renal Circulation; Renin-Angiotensin System; Water-Electrolyte Balance | 1987 |
Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 2; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Renin-Angiotensin System | 1987 |
Effects of captopril on cardiorenal hemodynamics in patients with severe chronic congestive heart failure.
Topics: Blood Pressure; Captopril; Coronary Circulation; Electrolytes; Glomerular Filtration Rate; Heart Failure; Humans; Peptidyl-Dipeptidase A; Renal Circulation; Renin | 1987 |
Echocardiographic assessment of the effect of therapy on left ventricular function in congestive heart failure.
Topics: Aged; Captopril; Digoxin; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1988 |
Direct and indirect assessment of skeletal muscle blood flow in chronic congestive heart failure.
Topics: Captopril; Cardiac Output; Heart Failure; Humans; Lactates; Lactic Acid; Milrinone; Muscles; Phosphodiesterase Inhibitors; Physical Exertion; Pyridones; Regional Blood Flow; Thermodilution; Xenon Radioisotopes | 1988 |
Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Failure; Humans; Muscles; Oxygen Consumption; Physical Exertion; Regional Blood Flow; Vascular Resistance; Vasodilation | 1988 |
Role of vasopressin in experimental heart failure.
Topics: Animals; Aortic Valve Stenosis; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Valve Stenosis; Rats; Renin-Angiotensin System; Teprotide; Water-Electrolyte Balance | 1988 |
Renal artery stenosis in heart failure.
Topics: Aged; Captopril; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; Renal Artery Obstruction | 1988 |
[Captopril in the treatment of chronic heart failure].
Topics: Captopril; Chronic Disease; Combined Modality Therapy; Diet, Sodium-Restricted; Drug Evaluation; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Kidney; Rheumatic Heart Disease | 1988 |
Influence of captopril on the arterial baroreceptor reflex in patients with heart failure.
Topics: Adult; Aged; Autonomic Nervous System; Captopril; Carotid Sinus; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Pressoreceptors; Reflex; Renin; Vagus Nerve | 1988 |
Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
Topics: Blood Pressure; Captopril; Cardiac Output; Drug Combinations; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Contraction; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1988 |
Comparative effects of captopril, nitroprusside, dopamine and lanatoside C on a new model of rabbit congestive heart failure.
Topics: Animals; Captopril; Disease Models, Animal; Dopamine; Female; Ferricyanides; Heart Failure; Hemodynamics; Lanatosides; Male; Myocardial Contraction; Nitroprusside; Rabbits | 1988 |
Angiotensin converting enzyme inhibition and ventricular remodeling in heart failure.
Topics: Animals; Blood Pressure; Captopril; Female; Heart Failure; Hemodynamics; Hypertension; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1988 |
Exercise tolerance in congestive heart failure. Role of cardiac function, peripheral blood flow, and muscle metabolism and effect of treatment.
Topics: Captopril; Extremities; Heart; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Spectroscopy; Muscles; Oxygen Consumption; Phosphocreatine; Physical Exertion; Regional Blood Flow | 1988 |
The renin-angiotensin system and treatment of heart failure.
Topics: Angiotensin I; Captopril; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Renin-Angiotensin System; Sodium | 1988 |
Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Cardiac Volume; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stroke Volume | 1988 |
[Renal effects of captopril in chronic heart failure].
Topics: Captopril; Chronic Disease; Diuresis; Heart Failure; Humans; Kidney; Middle Aged; Renin-Angiotensin System | 1988 |
Indications and effects of captopril therapy in childhood.
Topics: Adolescent; Captopril; Cardiomyopathy, Dilated; Cardiomyopathy, Restrictive; Child; Child, Preschool; Digitalis; Diuretics; Drug Resistance; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Infant; Male; Plants, Medicinal; Plants, Toxic; Stroke Volume | 1988 |
[Hyponatremia induced by captopril in patients with congestive cardiac insufficiency. A report of 2 cases].
Topics: Captopril; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Sodium | 1988 |
Treatment of cardiac failure in infants.
Topics: Alprostadil; Captopril; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Indomethacin; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside | 1986 |
Captopril in elderly patients with heart failure.
Topics: Aged; Captopril; Cardiac Output; Heart Failure; Humans; Stroke Volume | 1986 |
Effect of captopril on the cerebral circulation in chronic heart failure.
Topics: Adult; Blood Pressure; Captopril; Cerebrovascular Circulation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Xenon Radioisotopes | 1986 |
[Short and intermediate-term hemodynamic study at rest and during exercise of cardiac insufficiency treated by captopril].
Topics: Adult; Captopril; Echocardiography; Exercise Test; Heart Failure; Heart Rate; Hemodynamics; Humans; Lactates; Middle Aged; Rest | 1986 |
Sympathetic activation on effort in patients with chronic heart failure. Long term effects of captopril.
Topics: Adult; Aged; Captopril; Carbon Dioxide; Cardiac Output; Echocardiography; Exercise Test; Heart Failure; Humans; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Oxygen; Sympathetic Nervous System | 1988 |
Isometric exercise for the evaluation of vasodilatory therapy in severe congestive heart failure.
Topics: Adult; Aged; Captopril; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Severe cutaneous reactions to captopril.
Topics: Aged; Captopril; Dermatitis, Exfoliative; Erythema; Female; Heart Failure; Humans; Male; Middle Aged; Proline; Skin Diseases | 1985 |
Short-term hemodynamic effects of captopril in infants with congestive heart failure.
Topics: Captopril; Female; Heart Failure; Heart Septal Defects; Hemodynamics; Humans; Infant; Male; Pulmonary Circulation; Time Factors; Vascular Resistance | 1988 |
[Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
Topics: Aged; Captopril; Female; Heart Failure; Heart Ventricles; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Contraction; Systole; Vasodilator Agents | 1988 |
Captopril-induced oesophagitis.
Topics: Aged; Aged, 80 and over; Captopril; Esophagitis; Female; Heart Failure; Humans; Time Factors | 1988 |
Simplified determination of captopril in plasma by high-performance liquid chromatography.
Topics: Captopril; Chromatography, High Pressure Liquid; Disulfides; Heart Failure; Humans; Infant | 1988 |
Captopril in heart failure secondary to a left to right shunt.
Topics: Captopril; Heart Failure; Heart Septal Defects, Ventricular; Humans; Infant; Infant, Newborn; Retrospective Studies | 1988 |
Captopril and digoxin in mild to moderate heart failure.
Topics: Captopril; Digoxin; Exercise Test; Heart Failure; Hemodynamics; Humans | 1988 |
[Captopril in the treatment of mild cardiac insufficiency in combination with arterial hypertension].
Topics: Adult; Blood Pressure; Captopril; Coronary Disease; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction | 1987 |
Effect of captopril on left ventricular end-systolic pressure-volume and stress-shortening relations in severe cardiac failure.
Topics: Aged; Captopril; Cardiac Output; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Oxygen Consumption; Pressure; Radionuclide Imaging; Stroke Volume | 1987 |
Effects of captopril on peripheral hemodynamics in severe congestive heart failure.
Topics: Blood Pressure; Captopril; Female; Forearm; Heart Failure; Hemodynamics; Hormones; Humans; Indomethacin; Male; Middle Aged; Regional Blood Flow; Vascular Resistance | 1987 |
Recovery from neonatal myocardial dysfunction after treatment of acute hypertension.
Topics: Captopril; Female; Heart Failure; Humans; Hypertension, Renovascular; Infant, Newborn; Renal Artery Obstruction; Thrombosis | 1987 |
Captopril-induced liver dysfunction.
Topics: Captopril; Cholestasis, Intrahepatic; Heart Failure; Humans; Liver; Male; Middle Aged | 1987 |
Captopril in treatment of infant heart failure: a preliminary report.
Topics: Body Weight; Captopril; Cardiac Catheterization; Drug Evaluation; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Hypertension, Pulmonary; Hypotension; Infant; Infant, Newborn; Respiration; Retrospective Studies | 1987 |
Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure.
Topics: Adult; Aged; Blood Flow Velocity; Captopril; Exercise Test; Femoral Vein; Heart Failure; Humans; Lactates; Male; Middle Aged; Muscles; Oxygen; Oxygen Consumption | 1987 |
[Captopril in the treatment of chronic congestive heart failure].
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
[Decrease in arterial PO2 with captopril administration in secondary pulmonary hypertension and right heart failure].
Topics: Captopril; Heart Failure; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged; Oxygen; Pulmonary Heart Disease; Pulmonary Wedge Pressure; Ventilation-Perfusion Ratio | 1987 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
[New developments in the treatment of chronic circulatory insufficiency].
Topics: Captopril; Chronic Disease; Heart Failure; Humans; Nifedipine | 1987 |
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
Topics: Adult; Aged; Captopril; Coronary Disease; Dinoprostone; Heart Failure; Humans; Male; Middle Aged; Prostaglandins E; Renin-Angiotensin System | 1987 |
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril.
Topics: Animals; Captopril; Cardiomyopathies; Dobutamine; Doxorubicin; Heart Failure; Hemodynamics; Isosorbide Dinitrate; Rabbits; Regional Blood Flow | 1987 |
Arrhythmias during concurrent therapy with captopril and frusemide.
Topics: Aged; Arrhythmias, Cardiac; Captopril; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Hypokalemia; Male; Potassium | 1987 |
Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Renal Circulation; Renin | 1987 |
[Long-term administration of captopril in the treatment of severe congestive heart failure].
Topics: Adult; Aged; Captopril; Heart Failure; Humans; Middle Aged | 1986 |
Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Captopril; Cardiac Output; Cardiotonic Agents; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Time Factors; Vascular Resistance | 1986 |
Intravenous captopril treatment in patients with severe cardiac failure.
Topics: Adult; Aged; Captopril; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged | 1986 |
Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
Topics: Aged; Captopril; Cardiotonic Agents; Creatinine; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dopamine; Drug Resistance; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Sodium | 1986 |
Captopril in a case of severe congestive heart failure and peripheral vascular disease.
Topics: Blood Circulation; Captopril; Fingers; Heart Failure; Humans; Male; Middle Aged; Vascular Diseases | 1986 |
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
Topics: Aged; Arginine Vasopressin; Captopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Phentolamine; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction; Vasopressins | 1986 |
[Response to exertion after treatment with captopril in hypertensive patients with cardiac insufficiency of a mild degree].
Topics: Aged; Captopril; Female; Heart Failure; Heart Function Tests; Humans; Hypertension; Male; Middle Aged; Physical Exertion | 1986 |
Sodium and water balance in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Water; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Posture; Renin; Renin-Angiotensin System; Sodium; Vasoconstriction | 1986 |
Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Captopril; Cardiomyopathy, Dilated; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin | 1986 |
Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
Topics: Aged; Blood Pressure; Captopril; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Pulmonary Wedge Pressure; Vascular Resistance | 1986 |
[Effect of captopril in chronic aortic insufficiency].
Topics: Aortic Valve Insufficiency; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Renin | 1986 |
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
Topics: Arginine Vasopressin; Blood; Captopril; Heart Failure; Hemodynamics; Humans; Norepinephrine; Osmolar Concentration; Renin | 1986 |
[Clinical and hemodynamic effects of captopril in patients with chronic circulatory failure].
Topics: Adult; Aged; Captopril; Chronic Disease; Coronary Disease; Drug Evaluation; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1986 |
Long term captopril therapy in severe congestive heart failure.
Topics: Adult; Aged; Captopril; Heart Failure; Humans; Male; Middle Aged; Time Factors | 1986 |
Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failure.
Topics: Adolescent; Adult; Captopril; Cardiac Catheterization; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Imaging | 1986 |
Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Topics: Aged; Aged, 80 and over; Blood Pressure; Captopril; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance | 1986 |
ACE inhibitors or inotropic drugs after diuretics in heart failure--a personal critique.
Topics: Captopril; Cardiotonic Agents; Diuretics; Heart Failure; Humans; Quality of Life; Renin-Angiotensin System; Time Factors; Vasodilator Agents | 1986 |
Treatment of hyponatraemia with captopril.
Topics: Captopril; Heart Failure; Humans; Hyponatremia; Liver Diseases | 1986 |
Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure.
Topics: Animals; Blood Pressure; Captopril; Heart Failure; Longevity; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Stroke Volume | 1987 |
A correctable complication of advanced congestive heart failure.
Topics: Captopril; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Middle Aged; Sodium | 1987 |
[Efficacy of captopril in the treatment of patients with severe forms of chronic heart failure].
Topics: Captopril; Cardiac Glycosides; Diuretics; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Respiration | 1986 |
[Changes in peripheral hemodynamics and platelet aggregation during captopril treatment of patients with chronic circulatory failure].
Topics: Adolescent; Adult; Aged; Captopril; Chronic Disease; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Oxygen Consumption; Platelet Aggregation; Veins | 1986 |
Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
Topics: Adult; Captopril; Diuretics; Drug Therapy, Combination; Drug Tolerance; Edema; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Renin-Angiotensin System | 1987 |
Captopril therapy in heart failure.
Topics: Blood Pressure; Captopril; Heart Failure; Humans; Vasodilation | 1987 |
Captopril in congestive cardiac failure.
Topics: Adult; Aged; Captopril; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction | 1986 |
Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Proline; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Vascular Resistance | 1985 |
[Modification of organ perfusion by calcium blocker and converting enzyme inhibitor in the conscious rat with heart failure].
Topics: Animals; Benzazepines; Captopril; Coronary Circulation; Digestive System; Diltiazem; Heart Failure; Hemodynamics; Male; Muscles; Myocardial Infarction; Physical Exertion; Proline; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin | 1985 |
Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure.
Topics: Adult; Aged; Captopril; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Milrinone; Proline; Pyridones; Renal Circulation; Time Factors | 1985 |
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.
Topics: Animals; Captopril; Female; Heart Failure; Heart Ventricles; Myocardial Infarction; Proline; Rats; Rats, Inbred Strains; Time Factors | 1985 |
[Therapy and course of dilated cardiomyopathy].
Topics: Anti-Arrhythmia Agents; Captopril; Cardiomyopathy, Dilated; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1985 |
Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failure.
Topics: Aged; Captopril; Heart Failure; Hemodynamics; Humans; Kinetics; Middle Aged; Proline; Renin; Time Factors; Vascular Resistance | 1985 |
[Severe side-effects of captopril].
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Captopril; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Proline | 1985 |
Captopril-induced hyponatremia with irreversible neurologic damage.
Topics: Captopril; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Nervous System Diseases; Sodium; Thirst | 1985 |
[Lopril].
Topics: Captopril; Heart Failure; Humans; Hypertension | 1985 |
[Captopril in the treatment of refractory cardiac insufficiency].
Topics: Adult; Aged; Captopril; Chronic Disease; Diuresis; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Renin-Angiotensin System | 1985 |
Mixed venous blood temperature response to exercise in heart failure patients treated with short-term vasodilators.
Topics: Adult; Aged; Body Temperature; Captopril; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Minoxidil; Physical Exertion; Pulmonary Gas Exchange | 1985 |
Treatment of congestive heart failure by altering loading conditions of the heart.
Topics: Captopril; Cardiac Output; Child; Digoxin; Dopamine; Drug Therapy, Combination; Heart; Heart Failure; Humans; Hydralazine; Infant; Infant, Newborn; Nitroglycerin; Nitroprusside; Prazosin; Vasodilator Agents | 1985 |
[Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
Topics: Administration, Oral; Adolescent; Adult; Captopril; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Prazosin; Vasodilator Agents | 1985 |
[Classification and principles of the use of vasodilators in the treatment of left ventricular insufficiency].
Topics: Calcium Channel Blockers; Captopril; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Kinetics; Molsidomine; Nitroglycerin; Prognosis; Receptors, Adrenergic; Sydnones; Vasodilator Agents | 1985 |
Vasodilator therapy for chronic congestive heart failure.
Topics: Captopril; Cardiac Catheterization; Heart Failure; Hospitalization; Humans; Hydralazine; Myocardial Contraction; Nitrates; Nitroglycerin; Prazosin; Pressure; Vascular Resistance; Vasodilator Agents; Veins | 1985 |